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Abstract 
 
Cell migration and invasion is a central process in embryonic development, 
wound healing and immune responses. Errors during this process have 
serious consequences, including mental retardation, vascular disease, tumor 
formation and metastasis. An understanding of the mechanism by which cells 
migrate and invade may lead to the development of novel therapeutic 
strategies for controlling, for example, cancer metastasis. 
 
Fascin is an actin-bundling protein involved in filopodia assembly and cancer 
invasion and metastasis of multiple epithelial cancer types. In this thesis, I 
have investigated the role of fascin in invadopodia formation, which are 
invasive finger-like protrusions that cancer cells use to invade into and 
degrade extracellular matrix. I demonstrated that fascin and its actin bundling 
activity are required for the assembly of the actin cytoskeleton at invadopodia 
as well as for the degradation of matrix. Fascin is a very stable component of 
invadopodia and its presence enhance the stability of actin structures at 
invadopodia. Furthermore, fascin is required for invasive migration into 
collagen I-Matrigel gels particularly in cell types that use an elongated 
mesenchymal type of motility in 3D. These data provide a potential molecular 
mechanism for how fascin increases the invasiveness of cancer cells. 
 
During embryogenesis, melanoblasts proliferate and migrate ventrally through 
the developing dermis and epidermis as single cells. In the second part of this 
thesis, I examined the importance of small Rho GTPase Rac1 on melanoblast 
migration during development. I demonstrate that targeted deletion of Rac1 in 
the melanoblasts of developing mice causes defects in migration, cell cycle 
progression and cytokinesis.  Rac1 null cells migrate markedly less efficiently, 
but surprisingly global steering, crossing the dermal/epidermal junction 
and homing to hair follicles are normal.  Melanoblasts navigate in the 
epidermis using two classes of protrusion: short stubs and long pseudopods.  
Short stubs are driven by actin assembly, but unexpectedly are independent 
of Rac1, Arp2/3 complex, myosin or microtubules.  Rac1 positively regulates 
the frequency of initiation of long pseudopods, which promote migration speed 
and directional flexibility. Scar/WAVE and Arp2/3 complex drive actin 
assembly for long pseudopod extension, which is also microtubule dependent.  
Myosin contractility balances the extension of long pseudopods by effecting 
retraction and allowing force generation for movement through the complex 
3D epidermal environment. In addition, I demonstrated that expression of 
activated N-Ras did not affect migration and proliferation of melanoblast 
during embryogensis. However, Rac1 is required for constitutively active N-
Ras induced dermal melanocytes survival in mice.  
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1.1 Actin based cell motility 
1.1.1 2D Cell migration  
The directional migration of cancer cells largely relies on the actin 
cytoskeleton and its regulatory proteins, and indeed, cell motility genes are 
often found to be upregulated at certain stages during the metastasis 
progression (Machesky, 2008; Nürnberg et al., 2011). During migration on 2D 
surface, cells in response to an external signal, which leads to the generation 
of protrusions in the direction of migration such as lamellipodia and filopodia. 
In malignant cancer cells, another kind of actin-based protrusion termed 
invadopodia are generated from ventral surface of a cell and have proteolytic 
activity toward extracellular matrix (Figure 1.1). Within these protrusions, the 
actin cytoskeleton is dynamically remodelled into different kinds of protrusive 
structures that lie just beneath the plasma membrane and force generated by 
these protrusive structures pushes the plasma membrane forward which 
coupled with adhesion of this leading edge to the substrate drives cell 
migration.  
 
1.1.2 Actin polymerization 
The protrusive force of leading edge extension is generated by polymerization 
of globular actin (G-actin) subunits to form a double helical polymer called an 
actin filament (F-actin) (Pollard and Cooper, 2009). Based on the arrowhead-
like appearance created by decoration with the moter domain of myosin, one 
end is called the barbed end and the other the pointed end (Small et al., 
1978). The initial stage of actin polymerization is called nucleation. This 
process is a rate-limiting step due to the considerable instability of actin 
oligomers. Once the nucleus (trimer) is formed, actin polymerization proceeds 
quickly at the plus or barbed end and dissociation of actin monomers is 
favored at minus or pointed end (Bugyi and Carlier, 2010; Pollard and Cooper, 
2009). This kinetic asymmetry between the two ends is achieved by ATP 
hydrolysis. The ATP in actin filaments is hydrolyzed to ADP. Because the 
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between WAVE isoforms in lamellipodial actin regulation
(Kurisu S, 2005, unpublished observations).(12,54) This may be
simply due to higher expression levels of WAVE2, compared to
those of WAVE1 and WAVE3. Alternatively, it may be caused
by the higher affinity of WAVE2 for IRSp53, which preferen-
tially localizes and activates WAVE2 at the lamellipodial tips
(Fig. 3a). Therefore, inhibiting WAVE2 activity can discourage
cancer cells from showing a motile phenotype. Drugs that inter-
fere with WAVE2 activation may be promising therapy against
invasion and metastasis in cancer patients. Indeed, we have
shown that invasion and metastasis are effectively suppressed
when WAVE2 activity is inhibited in highly metastatic B16F10
cells.(12)
WASPs and WAVEs in 3D cancer cell invasion
Plasticity of cancer cell motility within the 3D ECM. Recently,
researchers have examined cancer motility in the 3D environ-
ment, which more closely mimics the in vivo cancer microenvi-
ronment than the 2D environment. One 3D observation strategy
is to implant cancer cells in live animals and directly observe
the cells under a microscope, which is sometimes called ‘‘intra-
vital imaging’’. Another technique is organotypic culture, in
which cancer cells are usually embedded in type I collagen gel
or in Matrigel, a mixture of ECM with similar constituents to
those of the basement membrane. Using these techniques, com-
bined with time-lapse fluorescent confocal microscopy, it has
been revealed that cancer cells show multiple ‘‘modes’’ of cell
migration in 3D.(56,57) There are at least three different modes
of migration: collective motility; elongated motility; and round-
shape motility (Fig. 2a,c,d). Collective motility, which refers to
cells moving in a group, is reported in organotypic cultures of
breast cancer, fibrosarcoma, melanoma, and squamous cell car-
cinoma cells.(58,59) From the histopathological resemblance
between human tumor samples and cultured cancer cells in 3D,
it is speculated that collective motility mimics the invasive
front of human tumors, although direct evidence of this is miss-
ing. The elongated and round-shape modes of motility describe
solitary cells that have departed from the primary tumor mass
through EMT or as a result of spontaneous cell–cell dissocia-
tion. Elongated motility is characterized by a bipolar spindle-
shaped morphology and dependence on protease activity for
migration. This type of motility is usually seen in cancers of
mesenchymal origin, such as glioma, fibrosarcoma, and mela-
noma, and in some aggressive carcinomas.(57,60,61) Round-
shape motility, which is in contrast characterized by a short
ellipsoid shape during cell movement and a relatively compro-
mised dependence on protease activity for migration, is
reported in some colon carcinoma and melanoma cells as well
as in non-neoplastic hematopoietic cells like lymphocytes and
neutrophils.(9,60,62) Importantly, some cancer cells can switch
their migration mode, and this plasticity is proposed to explain
why cancer cells continue to move even when one mode of
motility has been suppressed by pharmacological intervention.
Wolf et al.(57) first reported that a cocktail of protease inhibi-
tors triggers mode-shift from elongated to round-shape motility
in fibrosarcoma cells and in breast cancer cells, and they
assumed this switching mechanism might underlie the escape
pathway for cancers refractory to protease inhibitor-based
therapies.
Elongated motility versus round-shape motility from an actin
perspective. The actin morphology of migrating cells in 3D dif-
fers strikingly from that in 2D. Cells that have resumed elon-
gated motility no longer form broad lamellipodia at the leading
edge. Instead, they usually extend long finger-like protrusions
rich in F-actin, which here we call ‘‘pseudopodia’’ (Figs 2c).
(a) (b)
(c) (d)
Fig. 2. Multiple modes of cancer cell motility in 3D. (a) Cancer progression is illustrated from the standpoint of cell motility mode. A primary
tumor initially invades in a mode called collective migration. If cancer cells are released from a primary tumor mass and move as single cells, the
cells can adopt two modes of invasion, round-shape motility or elongated motility. EMT, epithelial-to-mesenchymal transition. (b) The actin
cytoskeleton of a two-dimensionally migrating cell. In 2D circumstances, characteristic actin structures (colored in red) are commonly seen in
many cell types. They generally form lamellipodia, filopodia, and stress fibers. In malignant cancer cells, invadopodia are sometimes evident as
large actin dots that show proteolytic activity around them. (c) The actin cytoskeleton in cells migrating in the elongated motility mode. The tip
contains dense actin networks and its biogenesis is dependent on Wiskott–Aldrich syndrome protein family verprolin-homologous protein and
actin-related protein 2 ⁄ 3 activities. (d) The actin cytoskeleton in cells migrating in the round-shape motility mode. Protrusions used for
migration are, in this case, membrane blebs. Both the formation and retraction of membrane blebs rely on actomyosin contractility.
Kurisu and Takenawa Cancer Sci | October 2010 | vol. 101 | no. 10 | 2097
ª 2010 Japanese Cancer Association
Figure 1.1 Actin-based structures in metazoan cells. 
A metazoan cell migrate on a 2D surface. Characteristic actin structures are commonly 
seen in many cell types. They generally form lamellipodia, filopodia, and stress fibers. 
whereas invadopodia are recognised as large actin dots. (B) side view of a cell, 
emphasizing that invadopodia are ventral. Figure adapted from (Kurisu and Takenawa, 
2010).
!
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 ADP-actin has lower binding affinity to the filaments end than ATP-actin and 
hydrolysis of ATP in the F-actin is irreversible, consequently, depolymerization 
is favoured at pointed end. Subsequently, ADP-actin monomers released from 
old filaments then undergo nucleotide exchange for next round of 
polymerization. Furthermore, because the barbed end of actin filaments face 
toward the cell plasma membrane, thus under cellular conditions, 
incorporation of new actin subunits at the barbed end provides mechanical 
force for the generation of membrane protrusions in migrating cells. In vivo, 
spontaneous formation of actin nuclei is disfavored due to the strong kinetic 
barrier and the large concentrations of monomer binding/sequestering 
proteins in cells (e.g. thymosin beta 4 and profilin). Therefore, F-actin 
polymerization is regulated by several actin nucleators from a number of 
different families and is assisted by various proteins that bind to actin 
monomers or to filament ends. 
 
1.1.3 Lamellipodia 
Actin powers protrusions by polymerizing just under the plasma membrane. 
One of the filament geometries is the formation of branched actin filaments, 
which lead to generation of sheet-like protrusions consist of highly branched 
short actin filaments at cell leading edge, termed lamellipodia, which are 
important in cell motility and cell spreading (Figure 1.2) (Nobes et al., 1995; 
Ridley et al., 1992). The major actin nucleator within lamellipodia is Arp2/3, an 
assembly of 7 subunits that include two actin related proteins Arp2 and Arp3 
and five non-Arp components, p41/ARPC1, p34/ARPC2, p21/ARPC3, 
p20/ARPC4 and p16/ARPC5, which was the first actin nucleation factor to be 
identified (Machesky et al., 1994). Arp2/3 complex binds to the preexisting 
‘mother’ filaments and promotes the formation of new ‘daughter’ filaments 
branching at a 70o angle from preexisting filaments.  Other regulators of actin 
dynamics at leading edge of lamellipodia include ADF/cofilin, which bind G-
actin monomers and depolymerize actin filaments through severing and 
increasing off-rate for actin monomers from the pointed end, thus maintain the 
G-actin monomer pool for polymerization at the plus end (McGough et al.,  
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Figure 1.2 The regulation of lamellipodia formation.
Simple schematic diagram of the regulation of actin polymerisation leading to lamellipodia 
formation. Scar/WAVE complex is recruited to the plasma membrane, possibly via the 
small GTPase Rac1 in response to a variety of signals. where it activates Arp2/3 complex 
to polymerize actin filaments at the free barbed ends off the sides of actin filaments near 
the plasma membrane. Branches grow and push against the plasma membrane. ADP 
bound actin filaments were depolymerized by binding of ADF/cofilin and actin monomers 
undergo a rapid cycling from ADP to ATP bound forms that is promoted by profilin. Rac or 
Cdc42 acts via group I Paks to stimulate LIMK, which inhibit cofilin-induced actin 
depolymerization, allowing increased accumulation of polymerized actin at the leading 
edge of cells.
PiP2
Capping proteins
Receptor tyrosine kinase
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1997). Other proteins include profilin, which binds and incorporates G-actin 
from the cytoplasmic pool to the growing barbed ends of the actin filaments. 
Capping protein, which binds to the barbed end of actin filaments. Capping 
protein restricts actin polymerization and affects the balance between 
branched and unbranched networks. Therefore, it optmizes the rate of motility 
by promoting more frequent filament nucleation by the Arp2/3 complex (Akin 
and Mullins, 2008; Dos Remedios et al., 2003; Le Clainche and Carlier, 2008). 
As Arp2/3 complex itself has little nucleation activity, nucleation-promoting 
factors (NPFs) are thus required to initiate a new actin filament via activation 
of Arp2/3 complex (Campellone and Welch, 2010). The main NPFs to activate 
Arp2/3 complex are the WASP family proteins, of which the best known are N-
WASP and SCAR/WAVE complex. SCAR/WAVE complex, which consists of 
five subunits (SCAR/WAVE, HSPC300, Abi, Nap1, and Cyfip) has been 
shown to be the major NPF to activate Arp2/3 complex in lamellipodia. 
SCAR/WAVE complex interacts with Arp2/3 complex and G-actin via 
Scar/WAVE verprolin central acidic domain (VCA) domain and this facilitates 
Arp2/3 catalytic activity (Insall and Machesky, 2009). SCAR/WAVE complex 
also acts as a scaffold that directly or indirectly link Arp2/3 complex activity to 
various regulatory proteins such as the Rho family of small GTPases. 
SCAR/WAVE complex interacts with the small GTPase Rac1 (described 
below) via Cyfip and it has been proposed to be recruited to the plasma 
membrane at sites of lamellipodial assembly by Rac1, thus allow signaling to 
catalyze rapid filament growth (Innocenti et al., 2004; Kunda et al., 2003). 
However, this dendritic branched network model of actin filament organization 
in the protruding lamellipodia is recurrently being challenged. Victor Small and 
colleagues used cryo-electron tomograms and negatively stained 
cytoskeletons to visulaise actin networks in the lamellipodia in frozen 'live' 
cells (Urban et al., 2010). They demonstrate that actin filaments at the leading 
edge diverge at various angles and are unbranched. The authors propose a 
new model for lamellipodial protrusion and suggest that Arp2/3 nucleates 
actin filaments on the membrane and rides on the filament pointed end after 
nucleation initiated by WAVE complex until being released and recycled at the 
lamellipodium tip. They propose that tetramers of VASP, a barbed end binding 
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protein that can compete with capping protein, mediates elongation of long 
unbranched filaments adjacent to the plasma membrane (Urban et al., 2010). 
 
1.1.4 Filopodia 
In addition to lamellipodia, filopodia are slender cytoplasmic projections that 
extend beyond the leading edge of lamellipodia in migrating cells. They are 
made up of bundles of parallel actin filaments, which grow at the tip end 
(Oldenbourg et al., 2000). They can form focal adhesions with the substratum 
and are believed to function as directional sensors (Zheng et al., 1996). 
Earlier work suggested that N-WASP localizes to filopodia and that activation 
of N-WASP by the small Rho GTPase Cdc42 leads to filopodia formation 
(Nobes et al., 1995; Stradal et al., 2004). Thus, it has been proposed that 
filopodia are generated by the reorganization of an Arp2/3 complex generated 
actin network (Figure 1.3). Proteins that mediate filament elongation such as 
VASP and formins bind to actin filaments in lamellipodia and come together to 
form a filopodial tip complex that elongates a group of actin filaments (Figure 
1.3) (Gupton and Gertler, 2007). The filopodial tip complex initiates filament 
cross-linking by recruiting and activating fascin (described below), which then 
allows the bundling process to keep pace with elongation and guarantees 
efficient pushing which then forming a filopodium. However, deletion of N-
WASP does not inhibit filopodia formation (Snapper et al., 2001). 
Furthermore, inhibition of Arp2/3 or WAVE complex only minimally affects 
filopodial protrusion (Steffen et al., 2006) . In addition, a recent study reported 
filopodia formation in Cdc42-/- fibroblastoid cells (Czuchra et al., 2005), but 
another paper disputes this and demonstrates a crtitical role for Cdc42 in 
filopodia formation in mouse embryonic fibroblast (Yang et al., 2006). 
Alternatively, it is proposed that filopodia are initiated by de novo nucleation of 
actin filaments presumably close to the plasma membrane, driven by the 
action of formins, which have been localised to filopodia tips for generating 
unbranched actin filaments (Gupton and Gertler, 2007). These assemblies of 
parallel nascent filopodial actin filaments are cross-linked by actin-bundling  
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Figure 1.3 The regulation of filopodia formation.
Simple schematic diagram of the regulation of actin polymerisation leading to filopodia 
formation. (A) A subset actin filaments of the ARP2/3 ceomplex nucleated dendritic network 
are targeted for continued elongation by the formin and/or by ENA/VASP proteins. Formin also 
nucleates the formation of new, unbranched actin filaments. ENA/VASP proteins can also 
function as initial F-actin-crosslinking proteins in the tip of an elongating filopodium. (B) The 
incorporation of the actin crosslinking protein fascin in the shaft of the filopodium generates a 
stiff actin filament bundle. Formins and/or by ENA/VASP are localized in the 'tip complex' and 
controls the barbed-end elongation of the filaments.
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proteins for force generation.  
 
1.1.5 Invadopodia 
1.1.5.1 Introduction to Invadopodia 
Invadopodia are finger like protrusions especially formed in invasive, tumoral, 
or transformed cells when they are grown on a thin layer of ECM (eg. gelatin 
or fibronectin). Invadopodia are observed as proteolytcally active protrusions 
that extend from the ventral surface of the cell, into the surrounding matrix, 
cause the focal pericellular degradation of ECM (Figure 1.4A). Invadopodia 
have highly dynamic actin that resembles actin comets when viewed with 
GFP-actin in time lapse (Baldassarre et al., 2006). Invadopodia are normally 
close to the nucleus and proximal to the Golgi complex (Baldassarre et al., 
2003). At ultrastructural level, invadopodia have been suggested to be large 
convolutions of cell membrane with long membrane extensions into the 
matrix, and these protrusions originate from the larger invagination at the 
ventral surface of cell with diameters range from hundreds of nm to a few µm 
(Baldassarre et al., 2003; Bowden et al., 1999). Under the fluoresce 
microscope, invadopodia appear as actin-rich formations with underlying 
holes of ECM degradation, and by using this kind of assay, several actin 
associated proteins, some special proteases and other cellular components 
are identified to be important for the formation of invadopodia over the past 
decade.  
 
1.1.5.2 Regulation of invadopodia formation 
Previous studies have implicated the N-WASP-Arp2/3-cortactin-dynamin2 
complex as a key player in invadopodia formation (Figure 1.4B) (Artym et al., 
2006; Ayala et al., 2008; Baldassarre et al., 2003; Buccione et al., 2004; 
Gimona and Buccione, 2006). Interestingly, only N-WASP, but not WAVE 
proteins were identified within invadopodia (Lorenz et al., 2004; Yamaguchi 
and Condeelis, 2007; Yamaguchi et al., 2005). In addition, expression of  
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Figure 1.4 The regulation of invadopodia formation. 
(A) MDA-MB-231 human breast adenocarcinoma cells cultured on Alexa594-gelatin coated 
glass coverslips were stained with Alexa488-phalloidin. Bottom images are XZ sections 
showing a cell with an invadopodium collected with a confocal microscope. Invadopodia and 
gelatin degradation were white arrowed. (B) Schematic diagram showing tumour cell with 
formation of invadopodia on a film of crosslinked gelatin. Degradation of gelatin by 
invadopodia-associated MT1-MMP results in the formation of fluorescence negative cavities 
beneath cells that can be visualised by confocal fluorescence microscopy.  Invadopodia are 
enriched with actin branches regulated by N-WASP, Arp2/3 complex and cortactin. Figure B 
adapted from (Stylli et al., 2008).
!
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dominant-active mutant of Cdc42 or Rac enhanced dot-like and diffused 
fibronectin degradation respectively in RPMI17951 melanoma cells (Nakahara 
et al., 2003). N-WASP drives formation of branched actin assembly via 
activation of the Arp2/3 complex. Expression of a truncated “dominant-
negative” N-WASP strongly inhibited formation of invadopodia as well as ECM 
degradation (Mizutani et al., 2002). Cortactin and dynamin-2 may function as 
scaffolds to bring together a multifunctional protein complex, such as Arp2/3 
complex and N-WASP, to coordinate cortical actin assembly/disassembly and 
protease secretion in a highly polarized manner (Artym et al., 2006; Clark and 
Weaver, 2008; Clark et al., 2007). Cortactin is a Src substrate that interacts 
with F-actin and can stimulate actin polymerization by direct interaction with 
the Arp2/3 complex. Cortactin is frequently used as a marker of invadopodia, 
due to its strong localization to these structures. Furthermore, research using 
live cell imaging to study the dynamics of invadopodia formation suggested 
that cortactin localization marks the early stage of invadopodia assembly 
(Artym et al., 2006). Furthermore, invadopodia are sites of tyrosine 
phosphorylation and require Src kinase signaling (Bowden et al., 2006). 
Adhesion receptors including many kinds of integrins and CD44, are also 
found enriched at invadopodia (Mueller et al., 1999). However, proteins that 
are important in focal adhesion complexes, such as vinculin, are not localized 
at invadopodia, indicating the specialized role of integrins at invadopodia 
compared with their function in focal adhesion complexes (Machesky, 2008). 
Notably, consistent with their matrix degradation activity, invadopodia are 
enriched in soluble proteases, such as MMP2, MMP9 and transmembrane 
metalloproteinases MT1-MMP (Clark and Weaver, 2008). Live-cell imaging 
showed that the ECM degradation happened almost simultaneously with the 
recruitment of MT1-MMP to the sites of invadopodia (Artym et al., 2006). 
There also must be a mechanism for the trafficking of proteases to the cell 
surface at invadopodia. Indeed, a potential mechanism for MMP delivery to 
invadopodia has emerged recently with the discovery of the role of the 
exocyst complex and SNARE proteins in MT1-MMP trafficking and 
invadopodia formation (Liu et al., 2009; Poincloux et al., 2009; Sakurai-Yageta 
et al., 2008; Steffen et al., 2008). 
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It has become now accepted that invadopodia initiation is due to engagement 
of cell surface integrins by substrate components. This was shown first for 
α5β1 and α3β1 integrins (Mueller et al., 1999), despite the specific integrin 
combination might be cell-type dependent. α3β1 integrin activation can 
promote Src dependent tyrosine phosphorylation of p190RhoGAP (Nakahara 
et al., 1998), which in turn affected the actin cytoskeleton, through the Rho 
family GTPases, thus activating membrane-protrusive and proteolytic activity, 
leading to invadopodia formation and cell invasion.  
The actin filament organization during the formation of invadopodia, however, 
is still not clear, it may be possible that a precursor structure containing the N-
WASP-Arp2/3-cortactin-dynamin2 complex results on the formation of a small 
branched actin network (Artym et al., 2006). The later development of 
invadopodia may involve both the insertion of new membrane material into the 
plasma membrane as suggested by the close spatial relationship between the 
Golgi complex and invadopodia, and also actin polymerization (Baldassarre et 
al., 2003). There are two possibilities regarding to the growth of actin-rich core 
in the invadopodia (Linder, 2007; Vignjevic and Montagnac, 2008). The first 
possibility is the continued growth of branched actin network initiated by the 
N-WASP and Arp2/3 complex though the whole invadopodia. The second 
possibility could be a process resembling the convergent growth of filopodia. 
This may involve the recruitment of actin bundling proteins, such as fascin, to 
crosslink the actin filaments that extend from the branched actin networks into 
bundles to push the plasma membrane. The latter possibility is supported by 
the observation that N-WASP was only active at the base of invadopodia 
(Lorenz et al., 2004), and Ena/VASP and diaphanous related formins mDia2 
are required for invadopodia formation (Lizárraga et al., 2009; Philippar et al., 
2008). 
The correlation between invadopodia and structures found when cancer cells 
invade in a 3D matrix is not yet well understood. Recent studies showed that 
during initial step of metastasis, invasive cancer cells use invadopodia 
degrade a holes as they force through the basement membrane using a 
machinery based on Arp2/3 nucleated actin assembly and N-WASP-cortactin 
in a 3D experimental setting (Hotary et al., 2006; Schoumacher et al., 2010).  
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1.1.6 Podosomes 
Podosomes were first identified within monocytic cells such as macrophages, 
dendritic cells and osteoclasts (Marchisio et al., 1984).  Similar to 
invadopodia, podosomes also present as dot-like structures at the ventral cell 
surface, which are enriched in F-actin, (N-)WASP, Arp2/3 complex and 
cortactin (Buccione et al., 2004). The presence of actin polymerization 
proteins such as Arp2/3 complex and WASP differentiate podosomes from 
focal adhesions (Marchisio et al., 1988). Podosomes also show a ring 
consisting of adhesion plaque proteins such as paxillin, vinculin, talin, α-
actinin, Src, and tyrosine-phosphorylated proteins surrounding the actin cores. 
The ultrastructure of dentritic cell podosome is recently been solved by 
transmission electron microscopy (Gawden-Bone et al., 2010), which contain 
actin foci surrounded by a specialised ring region that is rich in material 
containing paxillin, thus confirm the light microscopy data. In contrast, 
invadopodia seem to lack these ring structures (Gimona et al., 2008). 
Typically, cells form numerous (20-100) podosomes of roughly uniform size 
(1-2 µm diameter), but only few (1-10) invadopodia of varying size. In 
addition, podosomes are rapidly turned over, as fast as 2-4 mins whereas 
invadapodia are thought to be longer lived, can extend up to over 1 h (Linder, 
2007). Podosomes are able to form widespread but only shallow zones of 
degradation, probably through their high number and fast turnover. In 
contrast, the longer-lived invadopodia form more aggressive, deeper matrix 
degradation. Little is known about the precise function of podosomes. In 
myeloid cells, podosomes are necessary for directional movement and trans-
cellular diapedesis at sites of inflammation (Calle et al., 2006). In osteoclasts, 
podosomes are thought to aid in the creation of sealing rings associated with 
the area of bone resorption. A role in adhesion is considered due to the 
similarities between podosomes and focal adhesions. The dynamic nature of 
podosomes suggested that they might transfer membrane tension along the 
substrate, as the lamellipodium extends forwards (Buccione et al., 2004).  
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1.1.7 3D Cell migration: Mesenchymal vs Amoeboid 
1.1.7.1 Introduction to 3D cell migration 
Tumour cell invasion occurs in 3 dimensions. The behavior of cells in 3D has 
been studied within reconstituted extracellular matrices such as collagen and 
matrigel. Tumour cells can migrate using both actin-based protrusions and 
myosin-based contractile activities in 3D (Sahai, 2005; Wolf et al., 2003a), 
which have been described as mesenchymal type motility and amoeboid type 
motility (Figure 1.5). 
 
1.1.7.2 Mesenchymal type motility 
Mesenchymal cell migration as used by MDA-MB-231 carcinoma cells or 
HT1080 fibrosarcoma cells (Wolf et al., 2007), involves a long and narrow 
morphology aligned with the direction of migration. Mesenchymal cells move 
by the formation of actin-rich pseudopodia at the leading edge, driven by Rho 
GTPases Rac and Cdc42. Rac activity is required for protrusive actin 
polymerization and Cdc42 is important in defining polarity, largely through its 
positioning of the microtubule-organising centre between the nucleus and the 
leading edge. In addition, integrin clusters attach to the ECM and matrix 
metalloprotease activity is required for ECM degradation and navigating the 
cell through dense matrix (Friedl and Wolf, 2003). 
  
1.1.7.3 Ameoboid type motility 
Cells moving in an amoeboid mode, such as MTLn3 rat mammary 
adenocarcinoma and A375MM human melanoma cells (Sanz-Moreno et al., 
2008; Wyckoff et al., 2006), are more rounded and more reliant on Rho and 
ROCK activity and acto-myosin contraction to remodel the cytoskeleton and 
propel them through gaps between matrix fibres. Cell using ameoboid type of 
migration normally squeeze through existing gaps in the ECM without 
clustering integrins or concentrating proteinases to sites of adhesion (Wolf et  
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Figure 1.5 Reciprocal regulation between Rho and Rac during mesenchymal or 
amoeboid motility styles. 
Rac, which drives oriented mesenchymal motility, leading edge protrusion and lamellipodia 
formation. Mesenchymal cells also use integrins to actively contact the ECM and use MMP to 
proteolytically degrade ECM to generate path for migration. Rho activation is responsible for 
amoeboid motility, a non-oriented movement which enables the cell to squeeze between gaps 
of ECM, which is integrin and MMP independent. mesenchymal or amoeboid motility are 
interchangable. Activated RhoA is able to inhibit Rac through the ARHGAP2, while Rac1 
activates WAVE2 which in turn inhibits RhoA. Figure adapted from (Wolf et al., 2003).
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al., 2003a), indicating that amoeboid type migration is ECM degradation 
independent (Sahai and Marshall, 2003; Wolf et al., 2003a). This is similar to 
the mechanism used by lymphocyte (Wolf et al., 2003b). In addition, The low 
levels of attachments to ECM made by amoeboid cells is believed to allow 
them to move faster through 3D environments than their mesenchymal 
counterparts (Paňková et al., 2010)  
 
1.1.7.4 Regulation of mesenchymal and ameoboid type motility 
It has been shown that tumour cells can invade using either amoeboid or 
mesenchymal type of movement, interchanging between the two depending 
on the up or down regulation of specific molecular pathways governing the 
mode of motility (Figure 1.5). For instance, activation of the Rac through a 
complex containing adaptor molecule NEDD9 and a Rac GEF DOCK3 is 
required for mesenchymal migration in A375MM cells. Rac signals through 
WAVE2 to direct mesenchymal movement and suppress amoeboid 
movement through decreasing myosin light chain phosphorylaton (Sanz-
Moreno et al., 2008). It has also recently been proposed that Rab5 may play a 
role in the process of amoeboid to mesenchymal transition of cancer cells by 
influence the trafficking of Rac (Palamidessi et al., 2008). Conversely, in 
amoeboid movement, Rho-kinase signaling activates a Rac GAP, 
ARHGAP22, which inactivate Rac and suppress mesenchymal movement 
(Sanz-Moreno et al., 2008). In addition, a Cdc42 GEF DOCK10 and 
expression of dominant active Cdc42 can enhance the amoeboid migration 
and cell invasion by suppress Rac activity. Furthermore, the Cdc42 effectors 
N-WASP and Pak2 are required for the maintenance of the rounded-
amoeboid phenotype in melanoma cells (Gadea et al., 2008). However, 
blocking Cdc42 also results in loss of mesenchymal morphology, suggest that 
Cdc42 is also involved in mesenchymal morphology.  
 
When mesenchymal HT1080 and MDA-MB-231 cells were subject to 
protease inhibitors in 3D collagen matrix, they changed from mesenchymal 
morphology to amoeboid morphology (Wolf et al., 2003a). It is likely that 
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tumour cells can compensate to environmental factors by change the style of 
migration through different activation and effectors pathways.  
 
1.2 Cancer metastasis  
1.2.1 Metastasis is a multifaceted process 
Metastasis is the ability of cancer cells to spread from their tissue of origin to 
other parts of the body via the bloodstream or the lymphatic system. It is a 
critical step in cancer progression and is a major cause of human cancer 
death (Sporn, 1997). Metastatic development is a multi-step process involving 
the acquisition of invasive behaviour, escape from the primary tumour, 
invasion into the surrounding tissue, transit in the circulatory system, and 
finally the establishment of secondary tumours at new sites (Figure 1.6) 
(Chambers et al., 2002). A primary step in the metastatic cascade is the 
detachment of cancer cells from a solid tumour mass, which is mediated by 
their decreased adhesive potential and dedifferentiation of epithelial cells 
toward a mesenchymal state. This process is termed epithelial-mesenchymal 
transition (EMT) (Thiery et al., 2009).  One of the most important changes 
during this process is the down-regulation of E-cadherin, which under normal 
circumstances provides a bridge between adjacent epithelial cells and serves 
as a scaffold for anti-growth signalling to its downstream effectors such as β-
catenin and TCF transcription factor (Christofori and Semb, 1999). As cell-cell 
junction proteins are suppressed, individual epithelial cancer cells start to 
separate from other cells that normally form a sheet-like structure. These cells 
become more elongated fibroblast-like and gain invasive features such as the 
up regulation of N-cadherin, fibronectin, metalloproteinases, and decrease in 
the abundance of protease inhibitors and altered expression of intergrins that 
preferentially bind the degraded stromal components produced by 
extracellular proteases (Lozano et al., 2003). Therefore, cells become 
differently polarised and rearrange their actin cytoskeleton with the formation 
of specific membrane protrusions. Matrix-degrading proteases are secreted at 
cell at leading edge to allow the cell to degrade and navigate through the 
basement membrane and extracellular matrix. Cancer cells get into the blood 
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Figure 1.6 The main steps in the formation of a metastasis. Formation of 
metastases is a multistep process, involving loss of differentiation, enhanced 
proliferation and angiogensis. The active invasion of a subset of cancer cells then 
escape the primary tumour through the surrounding matrix, enter the circulation which 
they travel to the distant sites of the body, where they extravasate to populate new 
niches and form secondary lesions. Figure adapted from (Bacac and Stamenkovic, 
2008).
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Figure 1
Principal steps in metastasis. Transformatio of normal epithelial cells leads to c rcinoma in situ, which,
as a result of loss of adherens junctions, evolves toward the invasive carcinoma stage. Following basement
membrane degradation, tumor cells invade the surrounding stroma, migrate and intravasate into blood or
lymph vessels, and become transported until they arrest in the capillaries of a distant organ.
their microenvironment to metastasize and
that t ey even rely on host tissue stromal cells
to provide functions, such as a diversity of
proteolytic activity, that they themselves may
lack. Understanding tumor-host interactions
may therefore provide a key to understanding
metastasis. A more recently emerging view,
based on gene expression profile analysis of
diverse primary and metastatic tumors, is
that metastatic cells may constitute part of
the early makeup of a malignant tumor. This
review highlights our current understanding
of tumor cell properties and host tissue
responses whose combination culminates in
cancer metastasis and discusses the origin of
metastatic cells in light of recent observations.
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 vessel via process called intravasation. Once trapped in the vessel, cancer 
cells must be able to avoid anoikis (A form of programmed cell death which is 
induced by anchorage-dependent cells detaching from the surrounding ECM), 
oppose hydrostatic shear forces that could lead to physical damage and they 
also need to evade being targeted by immune surveillance probably via 
interaction with platelets, lymphocytes and other blood cells. As only a few 
cancer cells can finally survive and be able to escape from the vasculature via 
process called extravasation. This process requires adherence and invasion 
through endothelium and basement membrane into the new tissue. Surviving 
cancer cells can either undergo proliferation within the blood vessel to form a 
small tumour that can then physically disrupt the endothelium or, probably 
following leukocytes in a process similar to diapedesis (a process that 
leukocytes secrete proteases to degrade the basement membrane and 
allowing them to escape from the blood vessel) to eventually invade into the 
new tissue to establish growth as a metastasis. Within the new tissue, 
metastatic tumor cells will frequently undergo reversion from a mesenchymal 
phenotype back to something that is more similar to the original tumor.  
 
1.2.2 Cell migration and invasion in cancer metastasis 
Cell migration and invasion are required at multiple steps of metastasis – 
during invasion through the basement membrane and extracellular matrix 
toward blood or lymphatic vessels, into and out of a vascular or lymphatic 
vessel, and invading into the new tissue in distant organs. In addition, they are 
also important in many physiological events such as embryogenesis, 
morphogenesis, neurogenesis, angiogenesis, wound healing and 
inflammation. For instance, during embryogenesis, the directed migration of 
highly motile neural crest cells involves modulation of expression of the cell-
cell adhesion molecule cadherin (Kuriyama and Mayor, 2008). Such change is 
commonly seen in invasive cancer cells undergo EMT and a lack of cadherins 
correlates with cancer cells that start to migrate. In addition, invasion is critical 
for leukocytes transmigrate through the endothelial cell layer from the 
bloodstream to invade to the sites of infection during inflammation (Madri and 
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Graesser, 2000). Moreover, the cellular similarities between wound healing 
and tumor cell invasion have been noted for some time and recent 
comparison of gene expression between these two cellular process further 
confirm these similarities at genetic level (Chang et al., 2004; Pedersen et al., 
2003). Therefore, tumor cell migration and invasion are believed to be 
processes where normal cellular behaviors occur in a mis-regulated manner 
and in an inappropriate context.  
 
1.3 Fascin: the actin bundling protein 
1.3.1 Introduction to fascin  
Fascin was originally characterized as a 55kDa actin-binding and bundling 
protein purified from extracts of sea urchin oocytes and coelomocytes and is 
later found to be highly conserved throughout evolution with the identification 
of orthologues in a number of other species, including the related Drosophila 
singed protein (Bryan et al., 1993; Kane, 1975). Fascin is an actin cross-
linking protein, which bundles adjacent actin filaments using two actin-binding 
sites located at N- and C-terminus of the proteins. Fascin is found in 
membrane ruffles, microspikes, and stress fibers and is important for the 
assembly of filopodia.  It localises along the length of filopodia and regulates 
the formation and dynamics of actin bundles (Vignjevic et al., 2006; Vignjevic 
et al., 2003). 
 
1.3.2 Strcuture of fascin 
The mammalian genome encodes 3 isoforms of fascin. Fascin 1 (The isoform 
studied in this thesis) is widely expressed in mesenchymal and nervous 
tissues (De Arcangelis et al., 2004). Fascin 2 is specifically expressed in 
retina and ear hair cell stereocilia (Chou et al., 2011; Shin et al., 1999; Wada 
et al., 2003; Wada et al., 2001), whereas fascin 3 is expressed only in testis 
(Tubb et al., 2002). The structure of fascin is unique among actin binding 
proteins.  Fascin has four β-trefoil folds, with each β-trefoil comprising six two-
	   42	  
stranded β-hairpins. Previous mutagenesis studies indicate that the actin-
binding sites are located at the amino terminus in the first beta-trefil domain 
between aa33–47, and the other lies between aa277–493 (Figure 1.7) (Cant 
and Cooley, 1996; Ono et al., 1997). The recent structural analysis, however, 
implicated that the N and C termini constitute one of the actin-binding sites 
with both termini located in the same cleft. A stretch of residues (29–42) at the 
N-terminus has similarity to an actin-binding site of MARCKS and also faces 
the trefoil 1–4 cleft suggesting that this cleft represents one of the actin-
binding sites (Chen et al., 2010). It has also been proposed that F-actin 
binding in this cleft between trefoils 1 and 4 could induce a conformational 
change at the opposite end of fascin, between trefoils 2 and 3, that might alter 
the actin-binding activity and result in cooperative binding to F-actin (Sedeh et 
al., 2010). 
 
1.3.3 Expression and regulation of fascin 
Fascin is principally expressed in nervous system, somites and mesenchyme 
during mammalian embryonic development (De Arcangelis et al., 2004). In 
adult human tissues, fascin is expressed in vascular endothelial cells, 
neuronal cells, and fibroblasts as well as dendritic cells but is not expressed in 
most normal epithelia (Zhang et al., 2008). Fascin is upregulated both at 
mRNA and protein level in many different types of cancers, including colon, 
prostate, breast, stomach and oral squamous cell carcinoma (Machesky and 
Li, 2010).  In colon cancer, fascin is identified as a downstream target of β-
catenin-TCF signaling and is preferentially expressed at the invasive fronts of 
tumors and is thought to be upregulated only during the active phase of 
metastasis and then downregulated again when a new metastasis is 
established as a tumor (Vignjevic et al., 2007).  However, a recent detailed 
promoter analysis has revealed that fascin expression levels are regulated by 
the CREB and AhR transcription factors, but did not support a specific role for 
β-catenin regulation of expression in fascin positive carcinoma cells 
(Hashimoto et al., 2009). How this may be related to increased expression in 
cancers is not yet understood. Interestingly, recent studies demonstrate that 
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Figure 1.7 Fascin strcuture. 
Schematic representation of fascin: !-trefoil domains 1–4 and binding partners and the 
domains involved on interactions. Mutantions on residues marked with star lead to the loss of 
binding with each partner.
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 fascin mRNA is negatively regulated by miRNA 145 both in normal 
(Quintavalle et al., 2010) and cancer cells (Chiyomaru et al., 2010; Kano et 
al., 2010), suggesting a new source of regulation of fascin at the 
transcriptional level.  
In addition to actin, fascin also binds to several other proteins that can 
regulate its activity. Fascin binds directly to PKC and is a substrate for PKC 
phosphorylation on serine 39 (S39), this turns off the actin bundling activity via 
the actin binding site at the N-terminus (Figure 1.7 and 1.8) (Ono et al., 1997). 
FRET/FLIM revealed the interaction of fascin and active PKC within 
protrusions and filopodia of migrating cells and this complex is regulated by 
the activity of the small GTPase Rac via Pak (Parsons and Adams, 2008). 
Interestingly, recent studies indicated that phosphorylation of fascin negatively 
correlated with the poor survival in patients with esophageal squamous cell 
carcinoma; this suggests the importance of fascin S39 phosphorylation in 
cancer progression (Zhao et al., 2010). Extracellular signals and ECM 
components can also regulate the phosphorylation status of fascin in cells and 
thus affect its actin bundling propensity (Figure 1.8) (Adams, 2004a; Kureishy 
et al., 2002) . In Drosophila, fascin homologue singed binds directly to the 
small GTPase Rab35 that is known to be involved in intracellular vesicle 
trafficking. Rab35 is postulated to recruit and activate fascin to sites of actin 
assembly, and this is dependent upon both GTP-bound Rab35 and fascin S39 
phosphorylation status (Figure 1.8) (Zhang et al., 2009). A recent study 
showed that the bacterial macrolide compound migrastatin, which is an 
organic compound which naturally occurs in the Streptomyces platensis 
bacteria, have shown to have potential in treating cancer, as it inhibits the 
metastasis of cancer cells (Shan et al., 2005). More recently, macroketone, 
the synthetic substance based on the fourteen-membered lactone ring found 
in the bacterial antibiotic migrastatin, have been shown bind to one of the 
actin-binding sites on fascin and therefore inhibit fascin activity and tumour 
cell metastasis in vivo (Chen et al., 2010a).  
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Figure 1.8 Regulation of fascin. 
Schematic representation of regulation of fascin activity and its role in cytoskeletal 
reorganization and cell motility.  ECM components control fascin-based protrusions. TSP and 
laminin acts through syndecan-1 and !3"1 integrins to promote the bundling of F-actin by 
fascin. Fascin interaction with GTP bound Rab35 is required for trafficking and localization of 
fascin. In contrast, ligation of !5"1 integrins by fibronectin disfavors fascin protrusions by 
activating Rac which acts via Pak1 to increase the content of S39- phosphorylated fascin as a 
result of PKC activity, and modulates the assembly of focal adhesions as a result of the 
interaction of S39-phosphorylated fascin-1 with the regulatory domain of PKC. How 
dephosphorylation of S39 is regulated is unknown. 
P
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1.3.4 Biological function of fascin 
Fascin has an important role in filopodia formation and dynamics (Jayo and 
Parsons, 2010) and in biochemical experiments it forms very stable actin 
bundles and displays slow dissociation kinetics (Aratyn et al., 2007).  Fascin 
forms both polarized parallel bundles and side-branched actin structures in 
vitro, which agrees with its localization in both lamellipodia and filopodia of 
cells (Tseng et al., 2001).  Depletion of fascin in B16 melanoma cells or 
human colon carcinoma cells led to a loss of filopodial protrusions (Vignjevic 
et al., 2006; Vignjevic et al., 2007).  Depletion of fascin in colon carcinoma 
SW480 cells also led to a decrease in migration and a reduction in focal 
adhesion dynamics (Hashimoto et al., 2007).  In glioma cells, fascin 
knockdown decreased migration and transwell invasion of cells and 
decreased invasion into brain slices ex-vivo (Hwang et al., 2008). Fascin 
expression has been shown to correlate with tumor growth and metastasis in 
a few studies.  Hashimoto et al. found that fascin knockdown significantly 
reduced tumour growth and metastasis in sub-cutaneous xenografts of 
SW480 colon cancer cells (Hashimoto et al., 2007).  Another recent study 
showed that fascin knockdown reduced the metastasis and tumor growth of 
DU145 cells implanted in the prostate of Severe comined immunodenficient 
(SCID) mice and high fascin expression correlated with a low probability of 
disease-free survival (Darnel et al., 2009).  Expression of fascin in HT29 colon 
cancer cells also increased the formation of lung tumours following tail vein 
injection of SCID mice (Vignjevic et al., 2007). Fascin localises to the actin-
rich core of podosomes in smooth muscle cells where it promotes adhesion 
stability and migration (Quintavalle et al., 2010). Conversely, more recent 
study using fascin1-null mature dendritic cells showed that fascin is required 
for podosomes disassembly, suggesting a cell type specific role of fascin in 
regulating podosome formation (Yamakita et al., 2011).  
Surprisingly, fascin deficient mice were recently shown to be viable and fertile 
with no gross developmental abnormalities other than minor defects in 
neuronal cell behaviour (Yamakita et al., 2009). In addition, Fascin-1 null 
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fibroblasts protruded filopodia about half as often as normal fibroblasts and 
those filopodia were shorter and had a shorter lifespan (Yamakita et al., 
2009), suggest that fascin is not essential for filopodia formation, but may be 
more important for filopodia stabilization.  
Conversely, the Drosophila singed mutant animals are female sterile and 
display aberrant assembly of F-actin-rich structures during bristle extension, 
which also depend on Rab35 to localize fascin to specific subcellular sites for 
F-actin bundling (Zhang et al., 2009). In addition, fascin is required for 
polarization and migration of the Drosophila macrophage equivalent cells, 
hemocytes (Zanet et al., 2009). Fascin localised to and stabilize dynamic 
actin-rich microspikes within hemocytes during migration. Interestingly, the 
highly conserved PKC substrate serine site in the N-terminus (S52 in 
drosophila) was not required for motility in vivo, suggest other regulatory 
mechanisms upstream of fascin may exist in different organisms. 
 
1.4 Rac and Rho family GTPase 
1.4.1 Introduction to Rho GTPase 
The Rho family GTPase comprises a subset of the larger Ras superfamily of 
small GTPases. Small GTPases are generally 20-25 kDa signalling 
molecules, which act as molecular switches and involved in multiple signaling 
pathways leading to cell adhesion, migration proliferation and transformation 
(Wennerberg et al., 2005). There are approximately 20 members of the Rho 
family that can be divided into 6 subgroups base on their amino acid 
sequence identity, structural motifs and biological functions (Figure 1.9) 
(Heasman and Ridley, 2008; Wherlock and Mellor, 2002). The most 
extensively characterized members of Rho family GTPas are Cdc42, Rac1 
and RhoA. Their roles on actin cytoskeleton have been demostrated via 
microinjection of active forms (Hall, 1998). This has led to the identification 
that Rho GTPases play an important role in filopodia, lamellipodia, and stress 
fibre formation respectively in different type of cells.  
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growth24. How the loss of CDC42 in mouse neurons 
leads to increased cofilin phosphorylation remains 
unknown. It is unlikely that CDC42 affects cofilin 
through changes in RAC1 or Rho signalling, as RAC1 
activity is not affected in CDC42-null neurons and the 
addition of Rho inhibitors did not rescue their pheno-
type13. It is possible that it occurs through an indirect 
upregulation of another Rho GTPase, such as RhoQ or 
RhoJ (FIG. 1), or deregulation of a cofilin phosphatase. 
Together, these data point to a new link between CDC42 
and cofilin in axon extension.
Axon myelination. A novel function for CDC42 has 
been suggested by studies of glial cells, which wrap mul-
tiple layers of their plasma membrane around axons to 
form myelin25. In oligodendrocytes — the glial cells of the 
central nervous system — myelin sheaths are thinner in 
the absence of CDC42, which seems to be the result of 
a defect in removing cytoplasm as the oligodendrocyte 
plasma membranes wrap around the axon26. Although 
the mechanistic basis for this phenotype is unknown, it 
is possible that CDC42-driven cortical actomyosin con-
traction could push cytoplasm out as the membranes 
extend around the axon. Schwann cells — the glial cells 
of the peripheral nervous system — that lack CDC42 are 
also defective in axon myelination. However, CDC42 is 
required for Schwann-cell proliferation, which precludes 
analysis of the role of CDC42 during myelination27.
Migration and chemotaxis. CDC42 has been implicated 
in chemotaxis and directed migration of several cell types 
both in vitro and in vivo, including macrophages, T cells, 
fibroblasts and D. melanogaster haemocytes28–32. Studies 
on CDC42-deficient MEFs and haematopoietic stem 
cells (HSCs) support a central role for CDC42 in chemo-
taxis14,33. By contrast, directed migration of CDC42-null 
fibroblastoid cells was reported to be normal15, which 
indicates that the contribution of CDC42 could be cell-
type-specific. CDC42 could affect chemotaxis by decres-
ing Rac localization and activation to the leading edge, 
thereby reducing the stability of lamellipodia so that cells 
cannot move persistently in one direction32,34. Indeed, a 
common observation in CDC42-null cells is a reduction 
of RAC1 activity15,35. Conversely, an increase in CDC42 
activity can stimulate migration speed, for example in 
neutrophils isolated from Cdc42GAP-knockout mice36 
and RAC2-null HSCs/progenitor cells (HSC/P cells)37. 
This could be due to the ability of overactivated CDC42 
to stimulate Rac-dependent lamellipodial protrusion.
CDC42-null or CDC42GAP-null leukocytes show 
alterations in recruitment to inflammatory sites and/or 
homing in vivo33,36, but it is unknown whether these 
defects reflect changes to adhesion, migration or chemo-
taxis. Loss of CDC42 strongly affects haematopoietic cell 
differentiation and cell-cycle progression33, both of which 
could indirectly affect the migratory capacity of cells.
Regulating polarity through the PAR complex. Cell 
polarization is the process by which a cell responds to 
an extracellular stimulus by redistributing and maintain-
ing proteins and organelles in an asymmetrical layout. 
Polarity is fundamental to many cellular processes, 
including migration, differentiation and morphogen-
esis. CDC42 seems to function primarily through the 
polarity protein partitioning-defective-6 (PAR6) and 
thereby with PAR3 and/or atypical protein kinase C 
(aPKC) isoforms to induce polarity in several different 
animal models5,38. For example, CDC42 and the PAR 
complex (PAR6–PAR3–aPKC) have been proposed to 
mediate the capture and stabilization of microtubules 
at the front of the cell and to orientate the Golgi and 
microtubule-organizing centre (MTOC) during the 
establishment of migratory polarity39,40. CDC42 can also 
Figure 1 | Rho GTPase family. An unrooted phylogentic tree that is based on the ClustlW 
alignment of the amino-acid sequences of the 20 Rho GTPase proteins. The tree 
demonstrates the relationship between the different family members. The Rho GTPases 
form 8 subfamilies; subfamily one comprises RAC1, RAC2, AC3 and RhoG; subfamily 
two comprises CDC42, TC10 (also known as RhoQ) and TC10-like protein (TCL; also 
known as RhoJ); subfamily three comprises CHP (also known as RhoV) and 
WNT1-responsive CDC42 homologue-1 (WRCH1; also known as RhoU); subfamily  
four comprises RhoH; subfamily five comprises RhoBTB1 and RhoBTB2; subfamily six 
comprises RhoA, RhoB and RhoC; subfamily seven comprises RND1, RND2 and RND3 
(also known as RhoE); and subfamily eight comprises RAP1-interacting factor-1  
(RIF; also known as RhoF) and RhoD. EMBOSS pairwise alignment was used to calculate 
the percentage of amino-acid-sequence identity within subfamilies. High sequence 
similarity is found between proteins within the Rac and Rho subfamilies, whereas the 
other subfamilies are much less similar. The classical Rho GTPases include the Rho, Rac, 
CDC42 and RhoF and RhoD subfamilies and these all cycle between active GTP-bound 
forms and inactive GDP-bound forms. The atypical Rho GTPases comprise the RhoBTB, 
Rnd, RhoU and RhoV subfamilies and RhoH. These proteins are all effectively GTP-bound 
and are thought to be regulated by other mechanisms, including phosphorylation and 
protein levels.
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Figure 1.9 Mamalian Rho GTPase family. 
On the basis of primary amino acid sequence identity, closely related proteins can be further 
grouped within the family (colour patches). Sequences were aligned using the ClustalW 
algorithm and sequence distances displayed as unrooted dendrograms in TreeView.  
EMBOSS pairwise alignment was used to calculate the percentage of amino-acid-sequence 
identity within subfamilies. The classical Rho GTPases include the Rho, Rac, CDC42 and 
RhoF and RhoD subfamilies and these all cycle between active GTP-bound forms and inactive 
GDP-bound forms. The atypical Rho GTPases comprise the RhoBTB, Rnd, RhoU and RhoV 
subfamilies and RhoH. These proteins are all effectively GTP-bound and are thought to be 
regulated by other mechanisms, including phosphorylation and protein l vels. Figure adapted 
from sarah mammalian Rho GTpase. Figur adapted from (Heasman and Ridley, 2008).
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1.4.2 Regulation of Rho GTPase 
Most Rho GTPases shuttle between an inactive GDP-bound state and an 
active GTP-bound state while some others thought to be regulated by 
expression level, localization and posttranslational modification (Figure 1.10). 
This exchange cycle between GDP and GTP cycle is control by 3 types of 
regulating protein: GEFs, GAPs and GDIs. In response to diverse extracellular 
stimuli, GEFs activate GTPases by stabilising their nucleotide free form and 
stimulating the exchange of GDP to GTP (Rossman et al., 2005). Binding of 
GTP to Rho GTPases induces a conformational change that allows GTPases 
to interact with and activate downstream effectors. GAPs, on the other hand, 
act as negative regulators of Rho GTPases by enhacing the intrinsic 
hydrolytic activity of GTP-bound GTPases and thereby promoting the 
transition into GDP-bound form, which results in termination of signaling 
(Tcherkezian and Lamarche-vane, 2007). GDIs is able to form cytosolic 
complexes with most members of the Rho family thus block the spontaneous 
dissociation of GDP and prevent the interaction with GEFs, which in turn limit 
the function of GTPases by sequestering them from the active pool (Dovas 
and Couchman, 2005). 
 
1.4.3 Introduction to Rac  
Based on sequence similarity, the Rac1 subfamily comprises four proteins: 
Rac1, Rac2, Rac3 and RhoG. All Rac proteins are able to stimulate the 
formation of lamellipodia and membrane ruffles, RhoG promotes formation of 
lamellipodia via activating Rac GEF: DOCKs (Dovas and Couchman, 2005; 
Wennerberg and Der, 2004). The three Rac isoforms have different 
expression patterns despite their high sequence similarity. Rac1 is 
ubiquitously expressed, whereas Rac2 expression is mostly restricted to cells 
of haematopoietic origin and Rac3 mRNA is most abundant in the brain 
(Didsbury et al., 1989; Haataja et al., 1997; Heasman and Ridley, 2008).  
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different changes in the RHO-family proteins are advan-
tageous to growth in different cellular or genetic back-
grounds, so are selected for in the individual tumour.
This could account for the differences in RHO-protein
activity that are found among transformed cells.
RHO proteins in invasion and metastasis
In addition to deregulated proliferation, tumour cells
have altered morphological characteristics and, in the
case of metastasis, acquire the ability to traverse tissue
boundaries. It is clear that RHO-family GTPases are
involved in the control of cell morphology and motil-
ity in untransformed cells. CDC42 is important for
the extension of actin-rich spikes — called filopodia
— which are thought to sense tactic signals and, sub-
sequently, establish the directionality of movement.
Actin-rich ruffles — called lamellipodia — are then
assembled at the leading edge of the cell in a RAC-
dependent manner. RHOA is involved in the genera-
tion of contractile force, and in moving the body and
tail of the cell behind the leading edge (reviewed in
REF. 39). All three of these proteins are also involved 
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R E V I EW S
RHO–GDPRHO–GDP RHO–GTP Cytoskeleton and
cell regulation
RHO–GDI
GEF
GAP
Activation
Inactivation
Sequestration
Effector
P
Growth factors and 
integrin engagement
Table 1 | RHO proteins, their effectors and functions
RHO protein Effectors Effector protein type Function
RHOA, C ROCK I, II Kinase Actomyosin contraction, transformation,
transcription (SRF)2–4
Scaffold Actin polymerization, transcription (SRF)2–4,
microtubules132
PRK1/PKN Kinase Endocytosis, p38γ MAPK activation75, 
transcription (MEF2C)2–4
Citron Kinase Cytokinesis2–4
RHOB PRK1/PKN Kinase EGFR trafficking103, motility and cell adhesion27
RHOD Unknown – Vesicle transport104
RND1, 2, 3/RHOE Unknown – Antagonist of RHOA43,44
RHOG Kinectin Scaffold Microtubule binding109
Unknown Unknown RAC1 and CDC42 activation8
RHOH Unknown – Implicated in tumours of myeloid origin15,16
RIF Unknown – Actin organization133
CHP PAK Kinase JNK activation134
WRCH1 PAK Kinase JNK activation, morphological transformation30
RAC1, 2, 3 PAK1, 2, 3 Kinase JNK activation, transformation2–4
MLK2, 3 Kinase JNK activation2–4
PAR6 Kinase Cell polarity, transformation2–4
p67PHOX Enzyme NADPH oxidation, transcription (NFκB)2–4
IQGAP1, 2 Scaffold/GAP Adherens junctions2–4
POSH Scaffold JNK activation, transcription (NFκB)2–4
IRSp53 Scaffold Actin polymerization2–4
CDC42 PAK1, 2, 3, 4 Kinase JNK activation, transformation2–4
MLK2, 3 Kinase JNK activation2–4
PAR6 Scaffold Cell polarity, transformation2–4
N-WASP, WASP Scaffold Actin polymerization2–4
MRCK1, 2 Kinase Actin organization2–4
TC10 (TCL) PAK Kinase JNK activation9,135
WASP Scaffold Actin polymerization9,135
PIST136 Scaffold ?
? ? GLUT4 translocation, glucose uptake137
CHP, CDC42 homologue protein; EGFR, epidermal growth-factor receptor; GLUT4, glucose transporter 4; IQGAP, IQ-motif-containing
GTPase-activating protein; IRS, insulin-receptor substrate; JNK, JUN N-terminal kinase; MAPK, mitogen-activated protein kinase;
MEF2C, myocyte-enhancer factor 2C; MLK, mixed-lineage kinase; NF-κB, nuclear factor of κB; PAK, p21-activated kinase; 
PAR, partitioning defective; PIST, PD2 domain protein interacting specifically with TC10; PKN, protein kinase N; POSH, plenty of SH3
domains; PRK, protein-kinase-C-related kinase; RIF, RHO in filopodia; ROCK, RHO-associated coiled-coil-forming kinase; SRF, serum
response factor; WASP, Wiskott–Aldrich syndrome protein; WRCH, WNT-responsive CDC42 homologue.
Figure 2 | Model of RHO-protein regulation. RHO proteins can bind either GTP or GDP. When
bound to GDP, they can be sequestered in the cytoplasm by RHO–GDP dissociation inhibitors
(RHO–GDIs). The exchange of GDP for GTP is promoted by RHO guanine nucleotide exchange
factors (RHO–GEFs), and is often associated with translocation of RHO proteins to cell membranes.
GTP-bound RHO proteins interact with a range of effector proteins and modulate their ability to
regulate cell behaviour. Most RHO proteins have an intrinsic ability to hydrolyse GTP to GDP and
inorganic phosphate (P), which can be promoted by RHO–GTPase-activating proteins (RHO–GAPs).
RND1, RND2 , RND3/RHOE and RHOH are unable to hydrolyse GTP, and their regulation is likely to
be through changes in protein level or localization, not through GDP/GTP binding.
Figure 1.10 Regulation of Rho GTPase.  
Rho proteins can bind either GTP or GDP. When bound to GDP, they can be sequestered in 
the cytoplasm by binding to GDIs. The exchange of GDP for GTP is stimulated by GEFs, and 
is often associated with translocation of Rho proteins to plasma membranes. Where GTP-
bound Rho proteins interact with a variety of effecters alter their ability to regulate cell 
behaviour. GAPs act as negative regulators of Rho GTPases by enhacing the intrinsic 
hydrolytic activity of GTP-bound GTPases and thereby promoting the transition into GDP-
bound form, which results in termination of signalling. Figure adapted from (Sahai and 
Marshall, 2002).
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1.4.4 Biological function of Rac   
It has been shown in multiple cell types including macrophages, T cells, 
epithelial cells and fibroblasts that expression dominant-negative RAC1 
inhibits lamellipodia extension and migration (Heasman and Ridley, 2008; 
Ridley, 2001). Similarly, RAC1-null fibroblasts, schwann cells, endothelial 
cells and platelets have impaired lamellipodia formation (McCarty et al., 
2005b; Nodari et al., 2007; Tan et al., 2008; Vidali et al., 2006). Surprisingly, 
RAC1-null macrophages can still form membrane ruffles and migrate at a 
similar speed to wild-type cells. However, they have an elongated morphology 
and fail to spread, which implies that they are defective in lamellipodia 
extension (Wells et al., 2004; Wheeler et al., 2006).	  
Rac regulates formation of lamellipodia through several signaling ways 
(Figure 1.11). First, Rac can activate Arp2/3 complex through WAVE complex 
(Kunda et al., 2003). Second, Rac can increase the availability of actin 
monomers for incorporation into actin filaments by regulating cofilin via Pak 
and LIM kinase (Edwards et al., 1999). 
 
In addition to the involvement in the regulation of the actin cytoskeleton 
organization, Rac1 also plays a role in the cell-cycle progression in both G1/S 
(Olson et al., 1995; Vidali et al., 2006) and G2/M phase (Michaelson et al., 
2008; Moore et al., 1997) in different cell types. Rac activity is also required 
for the activation of the JNK/SAPK, and p38 MAP kinase and TNF induced 
p42/44 MAP kinase cascades (Coso et al., 1995; Minden et al., 1994; 
Williams et al., 2008). Rac can regulate the activity of NADPH oxidase 
resulting in the production of superoxide radicals (Diekmann et al., 1994) and 
the activation of NF-κB (Perona et al., 1997; Williams et al., 2008). In addition, 
Rac1 activity is involved in tight junction biogenesis (Jou and Nelson, 1998; 
Mertens et al., 2005), cadherin-mediated cell-cell adhesion (Braga et al., 
2000; Braga et al., 1999; Braga et al., 1997; Takaishi et al., 1997) and 
integrin-mediated cell-matrix adhesion (Hotchin and Hall, 1995; Nobes and 
Hall, 1995; Price et al., 1998). In cancer, Rac1 is essential for H-Ras-induced  
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Rac1 
GTP
WAVE Pak
LIMK
Cofilin
Arp2/3
Actin Severing
Actin 
Polymerization
Lamellipodia
Figure 1.11 Rac regulate formation of lamellipodia
Left: Rac promote actin polymerization by activating Arp2/3 complex through WAVE complex. 
Right: Rac-mediated activation of PAK phosphorylates LIM kinase, which phosphorylates and 
inhibits cofilin, thereby regulating actin-filament turnover and actin filament severing. 
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transformation of NIH3T3 fibroblasts in vitro (Qiu et al., 1995), and expression 
of constitutively activated mutants of Rac1 is sufficient for their malignant 
transformation. Interestingly, Rac induced activation of Pak, JNK or induction 
of lamellipodia, was neither necessary nor sufficient for Rac1 transforming 
activity, suggest multiple pathways may contribute to Rac1-induced cellular 
transformation (Westwick et al., 1997).  
 
In vivo, expression of dominant negative Rac inhibits protrusion formation and 
collective migration of oocyte border cells in Drosophila egg chamber (Bianco 
et al., 2007; Duchek et al., 2001; Geisbrecht and Montell, 2004; Murphy and 
Montell, 1996; Wang et al., 2010). Likewise, sequestration of Rac activity in 
zebrafish germ cells inhibits actin brush formation, cell polarity and migration 
(Kardash et al., 2010). In mouse, global Rac1 knockout was embryonic lethal 
and developing embryos do not progress past E9.5, with a high incidence of 
apoptotic cell death in the mesoderm during gastrulation (Sugihara et al., 
1998), therefore tissue specific knockout of Rac have been widely used to 
study Rac1 function.  Deletion of Rac1 induced by wnt-1 Cre in murine neural 
crest cells showed non-requirement of Rac1 for migration of neural crest cells 
to initial target structures, but strong proliferation defect (Fuchs et al., 2009). 
Deletion of Rac1 in developing nervous with nestin Cre showed increased 
apoptosis and Rac1-deficient cerebellar granule neurons showed impaired 
migration and axon formation. In addition, Rac1 is required for protrusion 
formation and collective migration of anterior visceral endoderm cells to the 
developing anterior side of the embryo between days E5.5-6.0 during body 
axis specification. However, Rac1 is dispensable for proliferation in this 
system (Migeotte et al., 2010). Epidermal deletion of Rac1 in keratinocyte 
revealed an important role of Rac in maintaining the adult epidermal stem cell 
compartment (Benitah et al., 2005).  
 
In contrast to Rac1, Rac2 knockout mice revealed normal development but 
neutrophilic, phagocytic and lymphocytic defects (Croker et al., 2002; Li et al., 
2000; Roberts et al., 1999). Comparison of defects in hematopoietic cell 
function, observed after single and double deletion of Rac1 and Rac2, 
demonstrated both overlapping and distinct roles of these two related 
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GTPases in hematopoietic cells (Benvenuti et al., 2004; Gu et al., 2003; 
Walmsley et al., 2003). Similarly, The Rac3 protein is specifically expressed in 
the nervous system and Rac3-deficient mice have no obvious anatomical or 
physiological defects (Corbetta et al., 2005). However, more recent study 
using Rac1 and Rac3 double knockout mice revealed Rac1 and Rac3 play 
complementary roles during late stages of neuronal and brain development 
(Corbetta et al., 2009). 
 
 
1.5 Melanoblast migration 
1.5.1 Introduction to melanoblast migration 
Mammalian melanoblasts are the precursor cells of melanin producing 
melanocytes; they arise from the neural crest. During embryogenesis, 
melanoblasts migrate away from the neuroepithelium in an extraordinary 
journey with cycles of migration and proliferation to eventually populate the 
skin and hair follicles (Figure 1.12) (Kelsh et al., 2009).  
 
In mouse, neural crest cells undergo two migration pathways. Those that 
migrate in the space between the somites and the neural tube (ventral 
pathway) give rise to neuronal and glial cells, whereas those that migrate 
between the somite and the non-neural ectoderm (dorsolateral pathway) 
differentiate into melanoblasts (Serbedzija et al., 1990). Studies indicated that 
this melanogentic fate is detemined by expression of Kit (The major tyrosine 
kinase receptor in melanocytes) in neural crest cells before the migration 
(Wilson et al., 2004).  Melanoblasts reside in an area just near the neural 
tube, called the migration staging area, where they receive proliferation and 
survival signals from Kit-ligand (KitL), the ligand of Kit.  Between E8.5 and 
E10.5, their migration is dorsolateral and induced by transient expression of 
KitL in dermatome (Figure 1.12).  After E10.5 they begin to progress ventrally 
toward the face, ventral abdomen and the developing limbs (Figure 1.12).  
They also undergo a migration in the z-plane, as they emerge upward through 
the developing dermis and into the epidermis at around E13.5 (Figure 1.12) 
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Figure 1.12 Melanoblast dorsolateral migration pathway.
(1) Melanoblasts emerge from the dorsal neural tube at around embryonic day 8.5. 
Melanoblasts migrate along the dorsolateral pathway between the dermatome and the 
overlying ectoderm, and from E10.5 migrate ventrally through the developing dermis 
(2-3). At E14.5, they begin to invade the overlying epidermis (4) and then migrate into the 
developing hair follicles at E15.5 (5). NT: Neural tube, S: Somite. Figure adapted from
(Silver et al., 2006).
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 (Mayer, 1973).  Over the next few days they enter developing hair follicles 
(Figure 1.12). At birth, melanocytes are observed in both the epidermis and 
hair follicles, but within a few days, epidermal melanoblasts disappear, leaving 
only those in the hair follicles, which differentiate and produce melanin by 
around P4 (Jordan and Jackson, 2000; Mayer, 1973). As a consequence, the 
skin in the adult mouse is mostly unpigmented. In contrast, human 
melanocytes normally located in the bottom layer of the skinʼs 
epidermis, which comprise from 5% to 10% of the cells in the basal 
layer of epidermis. 
 
1.5.2 Regulaton of melanoblast migration 
To date several genes have been identified which are associated with coat-
color abnormalities in mice, indicating defects in melanoblast migration, 
proliferation and survival (Baxter et al., 2004; Bennett and Lamoreux, 2003; 
Kelsh et al., 2009). Some of these genes are also associated with neural crest 
and melanocyte disorders in humans. These genes include transcription 
factors: Mitf (Grüneberg, 1953; Hodgkinson et al., 1993; Hughes et al., 1993), 
SNAI2 (Perez-Losada et al., 2002), Sox10 (Britsch et al., 2001); Receptor 
tyrosine kinase Kit and its ligand KitL (Cable et al., 1995; Geissler et al., 1988; 
Mackenzie et al., 1997; Wehrle-Haller and Weston, 1995); G-protein coupled 
endothelin-3 receptor/ligand pair (Baynash et al., 1994; Hosoda et al., 1994) 
and secreted protease of the ADAM family of metalloproteinase ADAMTS20 
(Silver et al., 2008).  
For instance, signaling to Kit via KitL is known to trigger proliferation and 
survival via activation of Ras and downstream MAPK/ERK signaling 
(Mackenzie et al., 1997; Smalley, 2009; Steel et al., 1992; Yoshida et al., 
2001), and has been speculated to be involved in motility (Jordan and 
Jackson, 2000; Peters et al., 2002). Application of Kit function blocking 
antibody to mouse embryo was able to block proper melanoblast development 
(Nishimura et al., 2002; Yoshida et al., 1996). Furthermore, ectopic 
expression of Kitl in the basal layer of the skin promotes dermal melanoblasts 
survival (Kunisada et al., 1998).    
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Endothelin-3 signaling functions are necessary for the development of 
melanoblasts. Endothelin-3 is not required for melanogentic fate specification, 
but is needed for migration and survival of melanoblasts between E10.5 and 
E12.5 (Shin et al., 1999), and is also required for melanoblast development in 
the epidermis beyond E12.5 (Yoshida et al., 1996). Similar to KitL, ectopic 
expression of endothelin-3 in keratinocytes driven by keratin 5 promoter also 
result increased melanoblast proliferation and pigmented skin harboring 
dermal melanocytes, suggest a important role of endothelin-3 in Kit 
independent survival of melanocytes (Garcia et al., 2007).  
In addition to signaling molecules, melanoblast migration at different stages is 
tightly regulated by expression of cell-cell adhesion molecules (Pla et al., 
2001). For example, E-cadherin and P-cadherin are expressed in 
complementary regions of the developing skin and are required to maintain 
the correct organization of the epidermis, dermis and hair follicle. In general, 
E-cadherin is expressed by keratinocytes of the epidermis; P-cadherin is 
expressed by keratinocytes of the hair matrix, but not in the dermis. Similarly, 
Melanoblasts that migrate in dermis neither express E-cadherin nor P-
cadherin (Nishimura et al., 1999). Expression of E-cadherin is required for 
melanoblasts invading the epidermis, and localization of melanoblasts to the 
hair matrix requires P-cadherin expression (Nishimura et al., 1999). 
 
1.6 Thesis aim 
I aimed to investigate the role of two important cytoskeletal proteins, fascin-1, 
an actin bundling protein and Rac1, a signalling small GTPase in cell 
migration and cancer.  The actin cytoskeleton and cytoskeletal control are 
crucial in development and cancer invasion/metastasis and understanding the 
function of these key proteins in both normal and cancer cells will aid future 
development of diagnostic and therapeutic cancer research.   
The aims of my project are: 
1. To investigate the potential role of fascin on invadopodia formation.  
2. To investigate the potential role of fascin in cancer cell invasion. 
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3. To investigate the potential role of Rho GTPase Rac1 on melanoblast 
proliferation and migration during mouse embryogensis. 
4. To investigate the potential role of Rho GTPase Rac1 in activated N-Ras 
Q61K induced melanocyte hyperproliferation.  
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Chapter II 
Materials and Methods 
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2.1 Materials 
2.1.1 Reagents and Solutions 
Compound/Reagents Type Source 
Y-27632 Rho kinase inhibitor Dr. M, Olson, Beatson 
institute. 
Latrunculin A Actin polymerization 
inhibitor 
Sigma 
IPA-3 Pak1/2/3 inhibitor Dr. J. Chernoof, Fox 
Chase Cancer Centre 
LIMKi LIM kinase inhibitor Dr. M. Olson, Beatson 
institute. 
U0126 MEK1/2 inhibitor  Cell signalling 
Blebbistatin Myosin II inhibitor Sigma 
GM6001 Metalloprotease inhibitor Merck chemicals 
CK312 Arp2/3 complex inhibitor 
(Negative Control) 
Merck chemicals 
CK869 Arp2/3 complex inhibitor Merck chemicals 
Nocodazole Tubulin polymerization 
inhibitor 
Sigma 
Taxol Microtubules stabilizer Sigma 
EGF Growth factor Sigma 
Complete matrigel  ECM BD biosciences 
Growth factor reduced 
matrigel 
ECM BD biosciences 
Rat Tail Collagen I (High 
concentration) 
ECM BD biosciences 
PureCol Bovine 
Collagen 
ECM Advanced Biomatrix 
Human Fibronectin ECM BD biosciences 
Mouse laminin  ECM BD biosciences 
Ampicillin  Sigma 
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Kanamycin  Sigma 
DNA Ladders 1kb Invitrogen 
6xDNA loading dye  New Englend Biolabs 
Ethidium bromide  Invitrogen 
Fetal Bovine Serum  Autogen Bioclear 
Hybond-P PVDF 
membrane 
 GE Healthcare 
DMEM  Gibco 
F-12K Nutrient Mixture, 
Kaighn’s Modification 
 Gibco 
Luria Broth Agar LB + 1.5% agar Beatson Institute 
Central Services 
Luria Broth  1% w/v bacto-tryptone, 
86nM NaCl, 0.5% yeast 
extract 
Beatson Institute 
Central Services 
L-Glutamine (200mM)  Gibco 
NuPAGE Novex Bis-Tris 
Mini Gels 
10%, 12% and 4-12% 
gel percentage 
Invitrogen 
NuPAGE Sample 
Reducing Agent (10X)  
 Invitrogen 
NuPAGE Sample Buffer 
(4X) 
 Invitrogen 
NuPAGE MOPS SDS 
Running Buffer  
 Invitrogen 
NuPAGE Transfer 
Buffer 
 Invitrogen 
PE PBS + 1mM EDTA Beatson Institute 
Central Services 
Penicillin-Streptomycin  Gibco 
Primocin  InvivoGen 
PBS 170mM NaCl, 3.3mM 
KCl, 1.8mM Na2HPO4, 
10.6mM H2PO4 
Beatson Institute 
Central Services 
TBST 10mM Tris-HCl, pH 7.4, 
150mM NaCl 
Beatson Institute 
Central Services 
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TAE 40mM Tris, 0.1% glacial 
acetic acid, 1mM EDTA 
Beatson Institute 
Central Services 
TE 10mM Tris-HCl, pH 8.0, 
1mM EDT A 
Beatson Institute 
Central Services 
Trypsin  Gibco 
X-gal 5’-bromo-4-chloro-3-
indolyl-D- 
galactopyranoside 
Promega 
Collagenase type I  Gibco 
Collagenase type IV  Gibco 
Cell dissociation buffer  Gibco 
Sulfo-NHS-SS-biotin   Pierce Chemical 
NeutrAvidin agarose 
resin  
 Thermo Scientific 
RNase free water  Qiagen 
Medium 254  Cascade Biologics 
Human melanocyte 
growth supplement-2, 
TPA free 
 Cascade Biologics 
TPA  Sigma 
Geneticin   Gibco 
10XDMEM  Gibco 
OptiMEM  Gibco 
Annealing buffer  100 mM NaCl and 50 
mM HEPES pH 7.4 
In house 
QIAprep Maxiprep Kit   Qiagen 
2x HBS 50 mM HEPES, 250 mM 
NaCl, 1.5 mM NaHPO4, 
pH 7.1 
In house 
RIPA buffer  50 mM Tris-HCl, 150 
mM NaCl, 1% NP-40 
and 0.25% Na-
deoxycholate 
In house 
7.5% bicarbonate   GIBCO 
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BSA  Sigma 
Melanin bleach kit   Polyscience Inc. 
Brdu  Sigma 
Puromycin   Invivogen 
Protease inhibitor 
cocktail  
 Pierce 
Halt phosphatase 
inhibitor cocktail  
 Pierce 
SeeBlue Plus2 Pre-
Stained Standard  
 Invitrogen 
4-Hydroxytamoxifen  Sigma 
Image-iT FX Signal 
Enhancer  
 Invitrogen 
Citrate buffer, ph 6.4   Dako 
Peroxidase block  Dako 
X-Gal buffer  2 mM MgCl2, 0.02% 
NP-40, 2 mM 
K3Fe(CN)6 and 2 mM 
K4Fe(CN)6) containing 
2 mg/ml X-Gal 
In house 
Detergent buffer 2 mM MgCl2, 0.02% 
NP-40 and 0.01% 
sodium deoxycholate in 
PBS, pH 7.5 
In house 
HBSS  Gibco 
Prolong Gold Antifade 
reagent  
 Invitrogen 
Antibody Diluent  Dako 
Polybrene   Sigma 
NeutrAvidin Agarose 
Resin 
 Thermo Scientific 
TNE buffer 50mM Tris HCl pH7.5, 
150mM NaCl, 1% Triton 
X-100 and 1mM EDTA 
In house 
Table 1 – Reagents and Solution 
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2.1.2 Antibodies and Dyes 
Antibody Dilution Source 
Mouse anti-Fascin 
(55K2) 
WB – 1:500; IF – 1:100 Dako 
Mouse anti-Fascin 
(SPM133) 
IF – 1:100 Abcam 
Rabbit anti-Fascin IHC– 1:200 ATLAS antibodies 
Mouse anti-Cortactin 
(4F11) 
IF – 1:200 Millipore 
Mouse anti-Rac1 
(ARC03) 
WB – 1:500; IF – 1:100 Cytoskeleton Inc. 
Mouse anti-Myc (9E10) IF – 1:200 Dr. L. Machesky 
Rabbit anti-Pak1/2/3 WB – 1:500 Cell Signalling 
Rabbit anti-Pak1 WB – 1:500 Cell Signalling 
Rabbit anti-Pak2 WB – 1:500 Cell Signalling 
Rabbit anti-Phospho 
Pak1 
(Ser199/204)/Pak2 (Ser 
192/197) 
WB – 1:500 Cell Signalling 
Rabbit anti-p34-Arc WB – 1:500; IF – 1:200 Millipore 
Rabbit anti-actin WB – 1:500 Sigma 
Mouse anti-Cdc42  WB – 1:500 Santa Cruz 
Mouse anti-E-cadherin  WB – 1:500; IF – 1:100 BD bioscience 
Mouse anti-ZO-1 WB – 1:500; IF – 1:100 Invitrogen 
Rabbit anti-Collagen IV IF – 1:100 Abcam 
Rabbit anti-Phospho-
Cofilin (Ser3) 
WB – 1:500 Cell Signalling 
Rabbit anti-Phospho-
Myosin Light Chain 2 
(Ser19), 
WB – 1:500 Cell Signalling 
Rabbit anti-GAPDH WB – 1:500 Cell Signalling 
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Rabbit PhosphoHistone 
H3 (Ser10) 
IF – 1:100 Cell Signalling 
Rabbit anti-phospho-
Erk1/2 (Thr202/Tyr204) 
WB – 1:500 Cell Signalling 
Rabbit anti-ERK1/2  WB – 1:500 Cell Signalling 
Mouse anti-β1 integrin WB – 1:500 Millipore 
Mouse anti-active Rac1-
GTP 
IF – 1:100 NewEast Bioscience 
Goat anti-DCT (D-18) WB – 1:500; IF – 1:100; 
IHC – 1:5000 
Santa Cruz 
Goat anti-WAVE1 WB – 1:500 Santa Cruz 
Rabbit anti-WAVE2 WB – 1:500 Santa Cruz  
Mouse anti-BrdU IF – 1:100 BD Bioscience 
Rabbit anti-cleaved 
Caspase-3 (Asp175) 
IF – 1:100 Cell Signalling 
Mouse anti-vinculin WB – 1:500 Millipore 
Rabbit anti-Ki67 (SP6) WB – 1:500; IF – 1:100 Neomarkers 
Mouse anti-tubulin WB – 1:500; IF – 1:100 Sigma 
Mouse anti-Paxillin WB – 1:500; IF – 1:100 Sigma 
Rabbit anti-N-WASP WB – 1:500 ATLAS antibodies 
Mouse Anti-Abi1 IF – 1:100 Caltag medsystems 
Rabbit anti-Nap1 WB – 1:500 Millipore 
Mouse anti-MT1-MMP 
(3G4.2) 
WB – 1:500 Millipore 
Mouse anti-BrdU FC-1:50 Dako 
Anti-mouse IgG HRP 
linked 
WB – 1:5000 Cell Signalling 
Anti-Rabbit IgG HRP 
linked 
WB – 1:5000 Cell Signalling 
Anti-Goat IgG HRP 
linked 
WB – 1:5000 Cell Signalling 
Alexa Fluor 594 donkey 
anti-mouse IgG 
IF – 1:500 Molecular Probes 
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Alexa Fluor 594 donkey 
anti-rabbit IgG 
IF – 1:500 Molecular Probes 
Alexa Fluor 488 donkey 
anti-goat IgG 
IF – 1:500 Molecular Probes 
Alexa Fluor 488 donkey 
anti-rabbit IgG 
IF – 1:500 Molecular Probes 
Alexa Fluor 488 donkey 
anti-mouse IgG 
IF – 1:500 Molecular Probes 
Alexa Fluor 488 goat 
anti-mouse IgG 
IF – 1:500; FC – 1:50 Molecular Probes  
Alexa Fluor 488 goat 
anti-rabbit IgG 
IF – 1:500 Molecular Probes 
Alexa Fluor 594 goat 
anti-mouse IgG 
IF – 1:500 Molecular Probes 
Alexa Fluor 594 goat 
anti-rabbit IgG 
IF – 1:500 Molecular Probes 
Alexa Fluor 647 goat 
anti-mouse IgG 
IF – 1:500 Molecular Probes 
Alexa Fluor 647 goat 
anti-rabbit IgG 
IF – 1:500 Molecular Probes 
Alexa Fluor 350 goat 
anti-mouse IgG 
IF – 1:500 Molecular Probes 
Rhodamine Phalloidin IF – 1:200 Molecular Probes 
Calcein AM 5µM Molecular Probes 
WB: Western Blot   IF: Immunofluorescence  
IHC; Immunohistochemistry    FC: Flow cytometry    
Table 2 – Antibodies and Dyes 
 
2.1.3 DNA Constructs 
Construct Type Source 
LMP Retroviral shRNA vector Dr. J. Norman 
eCFP-C1- H. sapiens 
fascin 
Transient expression 
vector 
Dr. J. Adams 
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eGFP-C1- H. sapiens 
fascin S39A 
Transient expression 
vector 
Dr. J. Adams 
eGFP-C1- H. sapiens 
fascin S39E 
Transient expression 
vector 
Dr. J. Adams 
eGFP-C2- X. tropicalis 
fascin 
Transient expression 
vector 
Dr. J. Adams 
eGFP-C2- X. tropicalis 
fascin S33A 
Transient expression 
vector 
Dr. J. Adams 
eGFP-C2- X. tropicalis 
fascin S33D 
Transient expression 
vector 
Dr. J. Adams 
mCherry-C2- X. 
tropicalis fascin 
Transient expression 
vector 
This study 
mCherry-C2- X. 
tropicalis fascin S33A 
Transient expression 
vector 
This study 
mCherry-C2- X. 
tropicalis fascin S33D 
Transient expression 
vector 
This study 
mCherry-C2 Transient expression 
vector 
Dr. J. Norman 
eGFP-C1 Transient expression 
vector 
Dr. L. Machesky 
GFP-mDia2 Transient expression 
vector 
Dr. S. Narumiya 
GFP-mDia2 Transient expression 
vector 
Dr. S. Narumiya 
IRSP53-myc Transient expression 
vector 
Dr. L. Machesky 
IRTKS-myc Transient expression 
vector 
Dr. L. Machesky 
GFP-N-WASP Transient expression 
vector 
Dr. T. Takenawa 
GFP-Cortactin Transient expression 
vector 
Dr. R. Buccinone 
GFP-p21-ARC Transient expression 
vector 
Dr. L. Machesky 
GFP-actin Transient expression 
vector 
Dr. M. Parsons 
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RFP-actin Transient expression 
vector 
Dr. M. Parsons 
GFP-Lifeact Transient expression 
vector 
Dr. R. Wedlich-Soldner 
RFP-Lifeact Transient expression 
vector 
Dr. R. Wedlich-Soldner 
Table 3 – DNA Constructs 
 
2.1.4 Enzymes and kits 
Kit Supplier 
Amaxa Nucleofection Kit Lonza 
Glutathione sepharose beads Thermo Scientific 
Hyperfect Qiagen 
Lipofectamine 2000  Invitrogen 
QIAquick Gel Extraction Kit Qiagen 
Restriction enzymes and reaction 
buffers 
New England Biolabs 
SimplyBlue SafeStain Invitrogen 
Rapid DNA Ligation Kit  Roche 
SuperSignal West Pico 
Chemiluminescent Substrate 
Thermo Scientific 
Phusion High-Fidelity DNA 
Polymerase 
New England Biolabs 
Precision Red Advanced Protein 
Assay 
Cytoskeleton Inc. 
QIAquick PCR purification kit Qiagen 
QIAprep Spin Miniprep Kit  Qiagen 
Melanin bleach kit  Polyscience Inc. 
Vectastain ABC kit  Vector laboratories, Inc. 
Alkaline phosphatase substrate kit Vector laboratories, Inc. 
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EnVision Detection 
Systems Peroxidase/DAB, 
Rabbit/Mouse 
Dako 
Table 4 – Enzymes and Kits 
 
2.2 Methods 
2.2.1 Cell Culture 
2.2.1.1 Origin of cell lines 
A375MM human melanoma cells were obtained from R. Buccione (Consorzio 
Mario Negri Sud, Chieti, Italy). CHL-1 and WM266.4 human melanoma cells 
and Phonenix-Ampho retroviral packaging cells were obtained from B. 
Ozanne (Beatson Institute, Glasgow, UK). MV3 human melanoma cells were 
obtained from G. van Muijen (University of Nijmegen, Nijmegen, The 
Netherlands). SCC-9 human oral cancer cells and MDA-MB-231 human 
breast adenocarcinoma cells were obtained from ATCC. Adult epidermal 
melanocyte (A melanocytes) and neonatal melanocyte (N melanocytes) were 
obtained from (Cascade Biologics) and cultured according to the 
manufacturer’s instructions. Primary mouse melanocytes were established as 
described below. 
 
2.2.1.2 Maintenance of cell lines 
All cell lines were routinely grown in tissue culture treated 100 mm dishes 
(Falcon) at 37°C in a humidified atmosphere containing 5% CO2. All 
techniques were performed in sterile conditions. All cell lines were cultured in 
DMEM containing 2mM glutamine and 10% FBS, except SCC9 cells were 
cultured in DMEM/F-12 medium (1:1) containing 2mM glutamine, 400 ng/ml 
hydrocortisone and 10% FBS. Fresh media was added every 3-4 days. Cells 
were passaged when subconfluent, typically every 3 days with a 1:10 split 
ratio. After aspirating the medium and washing with PE buffer, 0.1 ml PE 
buffer with 0.25% trypsin was added and after approximately 3 min cells were 
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resuspended in 10 ml fresh medium, 1 ml of which was added to 19 ml fresh 
medium in a new 10 mm dish. Human primary melanocytes were cultured in 
medium 254 with human melanocyte growth supplement-2, PMA free and 
split when subconfluent and the medium was changed every 3 days. Cells 
were passaged as described above.  
 
2.2.1.3 Storage of cell lines 
Cells were stored in liquid nitrogen. Cells were trypsinised as described above 
and pelleted by centrifugation. Cells were resuspended in medium 
supplemented as described but with 20 % FCS and 10 % DMSO. 
Resuspended cells were placed in cryotubes, wrapped in cotton wool and 
frozen at -70°C overnight before transferring to liquid nitrogen. Cells were 
thawed by placing cryotubes in a 37°C water bath. Cells were diluted in 10 ml 
fresh medium, pelleted by centrifugation, resuspended in 10 ml fresh medium 
and placed in a new 10 mm dish. Medium was changed once the next day.  
 
2.2.1.4 Establishment of primary mouse melanocyte cell lines 
Method for obtaining primary mouse melanocytes was previously reported 
(Larue et al., 1992). Briefly, 1 day old Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- 
(#3 and #4) or Rac1 f/f Tyr::CreERT2o/o Ink4a-Arf-/- (#2) littermate mice were 
stunned and decapitated and briefly sterilized by rinsing twice in ice-cold 70 % 
ethanol for 5 s and twice in ice-cold PBS for 5 s. The skin, typically 1 cm2, was 
removed and cut into small pieces with scissors and forceps and incubated in 
2 ml of collagenase type 1 and 4 at 37°C, 5 % CO2 for 40 min. The epidermis 
and dermis were separated and transferred to 10 ml wash buffer, centrifuged 
at 1100 rpm at room temperature for 5 min and resuspended in 2 ml cell 
dissociation buffer. After incubating at 37 °C 5 % CO2 for 10 mins, the tissue 
was repeatedly put through 18 g and then 20 g needles to further dissociate 
and then resuspended and left to settle in 10 ml wash buffer for 10 mins. The 
supernatant was centrifuged at 1100 rpm for 5 min and resuspended in 2 ml 
PBS and the cells counted. Cells were centrifuged as before and plated at a 
density of 1 x 106 per well of a 6-well tissue culture plate in melanocyte growth 
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medium F-12 containing 200 nM TPA and 100 µg/ml primocin. After 2 days in 
culture, G418 was added to the culture medium at 50 µg/ml for 3 d every 
week in order to selectively impair the growth of fibroblasts and keratinocytes. 
Melanocytes were passaged at around 50% confluence. All experiments were 
done with melanocytes that were spontaneously immortalized (Ink4a-Arf-/- 
background (Sviderskaya et al., 2002)) and kept in culture for between 3 and 
4 months. Controls were done to ensure that OHT did not affect the 
morphology of cells not carrying inducible Rac1 deletion e.g. Tyr::CreER 
negative cell lines.   Pure populations of melanocytes were normally achieved 
after 1.5 months culture of N-RasQ61K positive cells and after 4 months culture 
of N-RasQ61K negative cells.  
 
2.2.2 Molecular Cloning 
2.2.2.1 Agarose gel electrophoresis 
Agarose was added to 1xTAE buffer at between 1 and 2 % depending on the 
size of the DNA to be visualized. Agarose in 1xTAE buffer was heated and 
Ethidium Bromide added at 0.5 µg/ml prior to solidification in a gel tray. DNA 
samples and 1 kb ladder in 1xDNA loading buffer were loaded on to the gel 
and electrophoresis performed at 100V in 1xTAE buffer. DNA bands were 
visualized using a UV transilluminator. The DNA bands of interest were cut 
and purified using QIAquick PCR purification kit according to the 
Manufacture’s instructions.  
 
2.2.2.2 Restriction enzyme digests 
 
Restriction enzyme digests contained 1x appropriate enzyme buffer, 
approximately 10 µg DNA and 5-10 U of restriction enzyme were used per 
microgram DNA, made up to volume of 20 µl with distilled water. Reactions 
were incubated for 2 hour at 37°C.  
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2.2.2.3 Ligations 
 
Ligations were performed using the Rapid DNA Ligation Kit. An approximate 2 
fold molar excess of insert DNA to vector DNA was diluted in DNA Dilution 
Buffer to a final volume of 9 µl. This was combined with 1xT4 DNA Ligation 
Buffer was to a final volume of 10 µl and 5 U T4 DNA ligase was added. The 
ligation reaction was incubated at room temperature for 1.5 h before 
transforming competent bacteria.  
 
2.2.2.4 Generation of mCherry-C2- X. tropicalis fascin constructs  
mCherry-X. tropicalis fascin, X. tropicalis fascin S33A and X. tropicalis fascin 
S33D constructs was generated by subcloning X. tropicalis fascin, X. 
tropicalis fascin S33A and X. tropicalis fascin S33D from EGFP-C2 vector to 
mCherry-C2 vector using BamHI /XhoI restriction sites.  
 
 
2.2.2.5 Transformation of competent cells 
Competent E. Coli DH5a cells were stored at –70°C and thawed on ice. 
Plasmid DNA, typically 20 ng, was gently mixed with 100 µl of cells and 
incubated for 15 minutes on ice. Cells were then heat-shocked at 42°C for 45 
seconds and placed back on ice for 1 min. 1ml L-broth was added and cells 
were incubated with shaking at 37°C for 1 h, 250 rpm. 200 µl of the 
transformation mixture was spread over pre-warmed LB agar plates 
containing 50 µg/ml ampicillin or kanamycin depend on the vector and 
incubated overnight at 37°C. 
 
 
2.2.2.6 Design of shRNA constructs  
Oligos siRNA sequences were designed based on siRNA sequence (see 
below). The resulting sequences were entered into an online shRNA oligo 
construction tool 
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(http//katahdin.cshl.org:9331/homepage/sirna/rnai.cgi?type=shrna) to design 
complimentary 110 nucleotide oligos suitable for ligation into the vector LMP. 
 
2.2.2.7 Oligos for shRNA constructs  
Primer Sequence 
Fascin 
SEQ1 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGCAACTG
GAAATAGCGAAATAAATAGTGAAGCCACAGATGTATTTA
TTTCGCTATTTCCAGTTTTGCCTACTGCCTCGG 
 
Fascin 
SEQ1 R 
AATTCCGAGGCAGTAGGCAAAACTGGAAATAGCGAAAT
AAATACATCTGTGGCTTCACTATTTATTTCGCTATTTCCA
GTTGCGCTCACTGTCAACAGCAATATACCTTC 
 
Fascin 
SEQ2 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGCCACGG
GCACCCTGGACGCCAATAGTGAAGCCACAGATGTATTG
GCGTCCAGGGTGCCCGTGATGCCTACTGCCTCGG 
 
Fascin 
SEQ2 R 
AATTCCGAGGCAGTAGGCATCACGGGCACCCTGGACG
CCAATACATCTGTGGCTTCACTATTGGCGTCCAGGGTG
CCCGTGGCGCTCACTGTCAACAGCAATATACCTTC 
 
Fascin 
SEQ3 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGACAGCT
GCTACTTTGACATCGATAGTGAAGCCACAGATGTATCGA
TGTCAAAGTAGCAGCTGGTGCCTACTGCCTCGG 
 
Fascin 
SEQ3 R 
AATTCCGAGGCAGTAGGCACCAGCTGCTACTTTGACAT
CGATACATCTGTGGCTTCACTATCGATGTCAAAGTAGCA
GCTGTCGCTCACTGTCAACAGCAATATACCTTC 
 
Fascin 
SEQ4 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGCCTGAG
CCTTATTTCTCTGGAATAGTGAAGCCACAGATGTATTCC
AGAGAAATAAGGCTCAGATGCCTACTGCCTCGG 
 
Fascin 
SEQ4 R 
AATTCCGAGGCAGTAGGCATCTGAGCCTTATTTCTCTGG
AATACATCTGTGGCTTCACTATTCCAGAGAAATAAGGCT
CAGGCGCTCACTGTCAACAGCAATATACCTTC 
 
Table 5 – Oligo sequences for shRNA constructs 
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2.2.2.8 Annealing shRNA oligos 
 
Oligos were dissolved in sterile, nuclease-free water to a concentration of 3 
mg/ml. The annealing reaction consisted of 1 µl each oligo in 48 µl annealing 
buffer. The mixture was incubated for 4 min at 90°C and then for 10 minutes 
at 72°C. The samples were cooled to 4°C and stored until ligation into vector 
LMP, which was digested with XhoI/EcoR1 restriction enzymes. 
 
 
2.2.2.9 Screening of transformants 
 
Individual colonies of bacteria were used to inoculate 5 ml LB media 
containing 50 µg/ml ampicillin or kanamycin as appropriate and cultured 
overnight at 37 °C. Plasmid DNA was prepared using the QIAprep Spin 
Miniprep Kit and analyzed for the presence of desired insert by restriction 
digest and subsequent visualization by gel electrophoresis. Samples that 
tested positive were sequenced using appropriate sequencing primers. After 
sequence confirmation, plasmid DNA was used to transform fresh bacteria 
and 100 ml cultures were used to prepare DNA using QIAprep Maxiprep Kit 
(some procedures performed by Beatson Research Services). 
 
 
2.2.2.10 Primers for sequencing 
 
Primer Sequence 
pRETROSUPER forward CCCTTGAACCTCCTCGTTCGACC 
pRETROSUPER reverse GAGACGTGCTACTTCCATTTGTC 
Table 6 – Primers for sequenceing 
 
 
2.2.3 Transfection 
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2.2.3.1 Transient transfection of plasmid DNA 
 
For transient transfection of plasmid DNA using Lipofectamine 2000, cells 
were set up at an appropriate density in culture dishes (e.g. 1x105 per well of 
a 6well dish for A375MM and CHL-1 cells). 16-24 hours later DNA was 
transfected according to the manufacturer’s instructions. Both DNA (~5-10µg) 
and Lipofectamine 2000 were diluted in OptiMEM, incubated at RT for 5min, 
then combined and incubated for a further 20min before being added directly 
to the cells. Expression was then tested for after 24-48 hours. 
 
Cells were also transfected by nucleofection. Cells were pelleted by 
centrifugation, resuspended to 2 x 106 cells per ml in the appropriate 
nucleofection reagent and 100 µl added to a 1.5 ml tube containing 5 µg DNA. 
Cells and DNA were pipetted into a nucleofection cuvette and placed in a 
nucleofection device (Lonza) and subjected to the appropriate program. Pre-
warmed media was added to the cuvette and cells were carefully pipetted into 
a 100mm culture plate containing 10 ml medium and cultured under standard 
conditions.  
 
 
2.2.3.2 siRNA transfections  
 
On receiving of siRNA, RNase free water was used to dilute siRNA to 20µm. 
For siRNA experiments, 4x104 (A375MM), 8x104 (MV3 and CHL-1), 1.2x105 
(MDA-MB-231) and 1.5x105 (primary mouse melanocyte) cells were treated 
with 50 to 100nmol/L of specific siRNA with Hyperfect, The cells were then 
grown for 2 days in 6 well tissue culture plate. The cells were then trypsinised 
and counted, replated and retransfected at the above concentration. This 
process was repeated again at 4 days, and the cells finally used for an 
experiment at 6 days. 
 
 
2.2.3.3 siRNA sequence for RNA interference 
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Gene Accession 
No. 
Company, 
Cat No. 
Target Sequence 
AllStars 
Negative 
Control siRNA 
 Qiagen, 
1027281 
Nvegative control siRNA 
Mm_Pak2_1 NM_177326 Qiagen, 
SI01368654 
AAGAGATTATGGAGAAATTAA 
Mm_Pak2_2 NM_177326 Qiagen, 
SI01368668 
AAAGAAGGAATTGATCATTAA 
Mm_Nap1_1 NM_016965 Dharmacon, 
J-041033-09 
GGAGCAAGTGACCGAGAAT 
Mm_Nap1_2 NM_016965 Dharmacon, 
J-041033-
011 
TTGAAAAGGATGACGATAA 
Mm_Pak1 NM_011035 Dharmacon, 
L-048101-
00-0005 
ON-TARGETplus SMARTpool 
Mm_p34 XM_001000089 Dharmacon, 
L-043464-
01-0005 
ON-TARGETplus SMARTpool 
Mm_N-WASP NM_028459 Dharmacon, 
L-055607-
01-0005 
ON-TARGETplus SMARTpool 
Hs_Fascin1_1 NM_003088 Dharmacon, 
J-019576-07 
GAGCATGGCTTCATCGGCT 
Hs_Fascin1_2 NM_003088 Qiagen, 
SI00421799 
CACGGGCACCCTGGACGCCAA 
Hs_p34 NM_005731 Qiagen, 
SI02661414 
AAGGATTCCATTGTGCATCAA 
Hs_MT1-
MMP 
NM_004995 Dharmacon, 
L-004145-
00-0005 
ON-TARGETplus SMARTpool 
Hs_N-WASP NM_003941 Dharmacon, 
L-006444-
00-0005 
ON-TARGETplus SMARTpool 
Table 7 – siRNA oligo sequences  
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2.2.3.4 Retroviral Infections 
2x106 Phonenix-Ampho retroviral packaging cells were plated in a 100 mm 
dish and the following day cells were transfected using calcium chloride 
precipitation method. 5µg DNA in 440µl distilled H2O was mixed with 500 µl 2 
x HBS and 60 µl 2M CaCl2 dropwise with vigorous shaking followed by 
precipitation for 30 minutes at 37oC and dropwise addition to Phonenix 
Ampho cells. Viral supernatant was harvested at 12 h intervals, purified 
through a 0.45 µm filter and added to target cells at 1 x105 cells/well in 6 well 
dish with addition of polybrene at a final concentration of 5 µg/ml. After 3 
rounds of infection over 36 hrs, target cells were passaged into 100 mm 
dishes and 48 hours later selected with puromycin at 1 µg/ml (MDA-MB-231) 
and 3 µg/ml (CHL-1). All retrovirally produced cell lines were generated on at 
least 2 separate occasions to ensure the resulting phenotypes were 
consistent and, unless otherwise stated, all resulting cell populations were 
pools of selected colonies. 
 
2.2.3.5 FACS of GFP or mRFP positive cell populations 
 
A375MM cells stably expressing RFP-Lifeact, CHL-1 cells stably expressing 
GFP/RFP, GFP/RFP -X. tropicalis fascin, GFP/RFP -X. tropicalis fascin S33A, 
GFP/RFP -X. tropicalis fascin S33D and GFP-Lifeact were selected with 
2mg/ml Geneticin. Cell pellets of 1 x106 were resuspended in 1 ml PBS and 
put through a 40 µm strainer. Cells expressing RFP or GFP were then sorted 
using Becton-Dickinson FACSAria. Typically, the brightest 10 % of the 
positive cell population were isolated for experimental use. The FacScan was 
operated by Tom Gilbey, Beatson Institute. 
 
2.2.4 Protein immunoblotting 
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2.2.4.1 Protein extraction from cells or tissue 
Fresh tissue or cells in tissue culture dishes were washed with ice cold PBS 
and lysed in RIPA buffer with protease inhibitor cocktail and Halt phosphatase 
inhibitor cocktail for 10 min on ice. Cells were scraped and tissue were 
homogenized with glass tissue grinder on ice and the lysates were transferred 
to ice cold 1.5 ml tubes and then centrifuged at 13,000 rpm for 5 minutes at 4 
oC. The relatve protein concentration of the resulting supernatent was then 
determined using Precision Red Advanced Protein Assay Reagent and stored 
at –70 oC. 
 
 
2.2.4.2 Separation of proteins by polyacrylamide gel electrophoresis 
(SDS-PAGE) 
NuPAGE LDS Sample Buffer (4X) and NuPAGE Reducing Agent (10X) were 
used to dilute protein samples to give a 1x solution and heated at 95 oC for 3 
minutes. Samples were resolved on precast NuPAGE Novex Bis-Tris Mini 
Gels (10% or 4%-12% depend on size of protein of interest) according to 
molecular weight by electrophoresis in gel tanks with 1 x NuPAGE MOPS 
SDS Running Buffer at 200V for approximately 50 mins until the dye front had 
reached the bottom of the gel. 10ul of SeeBlue Plus2 Pre-Stained Standard 
was load on side as molecular weight marker.  
 
 
2.2.4.3 Western blotting 
Proteins, separated by polyacrylamide gel electrophoresis, were transferred 
from the gel to PVDF membrane between Whatman 3MM paper at 250mA for 
150 min in 1x NuPAGE transfer buffer. Membranes were blocked in TBST, 3 
% BSA for 1 hour at room temperature and incubated with primary antibody at 
the appropriate dilution, time and temperature as advised by the 
manufacturer. Membranes were washed 3 times with TBST for 5 minutes, 
incubated with the appropriate secondary antibody in TBST, 3% BSA for 1 
hour at room temperature and washed 3 times with TBST for 5 minutes. All 
incubations and washes were performed with gentle agitation. Proteins on 
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membranes were visualized using supersignal west femto maximum 
sensitivity substrate or supersignal west pico chemiluminescent substrate. 
The images were recorded and processed using GeneSnap software and Bio-
imaging system. (Syngene). Western blots shown in figures are 
representative of typical results obtained on multiple occasions for each 
experiment shown. Quantification of western blots for siRNA experiments was 
done using Image J to outline the bands on the blots and calculate the pixel 
density compared with the non-targeting control.  
 
2.2.5 Cell surface biotinylation assay 
 
Cell surface proteins were biotinylated by incubating the cells with 0.5 mg/ml 
sulfo-NHS-SS-biotin on ice for 15 mins.  Cells were then quenched with 
50mM NH4Cl and washed with ice cold PBS. Cells were lysed RIPA buffer 
and cleared cell lysate containing 400 µg total protein from each sample was 
incubated with NeutrAvidin Agarose Resin to pull down biotinylated proteins. 
The samples were then analyzed by immunoblotting for E-cadherin. Western 
shown in figures is representative of typical results obtained on multiple 
occasions for each experiment shown. 
 
2.2.6 Effector Domain Pulldown Assays 
The relative levels of GTP-bound RhoA, Rac, or Cdc42 were determined by 
an effector pulldown assay as described previously (Vidali et al., 2006). 
Briefly, primary melanocytes incubated with DMSO or 1 µM OHT as described 
in 2.14 were lysed in a buffer containing 50mM Tris HCl PH7.5, 1mM EDTA, 
1% Triton X-100, 150 mM NaCl and protease inhibitor cocktail, and the 
lysates were probed with glutathione-agarose immobilized GST-Rhotekin (for 
RhoA) or GST-PAK1-PBD (for Cdc42 or Rac) domain (Cytoskeleton Inc). 
Bound proteins were analyzed by immunoblotting with anti-RhoA, -Rac1/2/3, 
or -Cdc42 monoclonal antibodies. Quantification of relative level of active 
RhoA or Cdc42 was done using ImageJ to outline the bands on the blots and 
calculate the pixel density compared with the DMSO treated control. 
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2.2.7 Fluorescent gelatin degradation assay (Invadopodia 
assay) 
Gelatin from Porcine skin (Sigma) was labelled with Alexa Fluor 594 using 
Protein labeling kit (Invitrogen) according to manufacturer’s protocol. 
Coverslips were acid-washed and coated with 50 µg/ml poly-L-lysine for 15 
min, washed with PBS, and crosslinked with 0.5% glutaraldehyde for 15 min. 
The coverslips were then inverted on an 80 µl drop of 1mg/ml Alexa Fluor 594 
conjugated or Oregon Green 488-conjugated gelatin or FITC-conjugated 
collagen type I for 10 min. After washing three times with PBS, the coverslips 
were then quenched with 5 mg/ml sodium borohydride for 3 mins followed by 
another three time washing with PBS. Finally, coverslips were sterilized with 
70% ethanol for 5 min and incubated in complete growth medium for 1 hour 
before use. To assess the ability of cells to form invadopodia, cells were 
cultured on cross-linked fluorescent conjugated matrix for 16 hours for 
A375MM and 3 hours for MDA-MB-231 cells. CHL-1 cells were incubated 
overnight on cross-linked fluorescent conjugated matrix in presence of 5µM 
GM6001 MMP inhibitor and invadopodia were assessed 2 hours after 
washout of the inhibitor.  The area of degradation was quantified using an 
Image J plug-in written for this purpose (Manuel Forero-Vargas, unpublished 
data). Quantification of area of degradation was done in at least three 
independent experiments in duplicate for each assay. 
 
2.2.8 Three dimensional collagen I degradation assay 
3D collagen degradation assay was performed as described previously (Wolf 
et al., 2003a; Wolf et al., 2007), with modifications. 1x106 CHL-1 cells treated 
with NT, fascin, N-WASP, MT1-MMP siRNA or 5µM GM6001 MMP inhibitor or 
cells expressing both NT or fascin siRNA and mCherry-X. tropicalis fascin, X. 
tropicalis fascin S33A or X. tropicalis fascin S33D in 150 phenol red free 
medium were mixed with 150 µl rat tail collagen I containing 3 µl DQ FITC- 
labeled type I collagen monomers (2%), 16 µl 10xMEM and 11 µl 7.5% 
bicarbonate in well of 24 well plate. Mix polymerizes after 2 to 5 min at 20°C. 
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Put immediately in incubator. When collagen is cloudy, add each 300 µl 
phenolred-free medium.  After 40 h of culture, solid-phase collagen including 
cells was pelleted by centrifuge at 13,000 rpm for 5 minutes at 4 oC, and the 
supernatant containing released FITC-collagen fragments was analyzed 
spectrofluorimentically with excitation at 490 nm and emission at 520 nm 
(QuantaMasterTM 40 spectrofluorometer; Photon technology international). 
The degradation of fibrillar collagen for each sample was calculated as 
fluorescence released from DQ FITC-labeled type I collagen monomers 
subtracted by background fluorescence, which was calculated by pelleting 
nondigested cell-free collagen lattices. Quantification of degradation was done 
in at least three independent experiments in duplicate for each assay. 
 
2.2.9 Inverted Invasion Assay 
2.2.9.1 Set up of invasion assay 
Inverted invasion assays were performed as described previously (Caswell et 
al., 2007). Collagen I (PureCol Bovine Collagen, 3mg/ml) was concentrated to 
10mg/ml using vivaspin 15R (Sartorius Stedim Biotech). 8 part of 
concentrated collagen I was then mixed with 1 part of 10xMEM and pH 
adjusted to 7.4 ± 0.2 by addition of 0.1M NaOH. An aliquot of matrigel, stored 
at -70 oC, was thawed on ice and diluted 1:1 with ice-cold PBS. Then, 70 µl of 
mixture of collagen I and matrigel yielding a final collagen concentration of 
approximately 4.4 mg/ml and a final Matrigel concentration of approximately 
2.2 mg/ml was polymerized in transwell inserts containing 8µm pore-size 
micropore polycarbonate membrane filter (Corning) within a 24 well tissue 
culture plate (Falcon) for 2 hr at 37°C. Inserts were then inverted, 100 µl of 
cell suspension at a concentration of 5 x 10 per ml of medium was pipetted on 
to the underside of the transwell filter, the base of the 24 well plate was 
carefully replaced and the cells allow to adhere for 5 hours at 37°C. Transwell 
inserts were then placed in 1ml serum-free medium in 24 well plate, and 
100µl normal growth medium was placed on top of the matrix, providing a 
chemotactic gradient. For experiments involving chemical inhibitors, 
appropriate inhibitors were added to both the serum free medium below the 
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transwell and the medium above the matrigel plug.  
 
 
2.2.9.2 Quantification of invasion assay 
72 hours after seeding, invading cells were stained by placing 500 µl of serum 
free medium containing 4 µM calcein AM above and below transwell invasion 
assays and incubating for 2 hours at 37 oC and cells that did not cross the 
transfilter were removed with tissue and the remaining cells were visualized 
by confocal microscopy using a 10 x objective at an excitation wavelength of 
488 nm and emission wavelength of 515 nm; serial optical sections were 
captured at 10 µm intervals upwards from the underside of the transwell filter. 
The fluorescence intensity for each section was then measured using a plug-
in (Area calculator) in ImageJ, which allocates each pixel an intensity value 
and allows a threshold intensity level to be set, below which pixels are not 
displayed. The threshold intensity of the images was set in order to register 
only cells that lay within each individual optical section. Finally, the 
percentage of invading cells was calculated as the fluorescence intensity of 
cells invaded above 20 µg against the total fluorescence intensity of all cells 
within the images of sections taken. At least three independent experiments in 
duplicate for each sample were carried out.  
 
 
2.2.10 Transfilter migration assay  
Transwell inserts (Corning) were coated with 20 µg/ml human placenta 
laminin overnight, which then blocked with 1mg/ml BSA for 1 hour and wash 
three times with PBS. For A375MM and MDA-MB-231 cells, 6x104 cells in 
500µl serum free medium were seeded into the top chambers of a 24-well, 
8µm pore-size micropore polycarbonate membrane filter (Corning), and the 
lower chambers were filled with 1ml DMEM containing 10% FBS as a 
chemoattractant and incubated for 12 h at 37°C.  For MV3 and CHL cells 
3x104 cells in 500µl serum were seeded and incubated for 12 hours at 37°C. 
Cells remaining on the upper surface of the transfilter were then carefully 
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removed with a cotton swab, and the membranes were fixed and stained with 
DAPI and rhodamine phalloidin. Migration was quantified by counting the 
migrated cells (DAPI staining) in 5 random 20x magnification fields per filter. 
At least three independent experiments in duplicate for each sample were 
carried out.  
 
2.2.11 2D anchorage-dependent cell growth assay  
Primary melanocytes were incubated with DMSO or 1 µM OHT for 5 days and 
then cultured in medium without DMSO or OHT for another two days. At day 
0, 1x104 cells were plated in each well of 6 well plates, and number of cells 
were	   trypsinized and counted every two days (for primary melanocytes) from 
one well of 6 well plates for 8 day using CASY Cell Counter (Roche Innovats). 
For cancer cells (A375MM, MDA-MB-231, MV3 and CHL-1), at day 0, 1x104 
cells were plated in each well of 6 well plates. Cells were then trypsinized and 
the number of cells was counted every day for 5 days. Each point (Mean ± 
SEM) is derived from the mean of hemocytometer count of cells from three 
replicate dishes from three independent experiments. 
 
2.2.12 3D anchorage-independent cell growth assay (Agar 
growth assay)  
1.5 ml of 0.7% SeaPlaque agarose/F-12/10% FBS was added to each well of 
6-well dishes, which incubate at RT for 1 hour. 1 × 104 cells were plated in 1 
ml of 0.35% SeaPlaque agarose/DME/10% FBS on the top. Once solidified, 
the agarose was covered with 2.5 ml DME/10% FBS, which was changed 
twice weekly. Digital images were captured 4 wk later at room temperature 
with a microscope (Axiovert Stemi 200C; Carl Zeiss, Inc.) using a 1.0× 
objective with a Canon 1000D camera processed with ImageJ. Number of 
colony in soft agar was quantified by determining the number of colonies >0.5 
mm in diameter 4 wk after plating. Relative size of colony was determined by 
measuring the diameter of 20 biggest colonies in each sample. Three 
replicate dishes from three independent experiments were quantified.  
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2.2.13 Flow cytometry  
Cells were pre-incubated for 2 hr with 10 uM BrdU and fixed in 70% 
ethanol/30% PBS overnight at -20 °C. Cells were then pellet, washed with 
PBS and bleached with melanin bleach kit. Cells were treated with 
pretreatment solution A for 2 min and followed with extensive wash with PBS 
and incubated with solution B for 1 min. After washes with PBS, cells were 
incubated with 4N HCl for 15 min and stained with mouse Anti-BrdU antibody 
(Dako, 1 in 40) in PBT (0.1% BSA+0.01% Tween 20 in PBS) for 30 min and 
followed with Alexa-488 conjugated goat anti-mouse secondary antibody (1 in 
50) in PBT for 30 min. After washes, cells were stained with propidium iodide 
(1 mg/ml) and RNaseA (250 µg/ml) for 30 min before processed on BD 
FASC-Calibur (BD bioscicence). 
 
 
2.2.14 Immunofluorescence 
Cells cultured on crosslinked gelatin coverslips were fixed and processed for 
immunofluorescence. For 2D or 3D staining with antibody to fascin, β-actin or 
cells expressing GFP-fascin, cells were fixed with -20oC methanol at -20oC for 
10 min and blocked for 30 min with Image-iT FX Signal Enhancer. For all 
other staining, cells were fixed in 4% formaldehyde and permeabilized for 4 
min in 0.1% Triton X-100 in PBS and blocked with Image-iT FX Signal 
Enhancer for 30 min and incubated with primary antibody for 1 hours 
(overnight for 3D staining). Cells were washed 3 times for 5 min (30 min for 
3D staining) in PBS and primary antibodies were detected with the use of 
appropriate species- and class- specific Alexa350, Alexa488, Alexa594 and 
Alexa647-conjugated secondary antibodies for 30 min (overnight for 3D 
staining). Samples were then examined using Olympus FV1000 inverted laser 
scanning confocal microscope or Nikon A1 inverted laser scanning confocal 
microscope or using a Zeiss Axioskop2 microscope equipped with a digital 
camera C4742-95 (Hamamatsu). 
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2.2.15 Live cell imaging  
 
2.2.15.1 Live cell imaging of invadopodia dynamics 
 
A375MM cells stably expressing RFP-Lifeact were transfected with control or 
fascin siRNA and cultured on Oregon Green 488-conjugated crosslinked 
gelatin overnight in presence of 5µM GM6001 MMP inhibitor. 1 hour after 
washout of the inhibitor, cells were recorded in a humidified CO2 chamber at 
37 oC with an inverted fluorescence microscope (Nikon) with a motorized 
stage. Timelapse images were captured using Metamorph software 
(Molecular Devices) every 5 min for 15 h.  
 
 
2.2.15.2 Live cell imaging of cell morphology during invasion  
CHL-1 cells stably expressing GFP-Lifeact were plated on a glass bottom 
microwell 35mm petri dish (MatTek Cor.) at 2x105 and starved overnight. The 
medium was then aspirated and 200µl of a mixture of collagen I-Matrigel 
(prepared as described in 2.2.9.1) was applied on top of cell monolayer and 
the gel was allowed to polymerize in 37 oC for 2 hours. The normal growth 
medium was added to the dish and samples were incubated for 48 hours. Cell 
that has invaded into the gel was imaged. Timelapse images were captured 
every 10 mins for 10 h using an Olympus FV1000 confocal microscope in a 
37 oC chamber with 5% CO2.  
 
 
2.2.15.3 Live cell imaging of cell migration on 2D surface 
For 2D melanocytes imaging, cells were plated overnight in glass bottomed 
dishes, which were coated with 10 µg/ml fibronectin for 1 h at 37 °C, and then 
incubated with 1% bovine serum albumin for 20 min. Time-lapse video 
microscopy was performed using a Nikon TE2000 microscope in a 37°C 
chamber with 5% CO2. 
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2.2.15.4 Live cell imaging of cell morphology on 3D collagen I matrix 
For live imaging of melanocytes on 3D think layer of collagen, Fibrillar rat-tail 
Collagen I was prepared from a 3 mg/ml as described in 2.11, 500 ul was then 
set in wells of 12 well plate for 1 h at 37 °C. Cells were seeded on top of 
collagen in medium and allowed to adhere for 24 hr. Time-lapse video 
microscopy was performed using a Nikon TE2000 microscope in a 37°C 
chamber with 5% CO2. For evaluation of the percentage of elongated cells, a 
cell was considered elongated when its longest dimension was twice the 
shortest.  
 
2.2.15.5 Fluorescence recovery after photobleaching (FRAP) 
FRAP was conducted using the following settings: pixel dwell time 4 µs/px, 
picture resolution 256 x 256, 2 % 488 nm or 561 nm laser power. GFP or 
mRFP signals at invadopodia were bleached using 45 % 405 nm laser power, 
4-µs/pixel dwell time for 1 region of interest frame. Images were captured 
every 0.428s. Recovery of the signal was measured using the region analysis 
tool of the Olympus FV1000 viewer software and averaged in Excel. The 
resulting data was corrected for imaging dependent intensity loss (non-
specific bleaching) and then normalized to the pre-bleached images. Each 
normalized single curve was then exported into SigmaPlot (Systat Inc.) for 
exponential curve fitting. Data were fit using the following exponential 
functions: y = y0 + a • (1 – e-bt). The half-time of recovery for each curve was 
calculated using the formula ln2 / b, where b was obtained from the 
exponential curve fit. The percentage of recovery was calculated using 
formula: Xm = F (∞)/F (I). Where F (I) denotes the average fluorescence 
intensity before photobleaching for each normalized curve, F (∞) refers to the 
average fluorescence intensity derived from the plateau for each normalized 
curve. 
 
 
2.2.16 Ex-vivo imaging of melanoblast migration 
Experiment set up was previously reported with modifications (Mort et al., 
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2010). Briefly, a freshly dissected E15.5 embryonic skin sample was 
sandwiched between a nucleopore membrane (Whatman) and a gas 
permeable Lumox membrane in Greiner Lumox culture dish (Greiner Bio-One 
GmbH) so that the epidermial side of skin was in contact with lummox 
membrane.  To immobilize the sample, Growth Factor Reduced Matrige was 
used to cover the whole assembly and incubate at 37°C for 10 min. Culture 
medium (Phenol red free DMEM supplied with 10% FBS and 100 µg/ml 
primocin was finally added. For drug treatment, drugs were added to Matrigel 
and medium 1 hr before imaging. All the drugs were used at 10µM, except 
CK869 and CK312, which was used at 20 µM, latrunculin A was used at 
0.3µM and nocodazole was used at 1µM. Timelapse images were captured 
using an Olympus FV1000 or Nikon A1 confocal microscope in a 37°C 
chamber with 5% CO2 at 20x magnification objective or 60x magnification 
objective for 5 hr. 
 
 
2.2.17 Histology and staining of tissue 
2.2.17.1 Immunohistochemistry (IHC)  
Formalin-fixed paraffin-embedded sections were deparaffinized and 
rehydrated by passage through xylene and a grade alcohol series. Antigen 
retrieval was performed by incubation of sections in microwave-heated 1x 
citrate buffer, pH 6.4 in a pressure cooker (see 2.2.17.2). For IHC using 
alkaline phosphatase substrate kit, sections were blocked in 10% serum for 1 
hr and then sections were washed three times with 1xTBST and incubated 
with primary antibody at RT. Sections were washed three times with 1xTBST 
and incubated with secondary antibody for 1 hr and after 5 min wash with 1x 
TBST, signal for secondary antibody was amplified using Vectastain ABC kit. 
The staining was visualized with alkaline phosphatase substrate kit according 
to manufacture’s introduction (Vector laboratories, Inc.) and hematoxylin was 
used as the nuclear counterstain. For IHC using Envision kit, sections were 
blocked with peroxidase block for 5 min. the sections were washed and 
incubated with primary antibody diluted in antibody dilute. The sections were 
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then washed three times with 1xTBST and incubated with peroxidase labeled 
polymer. After three times wash in 1xTBST, the staining was visualized with 
Liquid DAB + substrate-chromogen solution according to manufacture’s 
introduction. Slides were counterstained with haematoxylin, prior to being 
dehydrated in increasing concentrations of ethanol and mounted. For 
immunofluorescence on embryo sections, after antigen retrieval, sections 
were blocked with 5% serum for 1 hr and incubated with primary antibody 
overnight at 4 °C. Sections were then washed three times in PBS and 
incubated with fluorescent conjugated secondary antibodies for 1 h at RT and 
mounted with Prolong Gold Antifade reagent. For BrdU assay, mice were i.p. 
injected with 2.5 mg BrdU for either 2 hr or 24 hr before embryo dissection. 
For hematoxylin and eosin stain stainings, all steps were done according to 
standard protocols were performed by C. Nixon and colleagues, Beatson 
Institute. 
 
2.2.17.2 Miarowave antigen retrieval 
Microwave antigen retrieval was performed by pre-heating 1500ml Citrate 
buffer pH 6.4 in an open pressure cooker for ~15minutes until boiling. Slides 
were then placed into the solution and heated with the lid on until the pressure 
was optimised. Slides were then heated for a further 3-4 minutes, before 
being removed and allowed to cool at room temperature for 30 minutes. 
 
2.2.17.3 Whole-mount X-Gal staining of embryos 
Embryos or the dorsal skin from new born pups were fixed in 0.25% 
glutaraldehyde in PBS at 4 °C for 40 min, washed in detergent buffer and 
stained overnight in X-Gal buffer containing 2 mg/ml X-Gal in 
dimethylformamide. For quantification of the epidermis-dermis distribution of 
melanoblasts in embryos, X-Gal stained embryos were paraffin-embedded, 
sectioned and counterstained with hematoxylin or eosin.  
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2.2.17.4 Whole-mount immunofluorescence staining of embryos or skin 
explants 
For whole mount immunofluorescence, embryos or skin explants were fixed in 
4% paraformaldehyde at 4 °C overnight. Embryos or skin explants were then 
washed 3X in PBS containing 1% Triton for 30 min and incubated in blocking 
buffer (PBS 1% triton+ 10% FBS 0.2% sodium azide) for 1 hr at RT. Embryos 
or skin explants were washed another two times with blocking buffer and 
incubated in blocking buffer containing primary antibody for 4 days at 4 °C. 
Embryos or skin explants were washed 3X in blocking buffer for 1 hr and 3x in 
PBS 1% Triton for 10 min. Embryos or skin explants were then incubated with 
secondary antibody in blocking buffer for 4 days at 4 °C. Embryos or skin 
explants were washed 3x in PBS 1% Triton for 10 min and stored in dark at 4 
°C. 
 
2.2.18 Generation, maintenance and treatment of mouse 
colonies 
2.2.18.1 Transgenic mice  
All experiments were performed according to UK Home Office regulations. 
The Rac1 floxed mice in C57BL6/J background were previously described 
(Walmsley et al., 2003). Tyrosinase Cre A (Tyr::Cre) mice in C57BL6/J 
background were previously described (Delmas et al., 2003). The Tyr::Cre 
transgene is integrated on the X chromosome (Delmas et al., 2003). 
Therefore, only Rac1 f/f Tyr::Cre+/o males were analyzed as Rac1 null, which 
will carry one copy of Tyr::Cre and Rac1 f/f Tyr::Cre+/o female were excluded 
from this study. Tyr::Cre deletion of Rac1 caused a shakiness of the mice that 
required culling at around 3 week of age.  This is likely due to some 
expression of the Cre in the neuronal lineage (L. Larue, and R. Mort, 
unpublished). There are no phenotypes associated with Rac1 f/+ Tyr::Cre+/o 
animals. Therefore, heterozygous genotype with genotypes: Rac1 +/+ 
Tyr::Cre+/o , Rac1 +/+ Tyr::Creo/o , Rac1 f/+ Tyr::Creo/o served as control for 
this study. LacZ/EGFP (Z/EG) mice in C57BL6/J background were previously 
described (Novak et al., 2000), N-WASP floxed mice in 129SvEv background 
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were previously described (Snapper et al., 2001) which were backcrossed for 
6 generations with C57BL6/J mice. DCT-LacZ (DCT::LacZ) mice in mixed 
background were previously described (Mackenzie et al., 1997). Tyrosinase 
Cre-ERT2 (Tyr::Cre-ERT2) in C57BL6/J background were described in 
(Yajima et al., 2006). GFP-Lifeact floxed mice were generated by David 
Stevenson and Douglas Strathdee (Beatson institute) and INK4a-deficient 
mice in C57BL6/J background were described in (Ackermann et al., 2005; 
Serrano et al., 1996).  
 
2.2.18.2 Gentotyping 
Genomic DNA was prepared from tail or skin biopsies and genotyping of the 
transgene was performed as previously described (McClive and Sinclair, 
2001; Serrano et al., 1996) and by the company Transnetyx (Memphis, TN). 
 
 
2.2.19 Quantifications 
2.2.19.1 Melanoblast/mealnocyte migration speed, euclidean distance 
and persistence  
For melanoblast migration in skin explants, individual cell was tracked 
manually using ImageJ, Manual Tracking plugin, with distance/time 
measurements taken every 5 min for 3 hr. For melanocyte migration on 2D 
surface, individual cell was tracked manually every 10min for 15 hr. The 
migration speed (cell path/time), euclidean distance (the net movement that 
cell made), and persistence (euclidean distance/ cell path) were calculated 
using Chemotaxis Tool plugin. More then 60 cells were examined for each 
skin explants and mean value was taken, and each experiment was repeated 
with at least 3 skin explants. Mean values ± s.e.m and statistical analysis 
were calculated and plotted using Graphpad Prism (Graphpad Software). 
Two-tailed unpaired t-tests were conducted to determine significance. 
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2.2.19.2 Quantification of Number of Filopodia-Like Protrusions 
XY-series of sample stained with rhodamine phalloidin and DAPI were 
captured at 0.5µm Z-spacings. The total number of filopodia like protrusions 
(judged to be extending from the cell periphery) in each Z-stack was 
determined. The number of filopodia-like protrusions per cell was then 
determined by calculating the total number of filopodia like protrusions against 
the total number of cells (DAPI staining) in the Z-stack. Each siRNA treated 
cell population was analyzed in 3 random 20x magnification fields and 
duplicate in three independent experiments. 
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Chapter III 
The Actin-Bundling Protein Fascin 
Stabilizes Actin in Invadopodia and 
Potentiates Protrusive Invasion 
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3.1 Summary 
One of the defining features of invasive tumor cells is that they can degrade 
ECM and invade through the use of invadopodia.  Previous studies have 
shown a role for fascin, an actin-bundling protein, in metastasis and invasion 
as well as tumour progression in several types of cancer. This work led to the 
discovery that fascin is an integral component of invadopodia in multiple 
cancer cell types and that fascin is required for the assembly of the actin 
cytoskeleton in these structures as well as for the degradation of matrix. The 
phosphorylation state of fascin at S39, a PKC site, contributes to its regulation 
at invadopodia. Fascin is a very stable component of invadopodia and its 
presence enhance the stability of actin structures at invadopodia.  Thus we 
propose a major role for fascin in invasive migration in addition to its already 
established role in the formation of filopodia. Furthermore, fascin is required 
for invasive migration into collagen I-Matrigel gels particularly in cell types that 
use an elongated mesenchymal type of motility in 3D. 
 
3.2 Introduction 
Fascin is an evolutionarily conserved actin bundling protein important for 
filopodia dynamics in primary cells (Yamakita et al., 2009) and several types 
of cancer cells (Adams, 2004; Hashimoto et al., 2006; Vignjevic et al., 2006).  
Fascin forms stable bundles with slow dissociation kinetics in vitro (Tseng et 
al., 2001) and is regulated by phosphorylation of serine 39 by protein kinase C 
(Adams, 2004b).  Fascin is not expressed in normal epithelia but is often 
upregulated in epithelial cancers and is associated with a poor prognosis and 
higher grade (Hashimoto et al., 2004; Vignjevic et al., 2007). 
Invadopodia are protrusions on the ventral surface of cells that have matrix 
degrading activity and adhesive functions (Buccione et al., 2009).  Tumor cells 
on a thin matrix in vitro form invadopodia rich in actin and other actin 
assembly proteins such as Arp2/3 complex and N-WASP (Baldassarre et al., 
2006b; Yamaguchi et al., 2005).  In vivo, tumor cells are thought to form 
structures resembling invadopodia (Wang et al., 2005; Wyckoff et al., 2007) 
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but their function in metastasis isn’t clear. Invadopodia have highly dynamic 
actin that is assembled by both Arp2/3 complex and formins (Baldassarre et 
al., 2006; Lizarraga et al., 2009; Yamaguchi et al., 2005); they also contain 
components of membrane trafficking machinery such as dynamin and 
cortactin (Buccione et al., 2009) and have been compared with focal 
adhesions and podosomes (Buccione et al., 2004; Gimona et al., 2008). 
Mammalian cells migrate using both actin-based protrusions and myosin-
based contractile activities.  Tumor cells moving in a 3D matrix employ two 
major modes of motility: mesenchymal type motility in which cells are 
elongated and protrusive and use protease activity to navigate through dense 
matrix and amoeboid movement in which cells are more rounded and use 
acto-myosin contractility to squeeze through the matrix in a bleb-like fashion 
(Friedl and Wolf, 2003; Wolf et al., 2003a). 
In this Chaper, I have described a noval role of fascin as an integral 
component of invadopodia and that it is important for the stability of actin in 
invadopodia. I further implicated fascin in invasive migration into collagen I-
Matrigel gels and particularly in cell types that use an elongated mesenchymal 
type of motility in 3D. This work provides a potential molecular mechanism for 
how fascin increases the invasiveness of cancer cells.  
 
3.3 Results 
3.3.1 Fascin expression in human melanocyte and melanoma 
cells 
Multiple studies have reported a low or absence of fascin expression in 
normal epithelial tissue but highly upregulated in more aggressive and 
metastatic epithelial cancers and that high fascin expression is a significant 
independent prognostic indicator of poor outcome (Hashimoto et al., 2005; 
Machesky and Li, 2010). We therefore tested if this is the case for human 
melanoma. We first investigated the expression of fascin in a panel of human 
melanoma cell lines as well as normal primary human melanocytes by 
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western blot. Fascin expression was observed in all human melanoma cell 
lines and normal neonatal and adult epidermis melanocyte cells (Figure 3.1). 
Overall, no significant difference in fascin expression between human 
melanocyte and melanoma cells. 
 
3.3.2 Fascin Localize at filopodia and dorsal microspikes in 
A375MM melanoma cells  
A375MM melanoma cells are derived from the metastases of metastatic 
melanoma, thus are highly invasive (Kozlowski et al., 1984). To study the 
effect of fascin in human melanoma cell invasion, the distribution of fascin 
was analyzed in a A375MM cells. Phalloidin staining of A375MM cells 
revealed the formation of both filopodia at cell periphery and microspikes on 
the dorsal surface (Figure 3.2A). Immunostaining with fascin antibody (Figure 
3.2B) or exogenous expression of GFP-fascin showed a localization of fascin 
at both peripheral filopodia and dorsal microspikes (Figure 3.2C, E). Fascin-
enriched filopodia can also be observed on the ventral surface of cell body 
using total internal reflection fluorescence microscopy (Figure 3.2D). 
However, exogenous expression of GFP-fascin in A375MM cells did not 
obviously alter the general cell morphology.  
 
3.3.3 Fascin is important for filopodia formation in A375MM 
melanoma cells  
To investigate the function of fascin in filopodia, we used two independent 
siRNA to knock down fascin in A375MM cells by 90% and 85% respectively 
(Figure 3.3 A and B). We found that fascin knockdown did not affect cell 
proliferation (Figure 3.3 C). For both siRNA, fascin knockdown, however, 
results in a more than 1.6 fold reduction in the formation of peripheral filopodia 
without affecting the cell spreading and formation of lamellipodia (Figure 3.4 A 
and B). In addition, we also observed the decrease in the formation of 
microspikes in the dorsal surface of the cell with the remaining spikes 
appearing buckled (Data not shown). These findings are consistent with a 
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Figure 3.1. Fascin Is Expressed in Melanocytes and 
Melanoma Cells
(A) Western blot analysis of fascin expression in human (A 
melanocyte: adult epidermal melanocyte; N melanocyte: 
neonatal melanocyte; A375MM melanoma; MW266-4 
melanoma; MV3 melanoma; CHL-1 melanoma cell lines. Actin 
was probed as loading control. (B) Western blots were 
quantified and the relative intensity of fascin signal was 
normalised to total actin. The results shown are the means
±SEM of three independent experiments.  
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Figure 3.2. Localisation of fascin at filopodia in A375MM cells
Combined Z-stack images (1µm) of A375MM cells adherent on gelatin and stained with 
phalloidin (A) or anti-fascin (B) or expression of GFP-fascin (C) develop numerous filopodia 
at the periphery and microspikes on the dorsal surface and fascin localized at both 
peripheral filopodia and dorsal microspikes. (D) Total internal reflection microscopy images 
of A375MM cell expresses GFP-Fascin.  Scale bar is 10µm. (E) western blot showing 
A375MM cells transfected with human GFP-fascin. Immunoblot was probed with fascin 
antibody.
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Figure 3.3 Fascin knockdown does not alter cell growth rate in A375MM melanoma 
cells
(A) Cell lysates from A375MM human melanoma cells transiently transfected with non-
targeting pool control siRNA (NT) or fascin siRNA (sifascin 1 and sifascin 2) were analyzed 
by immunoblotting and probed for fascin. Membranes were also probed with actin antibody 
as a loading control. (B) Relative fascin expression level was qantified from 4 individual 
blots. (C) 1x104 A375MM cells express NT or fascin siRNA were plated in each well of 6 
well plates, and number of cells was counted every day for 3 days. Each point (Mean ± 
SEM) is derived from the mean of hemocytometer count of cells from three replicate dishes 
from two independent experiments. 
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 previous report (Vignjevic et al., 2006) using B16F1 mouse melanoma cells 
and suggest that fascin is required for filopodia formation in A375MM cells 
and may help to maintain the filopodia stiffness.  To further confirm the 
specificity of fascin knockdown phenotype on filopodia formation, we set up 
rescue experiment by expressing the GFP-tagged X. tropicalis fascin (GFP-
Xtfascin) refractory to RNAi in fascin siRNA treated cells (Hashimoto et al., 
2007). Fascin knockdown cells transfected with GFP-Xtfascin resulted 
formation of numerous filopodia on both cell periphery (Figure 3.4A, B. 
western blot of protein expression refer to Figure 3.20A) and dorsal side (Data 
not shown) with the number of filopodia statistically the same as control cells. 
Therefore, fascin knockdown phenotype could be rescued by expression of 
GFP-Xtfascin cDNA.  
 
3.3.4 Fascin is localized at invadopodia in A375MM melanoma 
cells. 
Early studies indicated that fascin is highly expressed in the invasive front 
when cancer cells start to invade into the local surrounding tissue (Hashimoto 
et al., 2005; Machesky and Li, 2010; Vignjevic et al., 2007). Invadopodia are 
finger-like proteolytically active protrusions that extend from the ventral 
surface of the cell into the surrounding matrix, causing the focal pericellular 
degradation of ECM to promote cell invasion (Ayala et al., 2006; Buccione et 
al., 2009; Weaver, 2006; Yamaguchi et al., 2006). Therefore we examined 
whether fascin was localized to invadopodia. Interestingly, 
immunofluorescence with two different antibodies to target endogenous fascin 
showed colocalization of fascin with actin and p34-Arc (ARPC2), a subunit of 
Arp2/3 complex, at invadopodia (Figure 3.5 A and B). In addition, GFP-fascin 
also colocalized with cortactin at invadopodia (Figure 3.5 C). Thus, fascin 
clearly localizes at invadopodia in A375MM cells. 
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Figure 3.4. Fascin knockdown reduces filopodia formation in A375MM cells
(A)  F-actin organization in A375MM cells. A375MM cells transfected with fascin siRNAs (siFascin 
1 and siFascin 2) adherent on gelatin were fixed and stained with rhodamine phalloidin. Fascin 
knockdown cells showed fewer peripheral filopodia compared to cells transfected with control NT 
siRNA and cells expressing both Fascin siRNA (siFascin 1) and rescued with GFP-X.tropicalis 
fascin. Examples of filopodia are arrowed. Bars, 10µm.
(B) Quantification of filopodia. The number of peripheral fiopodia was counted from 90 phalloidin 
stained cells in three independent experiments.  Error bars: Mean ± SEM. **, P< 0.01 compared 
to control cells by t-test.
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Figure 3.5. Fascin localize to invadopodia in A375MM melanoma cells
(A) A375MM cells on Oregon Green 488 gelatin matrix (shown as grey) immunolabeled with anti-
fascin (55K2) and anti-p34-Arc (Arp2/3 complex). Both X-Y and X-Z view were showen. Individual 
invadopodia were white arrowed (B) A375MM cells on Oregon Green 488 gelatin matrix 
immunolabeled with anti-fascin (primary SPM133) and anti-actin. (C) A375MM cells expressing 
GFP-fascin on Alexa594 labelled gelatin matrix immunolabeled with anti-cortactin. Example 
invadopodia are arrowed. Scale bar is 10µm.
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3.3.5 Fascin is localized throughout the comet structure of 
invadopodia and localization of filopodia proteins at 
invadopodia.  
A recent study of invadopodia dynamics revealed a comet-like organization 
resembling bacteria-propelling actin tails with cortactin and Arp2/3 complex 
distributed throughout the comet structure, while N-WASP was only 
concentrated at the “head” section (Baldassarre et al., 2006). Consistent with 
that study, we also observed numerous comet tails, which appeared tethered 
near the head with a dynamic tail that spins, at degradation sites in A375MM 
cells, somewhat reminiscent of a corkscrew (Movie 1 Part 1). Only large 
invadopodia appeared as obvious comets (Figure 3.6). We found that Arp2/3 
complex, cortactin, and fascin localized throughout comet heads and tails 
(Figure 3.6A, B, C and Movie 1 Part 2 and 3), whereas N-WASP concentrated 
mostly in the head (Figure 3.6D Part 4 and 5), which may be recruited to and 
activated at comet heads by phosphoinositides (Figure 3.6). In addition to 
fascin, IRSP53, IRTKS and mDia2, which are proteins that promote the 
formation of filopodia (Millard et al., 2007; Scita et al., 2008; Yang et al., 
2007), also localized at invadopodia in A375MM (Figure 3.7). Taken together, 
these data suggested that invadopodia might be a hybrid structure containing 
both actin branches and bundles. 
 
3.3.6 Fascin is required for invadopodia formation and ECM 
degradation in human A375MM melanoma cells. 
To determine whether fascin function is necessary for invadopodia formation, 
RNA interference was used to knock down fascin in A375MM cells. A375MM 
cells expressing control or fascin siRNA were cultured on crosslinked Oregon 
Green 488-conjugated gelatin or FITC-conjugated collagen I matrix for 16 
hours. Cells were then fixed and stained for actin and cortactin to visualize the 
invadopodia puncta (Figure 3.8A).  The area of degradation was quantified 
using a semi-automated ImageJ plugin (created by John Dawson and Manuel 
Forero-Vargas, Birmingham University).  The total areas of degradation per  
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Figure 3.6. Localization of different proteins at invadopodia-associated actin comets
(A-D) A375MM cells were incubated on crosslinked gelatin matrix for 16 hours and then fixed and 
proteins were localized as labeled on the panels. 3D reconstruction of individual actin comets are 
shown with head indicated by green dashed circles and tail indicated by cyan dashed line. All 
scale bars are 10µm.
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Figure 3.7. Localization of filopodia proteins at invadopodia
A375MM transiently transfected with GFP-mDia2 (A), myc-IRTKS (B) and myc-IRSP53 
(C) was incubated on crosslinked Alexa594 conjugated gelatin matrix for 16 hours and 
fixed. Myc-IRTKS and myc-IRSP53 transfected cells were stained with 9E10 myc 
antibody followed by secondary Alexa488 conjugated antibody. Cells expressing low 
levels of myc-IRSP53 were selected for testing the localization. Examples of 
invadopodia are arrowed. Bars, 10µm.
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Figure 3.8. Fascin is required for the formation of invadopodia in A375MM cells. (A)
Representative images from in vitro matrix degradation assay. Cells transfected with NT 
control or fascin siRNAs (siFascin 1 and siFascin 2) on Oregon Green 488 matrix (shown as 
grey) and stained with rhodamine phalloidin and anti-cortactin to localize invadopodia. the 
scale bar is 10µm. (B) Left: relative area of degradation per cell on gelatin (black) and 
collagen I (white). Middle: number of invadopodia per cell on gelatin (black) and collagen I 
(white). Right: area of degradation per invadopod of the ten biggest degradations per cell on 
gelatin (black) and collagen I (white). All error bars indicate mean ± standard error of the 
mean (SEM). **p < 0.01 by t test. Invadopodia were defined as puncta enriched for actin, 
cortactin, and gelatin degradation.
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cell in fascin-depleted cells were reduced by more than two-fold compared 
with control cells (Figure 3.8B). To determine whether there was a change in 
the size of individual invadopodia, we also measured the area of degradation 
from individual invadopodia from control and fascin knockdown cells. Fascin 
depletion in A375MM cells results in about 1.6-fold reduction the area of 
degradation of individual invadopodia (Figure 3.8B). Finally, there was more 
than three-fold reduction in the number of invadopodia per cell in fascin 
knockdown cells (Figure 3.8B). Together, this data indicates that fascin is 
important for invadopodia formation by affecting both the number and size of 
invadopodia in A375MM cells and this effect is not matrix specific.  
 
3.3.7 Fascin is localized at peripheral membrane ruffles and 
invadopodia in human CHL-1 melanoma cells. 
In order to determine whether the effect of fascin on invadopodia formation is 
cell type specific, CHL-1, another human melanoma cell line, which has a 
moderate level of fascin expression was used (Figure 3.1). Moreover, the 
morphology of this cell line was distinct to A375MM, with cells showing a 
highly ruffling morphology but very few filopodia like protrusions. In contrast to 
A375MM cells, CHL-1 cells barely form any filopodia and immunostaining of 
endogenous fascin with antibody or transient expression of GFP-fascin in 
CHL-1 cells showed the colocalization of fascin with actin or p34-Arc in 
peripheral membrane ruffles (Figure 3.9A). Importantly, We found the 
colocalization of endogenous fascin or GFP-fascin with actin or p34-Arc at 
invadopodia (Figure 3.9A,B) indicates that fascin localization at invadopodia is 
not cell type specific.  
 
3.3.8 Fascin is required for invadopodia formation and ECM 
degradation in human CHL-1 melanoma cells. 
To test whether the endogenous fascin is important for invadopodia function, 
fascin levels were depleted by transiently transfecting cells with two individual 
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Figure 3.9. Fascin localize to invadopodia in CHL-1 melanoma cells
(A) CHL-1 human melanoma cells on Oregon Green 488 gelatin matrix (gray) with anti-fascin 
(55K2) and anti-actin. (B) CHL-1 cells expressing GFP-fascin on Alexa594 gelatin matrix (gray) 
stained with anti-p34-Arc (ARPC2). Arrows show individual invadopodia. .Scale bar is 10µm.
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 siRNA in CHL-1 cells (Figure 3.10A). No dramatic change in cell growth was 
observed (Figure 3.10B). Moreover, no huge morphology change was 
observed in CHL-1 cells on tissue culture plastic, although CHL-1 cells were 
slightly more spread and less ruffling in the absence of fascin (Data not 
shown).  
Because CHL-1 cells were very efficient to form invadopodia as compared to 
A375 cells, which the whole area under the cells was often degraded after 
culture overnight on crosslinked gelatin (Figure 3.11B), which makes the 
quantification of degradation by individual invadopodia become impossible. 
Interestingly, A357MM cells only form invadopdia under the centre of the cell 
body (Figure 3.12A), which has been reported previously to be close to Golgi 
complex (Baldassarre et al., 2003) and this close spatial relationship with the 
Golgi complex is believed to be important for invadopodia function. However 
invadopodia formed by CHL-1 cells were all over the cell body (Figure 3.11B), 
suggesting that it may not be necessary for invadopodia or degradations to be 
close to the Golgi complex in all cell types.   
To explore the role of fascin in invadopodia formation in CHL-1 cells, we used 
a different protocol. In this case, cells express NT or fascin siRNA were plated 
on crosslinked gelatin or collagen I overnight in presence of 5µm of 
metalloprotease inhibitor GM6001. Cell capacity to form invadopodia was then 
assessed by wash off the GM6001 for 2 h. Fascin depletion in CHL-1 cells 
results in a significant reduction in the area of degradation per cell as well as 
area of degradation of individual invadopodia on both crosslinked gelatin and 
collagen I matrix. In addition, we observed a significant decrease in the 
number of invadopodia per cell in fascin knockdown cells (Figure 3.12B, C). 
Furthermore, N-WASP depletion in CHL-1 also reduces invaodpodia 
formation (Figure 3.12 A-C). Together, this data indicates that fascin is 
important for invadopodia formation by affecting both the number and size of 
invadopodia in CHL-1 cells. This effect thus is not matrix specific and is 
conserved in melanoma cells.   
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Figure 3.10 Fascin knockdown does not alter cell growth rate in CHL-1 melanoma 
cells
(A) Cell lysates from CHL-1 human melanoma cells transiently transfected with non-
targeting pool control siRNA (NT) or fascin siRNA (sifascin 1 and sifascin 2) were analyzed 
by immunoblotting and probed for fascin. Membranes were also probed with actin antibody 
as a loading control.  (B) 1x104 CHL-1 cells express NT or fascin siRNA were plated in 
each well of 6 well plates, and number of cells was counted every day for 3 days. Each 
point (Mean ± SEM) is derived from the mean of hemocytometer count of cells from three 
replicate dishes from two independent experiments. 
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Figure 3.11. Comparison of invadopodia formation by A375MM and CHL-1 melanoma 
cells
(A)A375MM or (B) CHL-1 human melanoma cells were plated on Oregon Green 488 gelatin 
matrix for 16 h. Cells were fixed and stained with anti-p34. Scale bar is 10µm.
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Figure 3.12. Fascin is required for the formation of invadopodia in CHL-1 cells. (A) Cell 
lysates from CHL-1 human melanoma cells transiently transfected with non-targeting pool control 
siRNA (NT) or N-WASP siRNA were analyzed by immunoblotting and probed for N-WASP. 
Membranes were also probed with actin antibody as a loading control.  (B)Representative images 
from in vitro matrix degradation assay. Cells transfected with NT control, fascin siRNAs (siFascin 1 
and siFascin 2), N-WASP siRNA or treated with 5µM GM6001 on Oregon Green 488 matrix 
(shown as grey) and stained with rhodamine phalloidin and anti-cortactin to localize invadopodia. 
the scale bar is 10µm. (B) Top: relative area of degradation per cell on gelatin (black) and collagen 
I (white). Middle: number of invadopodia per cell on gelatin (black) and collagen I (white). Bottom: 
area of degradation per invadopod of the ten biggest degradations per cell on crosslinked gelatin 
(black) and collagen I (white). All error bars indicate mean ± standard error of the mean (SEM). **p 
< 0.01 by t test. Invadopodia were defined as puncta enriched for actin, cortactin, and gelatin 
degradation.
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3.3.9 Fascin localized at invadopodia in SCC9 human head 
and neck squamous cell carcinoma cells and MDA-MB-231 
human breast adenocarcinoma cells. 
We have shown that fascin is important for invadopodia formation in 
melanoma cells. We next investigated if fascin is important for invadopodia 
formation in cells derived from cancer types other than melanoma. SCC9 
human head and neck squamous cell carcinoma cells (HNSCC) form 
invadopodia when cultured on crosslinked ECM (Lucas et al., 2010). We 
found that endogenous fascin co-localizes nicely with actin or Arp2/3 complex 
at invadopodia (Figure 3.13). Similarly, endogenous fascin or exogenous 
fascin-GFP co-localize with gelatin degradations (Figure 3.14A) in MDA-MB-
231 human breast adenocarcinoma cells, a cell type that is very commonly 
used for invadopodia study.  In addition, transient or stable knockdown of 
fascin significantly reduce invadopodia degradation in MDA-MB-231 cells 
(Figure 3.14B-E). Furthermore, siRNA against p34-Arc (ARPC2) in MDA-MB-
231 cells also reduced invadopodia degradation. Similar to other cell types, 
we found that fascin knockdown did not affect MDA-MB-231 cell proliferation 
(Figure 3.15). Together, these results demonstrate a general importance of 
fascin for invadopodia formation on various matrices and cells from different 
cancer types.  
 
3.3.10 Filopodia formation depends on fascin phosphorylation 
Phosphorylation of fascin at serine 39 is important for its actin bundling 
activity in vitro (Ono et al., 1997; Yamakita et al., 1996). To examine the roles 
of serine 39 phosphorylation in filopodia formation, A375MM cells were 
transiently transfected with GFP-fascin, or two different phosphorylation-state 
mutants of fascin, GFP-fascin S39A, an active dephosphomimic that retains 
its actin-bundling activity, or GFP-fascin S39E, an inactive phosphomimic that 
has lost its actin-bundling activity but that retains PKC-binding activity 
(Vignjevic et al., 2006). Interestingly, A375MM cells expressing H. sapiens 
GFP-fascin, GFP-fascin S39A showed similar morphology with formation 
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Figure 3.13. Fascin localize to invadopodia in SCC9 human squamous cell carcinoma 
cells
(A) SCC9  cells on Oregon Green 488 gelatin matrix (gray) with anti-fascin (55K2) and (A) anti-
p34-Arc and (B) anti-actin. Arrows show individual invadopodia. .Scale bar is 10µm.
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Figure 3.14. Fascin is required for the formation of invadopodia in MBA-MB-231 human 
breast adenocarcinoma cells. (A) Top: MDA-MB-231 cell on Oregon Green 488 gelatin matrix 
(gray) with anti-fascin (55K2). Bottom: MDA-MB-231 cell expressing GFP-fascin on Alexa594 
gelatin matrix (gray)  Arrows show individual invadopodia. (B) Cell lysates from MDA-MB-231 cells 
transiently transfected with NT, fascin or p34-ARC siRNA were analyzed by immunoblotting and 
probed with antibodies as indicated. Membranes were also probed with actin antibody as a loading 
control.  (C)Representative images from in vitro matrix degradation assay. Cells transfected with 
NT control, fascin siRNAs or p34-ARC siRNA on Oregon Green 488 matrix (shown as grey) and 
stained with rhodamine phalloidin. Relative area of degradation per cell on gelatin. (D) Cell lysates 
from MDA-MB-231 cells expressing empty LMP vector or vectors contain fascin shRNA were 
analyzed by immunoblotting and probed with antibodies as indicated. (E) Representative images 
from in vitro matrix degradation assay. Cells expressing empty LMP vector or vectors contain 
fascin shRNA on Oregon Green 488 matrix (shown as grey) and stained with Alexa350 phalloidin. 
Relative area of degradation per cell on gelatin. All error bars indicate mean ± standard error of the 
mean (SEM). **p < 0.01 by t test. All scale bars are 10µm.
LM
P
sh
Fa
sc
in 
1
sh
Fa
sc
in 
2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
** **
R
el
at
iv
e 
D
eg
ra
da
tio
n/
C
el
l
Fascin
(55kDa)
Actin
(42kDa)
	   115	  
 
 
  
0 1 2 3
0
2
4
6
8
10
NT
siFascin 1
siFascin 2
Day
N
um
be
r o
f C
el
ls
 (1
04
)
Figure 3.15 Fascin knockdown does not alter cell growth rate in MDA-MB-231 breast 
cancer adenocarcinoma cells 
1x104 MBA-MD-231 cells express NT or fascin siRNA were plated in each well of 6 well 
plates, and number of cells was counted every day for 3 days. Each point (Mean ± SEM) 
is derived from the mean of hemocytometer count of cells from three replicate dishes from 
two independent experiments. 
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numerous microspikes on the dorsal surface of the cells (Figure 3.16A). 
However, expression of GFP-fascin S39E inhibits the formation of 
microspikes on the surface of the cells (Figure 3.16A). To further confirm this 
effect, X. tropicalis GFP-fascin (Xtfascin), GFP- Xtfascin S33A (Serine 33 in 
X. tropicalis is equivalent to serine 39 in H. sapiens fascin. Also see 
(Hashimoto et al., 2007) or GFP- Xtfascin S33D were transiently expressed in 
A431 epithelial carcinoma cells and cells were plated on glass coverslips 
overnight and fixed. Consistent with data for H. sapiens GFP-fascin, cells 
expressing GFP- Xtfascin or GFP-Xtfascin S33A in A431 cell showed 
formation of filopodia (Figure 3.16B). Expression of GFP-Xtfascin S33D, 
however, suppresses the formation of filopodia (Figure 3.16B). Together, 
these data indicate that Serine 39 phosphorylation regulates fascin activity 
and formation of filopodia. These also suggest that the inactive phosphomimic 
mutant of fascin has a dominant-negative effect on filopodia formation. 
 
 
3.3.11 Phosphorylation of fascin regulates formation of 
invadopodia in CHL-1 cells 
We have shown that the phosphorylation of fascin at serine 39 regulates the 
formation filopodia. To determine whether fascin phosphorylation is likely to 
regulate invadopodia formation, we made fascin knockdown cells with 
expression of GFP, GFP-Xtfascin, GFP-Xtfascin S33A or GFP-Xtfascin S33D. 
Knockdown of fascin in CHL-1 cells did not alter the expression of Xtfascin 
(Figure 3.17). Knockdown of endogenous fascin strongly reduced the total 
area of degradation per cell; area of degradation of single invadopodia and 
number of invadopodia per cell as compared to control and this cannot be 
rescued by expressing GFP in the cells (Figure 3.18).  Invadopodia formation 
can be fully restored by express of wild type GFP-Xtfascin or GFP-Xtfascin 
S33A (Figure 3.18). In addition, both of these proteins localized to 
invadopodia together with cortactin (Figure 3.19). Although there was no 
defect on cell spreading, expression of GFP-Xtfascin S33D in fascin 
knockdown CHL-1 cells failed to rescue the formation of invadopodia with the  
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Figure 3.16. Effects of fascin mutants on filopodia formation in A375MM and A431 
cells
 (A) Combined Z-stack images (1µm) of A375MM melanoma cells expressing H. sapiens 
GFP-fascin, GFP-fascin S39A or GFP-fascin S39E were spreaded on glass coverslip 
overnight. (B) A431 epithelial carcinoma cells expressing  GFP-X. tropicalis fascin, GFP-X. 
tropicalis fascin  S33A or GFP- X. tropicalis fascin S33D were spreaded on glass coverslip 
overnight and fixed. Inserts show formation of filopodia. Scale bar is 10µm.
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Figure 3.17. Expression of X.tropicalis fascin in fascin knockdown CHL-1 cells.
Western blot showing CHL-1 cells stably expressing GFP, GFP-X. tropicalis fascin, GFP-X. 
tropicalis fascin S33A, and GFP-X. tropicalis fascin S33D were transfected with non-targeting (NT) 
control siRNA or fascin siRNA (siFascin 1). Immunoblots were probed with anti-fascin and anti-
actin as loading control.
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Figure 3.18. Fascin Regulation at Serine 39 Is Important for Invadopodia 
Formation in CHL-1 cells(C) Top: relative area of degradation on gelatin per cell. 
Middle: number of invadopodia per cell. Invadopodia were defined as puncta enriched 
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±SEM. ** p < 0.01 by t test. 
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Figure 3.19. Localization of fascin mutants in fascin knockdown CHL-1 
cells
CHL-1 cells stably expressing GFP, GFP-X. tropicalis fascin, GFP-X. tropicalis 
fascin S33A, and GFP-X. tropicalis fascin S33D were transfected with non-
targeting (NT) control siRNA or fascin siRNA (siFascin 1), cultured on Alexa594 
gelatin matrix, and labeled with anti-cortactin. Arrows show invadopodia. Scale 
bars represent 10 µm.
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total area of degradation per cell, area of degradation of single invadopodia 
and number of invadopodia per cell remaining similar to the fascin knockdown 
cells (Figure 3.18). Furthermore, GFP-Xtfascin S33D appeared diffuse with 
weak localization to residual invadopodia (Figure 3.19).  
 
 
3.3.12 Phosphorylation of fascin regulates formation of 
invadopodia in A375MM cells 
We have shown that fascin phosphorylation at serine 39 is very important for 
invadopodia formation in CHL-1 cells. To further confirm these results, 
A375MM cells expressing GFP, GFP-Xtfascin, GFP-Xtfascin S33A or GFP-
Xtfascin S33D were transfected with NT or fascin siRNA. Western blotting 
indicated that GFP-Xtfascin, GFP-Xtfascin S33A and GFP-Xtfascin S33D was 
not susceptible to the human fascin siRNA (Figure 3.20A). Similar to CHL-1 
cells, invadopodia formation was fully restored by expression of GFP-Xtfascin 
or GFP-Xtfascin S33A in fascin knockdown A375MM cells (Figure 3.21). Both 
of these proteins localized to invadopodia together with cortactin (Figure 
3.20B). GFP-Xtfascin S33D failed to rescue invadopodia formation (Figure 
3.21). In a few of GFP-Xtfascin S33D expressing cells with recognizable 
invadopodia-like staining, GFP-Xtfascin S33D was also weakly localized at 
invadopodia together with cortactin, although appeared diffuse with weak 
localization to invadopodia (Figure 3.20B). In addition, expression of H. 
sapiens GFP-fascin S39E in wild-type A375MM cells significantly decreased 
matrix degradation (Figure 3.22). However, expression of human GFP-fascin 
or GFP-fascin S39A did not significantly affect extracellular matrix (ECM) 
degradation (Figure 3.22). Together, these data suggest that the actin-
bundling activity of fascin may be required for invadopodia formation and that 
the inactive phosphomimic mutant of fascin has a dominant-negative effect. 
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Figure 3.20. Localization of fascin mutants in fascin knockdown A375MM cells
Western blot showing A375 cells stably expressing GFP, GFP-X. tropicalis fascin, GFP-X. 
tropicalis fascin S33A, and GFP-X. tropicalis fascin S33D were transfected with non-targeting 
(NT) control siRNA or fascin siRNA (siFascin 1). Immunoblots were probed with anti-fascin and 
anti-actin as loading control. (B) A375 cells expressing GFP, GFP-X. tropicalis fascin, GFP-X. 
tropicalis fascin S33A, and GFP-X. tropicalis fascin S33D were transfected with non-
targeting (NT) control siRNA or fascin siRNA (siFascin 1), cultured on Alexa594 gelatin matrix, 
and labeled with anti-cortactin. Arrows show invadopodia. Scale bars represent 10 µm.
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Figure 3.21. Fascin Regulation at Serine 39 Is Important for Invadopodia 
Formation in A375MM cells Top: relative area of degradation on gelatin per cell. 
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for actin, cortactin, and gelatin degradation. Bottom: area of degradation per invadopod 
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Figure 3.22. Expression of GFP-Fascin S39E Suppresses Invadopodia Formation in 
A375MM Cells
A375MM cells transiently transfected with GFP, H. sapiens GFP-fascin, H. sapiens GFP-
fascin S39A and H. sapiens GFP-fascin S39E were cultured on crosslinked Alexa594 
conjugated gelatin matrix for 16 hours. Quantifications of invadopodia on gelatin from three 
independent experiments in duplicate as described in Figure 1. (Mean ± SEM). **, P< 0.01 
compared to control cells by t-test.
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3.3.13 Fascin regulates actin stability at invadopodia 
To understand how fascin controls actin dynamics at invadopodia, the 
turnover rates of GFP-tagged actin, cortactin, N-WASP, p21-Arc (ARPC3), 
and fascin at invadopodia was examined (Figure 3.23) via FRAP. Although 
invadopodia persisted for hours, cortactin, N-WASP, and p21-Arc all rapidly 
recovered to more than 80% of prebleach values, and the recovery kinetics 
agree fairly closely with previously published values for turnover of actin, 
cortactin, and Arp2/3 complex in lamellipodia (Lai et al., 2008). Actin, 
however, only recovered to about 70% prebleach level, suggesting that 30% 
of actin is trapped (Figure 3.23 and Movie 2). Although fascin at invadopodia 
recovered to nearly prebleach level, the recovery rate of fascin was >10-fold 
slower than that of actin, cortactin, N-WASP, and p21-Arc with half time of 
recovery of about 65 seconds (Figure 3.23 and Movie 2). Fascin turnover in 
filopodia was more rapid, with a half-time of recovery of about 9 seconds 
(Figure 3.23 in agreement with (Aratyn et al., 2007; Vignjevic et al., 2006) and 
96% recovery. Together, these results indicate that rather than form a stable 
complex fascin, actin, cortactin, N-WASP, p21-Arc (ARPC3) at invadopodia 
undergo a constant association/dissociation cycle and majority of the proteins 
are dynamic. Fascin is particularly stable at invadopodia, perhaps to provide a 
platform for force production. 
 
Previous reports implicated fascin in stabilization of membrane protrusions 
and alteration of the equilibrium of actin polymerization (Yamakita et al., 2009; 
Yamashiro et al., 1998). In order to study whether the level of fascin in cells 
could change the actin dynamics at invadopodia, the actin dynamics were 
compared in fascin-depleted and -overexpressing cells via FRAP (Figure 
3.24A). The mobile fraction of actin at invadopodia was significantly increased 
in fascin knockdown cells and decreased in GFP-fascin-overexpressing cells 
(Figure 3.24B). However, the bulk turnover rates of actin at invadopodia were 
almost unaffected (Figure 3.24B, recovery half-time). Thus, the amount of 
actin trapped at invadopodia is at least partially dependent on fascin, but 
rapidly cycling actin may not be bundled by fascin. This is consistent with the 
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Figure 3.23. Fascin is Stably Associated with Invadopodia
(A) A375MM cells transiently transfected with GFP-cortactin, GFP-p21, GFP-N- WASP, GFP-actin 
and GFP-fascin were cultured on crosslinked Alexa594 gelatin matrix for 16 hr and analyzed by 
confocal microscope at 37°C. Invadopodia were defined as colocalization of GFP tagged protein 
with gelatin matrix degradation. Images from time-lapse movies of FRAP experiments before and 
after photobleaching on GFP- cortactin, GFP-actin, GFP-p21, GFP-N-WASP at invadopodia 
(arrowed) and GFP- fascin at invadopodia (arrowed) and filopodia (boxed). Bars, right, 10µm, left, 
1µm. Time in sec. (A) The recovery kinetics of GFP-cortactin (green triangles) (n = 28), GFP-actin 
(purple crosses) (n = 31), GFP-p21-Arc (red squares) (n = 30), GFP-N-WASP (blue diamond) (n = 
30) at invadopodia, GFP-fascin at invadopodia (light blue x symbols) (n = 22), and filopodia 
(orange dots) (n = 25) after photobleaching. Mobile fraction and half-time of recovery are indicated 
as mean ± SEM.
GFP-actin
GFP-Fascin
(Invadopodia)
GFP-p21
GFP-Cortactin
GFP-N-WASP
GFP-Fascin
(Filopodia)
	   127	  
  
!"!#
!"$#
!"%#
!"&#
!"'#
!"(#
!")#
!"*#
!"+#
!",#
$"!#
!# %# '# )# ,# $$# $&# $(# $*# $,# %$# %'#
!"
#
$%
&
'(
)*
+
!,
'-
#
$*
./
*
0
/*
!1
0
2*
0
.(
23
!
4(%*!5.6!
"4!
.(,&./(0!
7,89,&./(0! 59.1±2.7**
68.5±2.1 2.7±0.2
2.5±0.1
3.1±0.3
76.4±1.7**
Half-time (s)
Mobile 
fractionCondition
B
Pr
e-
bl
ea
ch
B
le
ac
h
Po
st
-
bl
ea
ch
GFP-Fascin siFascinNT
26
"
0"
26
"
0"
26
"
0"
NT
RFP-Actin
A
Figure 3.24. Fascin Knockdown Reduces Actin Recovery in Invadopoda
(A) A375MM cells expressing control or fascin siRNA transiently cotransfected 
with EGFP-fascin and mRFP-actin or transfected with mRFP-actin were cultured 
on crosslinked gelatin matrix for 16 hours. Images represented time-lapse 
sequence of FRAP experiments before and after photobleaching of mRFP-actin at 
invadopodia (arrowed). (B) Recovery kinetics of mRFP-actin at invadopodia in 
cells expressing NT control siRNA (blue diamond) (n = 50), GFP-fascin and 
control siRNA (EGFP- fascin) (green triangles) (n = 47), or fascin siRNA (siFascin) 
(red squares) (n = 45). Percentage of mobile fraction and half-time of recovery for 
each condition are indicated as mean ± SEM; **p < 0.01 by t test.
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 presence of unbundled highly dynamic actin, which is likely being rapidly 
turned over to produce force for motility and more stable actin in association 
with fascin to provide longevity of protrusions.  
 
Because fascin stabilizes the filamentous actin at invadopodia and itself 
exchanges slowly at invadopodia, this suggests that fascin might function at 
invadopodia to provide a more stable platform for degradation of matrix. To 
test this, the dynamics of invadopodia in control and fascin depleted A375MM 
cells were compared by time-lapse microscopy. Most (>50%) invadopodia in 
A375MM cells persisted for up to and beyond 6 to 8 hr (Figure 3.25 and Movie 
3). Fascin knockdown cells formed fewer invadopodia, and invadopodia were 
generally smaller and shorter lived (approximately 50% of invadopodia 
persisted for less than 2 hr) (Figure 3.25 and Movie 3). Together, these data 
indicate that fascin is important for invadopodia stability and function, by 
regulating the number and size of invadopodia, as well as their lifetime.  
 
 
3.3.14 Fascin and metalloproteases are not required for 
A375MM melanoma cell invasion  
We have shown that fascin stabilizes actin at invadopodia. We investigated 
the role for fascin in invasion of melanoma cells into 3D Collagen I/Matrigel 
matrix, a process that takes place over the timescale of days and which might 
require long-lived invasive protrusions. Consistent with previous reports, 
migrating A375MM cells in collagen I-Matrigel appeared rounded, 
characteristic of the so-called amoeboid type of migration (Figure 3.26A) 
(Gadea et al., 2008; Sanz-Moreno et al., 2008). Fascin protein levels were 
depleted by siRNA and the resulting cells were assayed in the inverse 
invasion assay. Surprisingly, The invasion of A375MM cells was found not to 
be dependent on endogenous fascin (Figure 3.26B). In addition, fascin 
knockdown had no apparent effect on the rounded shape of A375MM cells in 
3D Collagen I/Matrigel matrix (Figure 3.26A). Furthermore, fascin knockdown 
in A375MM cells had no effect on cell migration cross the filter in transwell  
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Figure 3.25. Fascin Knockdown reduces Lifetime of Invadopoda
(A) Time-lapse image sequence of A375MM cells stably expressing RFP-Lifeact 
were transfected with control or fascin siRNA and cultured on Oregon Green 488-
conjugated crosslinked gelatin overnight in presence of 5μM GM6001 MMP 
inhibitor. Time-lapse image was taken within 1 hour after washout of the inhibitor.  
Scale bars represent 10 µm. Red arrowheads show invadopodia and blue 
arrowheads show gelatin degradation. (B) Time-lapse lifetime of invadopodia was 
calculated with data from 30 cells from at least three independent experiments. n 
represents the total number of invadopodia analyzed. 
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Figure 3.26. A375MM cells migration and invasion is fascin and MMP independent  
(A) A375MM cells in collagen I-Matrigel matrix treated with NT, fascin siRNA or 5µM 
GM6001 were fixed and stained with rhodamine phalloidin and DAPI. Serial of z-stack 
images were taken with 0.5 µm interval and combined. (B) Representative images of 
A375MM cells invading into 3D collagen I-Matrigel matrix. Quantification of relative 
invasion >20 µM into collagen I-Matrigel.  Error bars show mean ± SEM. ** p < 0.01 by t 
test. (C) Representative images of transfilter migration assay. A375MM cells expressing 
NT or fascin siRNA crossed the filter were fixed and stained with DAPI. Quantification of 
relative migration of A375MM cells crossed filter. Scale bars represent 10 µm.
C
B
A
	   131	  
migration assay. Metalloprotease and matrix degradation have been showed 
previously to be not required for cell invade using amoeboid type of migration 
(Wyckoff et al., 2006). Treatments to inhibit protease activity did not affect 
invasion, migration and morphology of A375MM cells. Together, these results 
demonstrate that fascin and metalloproteases do not contribute to the 
invasion of A375MM melanoma cells and that amoeboid type cells may be 
less dependent on invadopodia for invasion. 
 
 
3.3.15 Mesenchymal-type cancer cells require fascin during 
cell invasion in a 3D environment 
In contrast to A375MM cells which use an amoeboid type migration for 
invasion, CHL-1 melanoma cells have been shown to use a more elongated 
lamellipodia-driven mesenchymal type of migration in 3D (Sanz-Moreno et al., 
2008). In addition, during invasion into collagen I-Matrigel matrix, CHL-1 cells 
appeared elongated and very spiky, with many long, fine actin-rich 
protrusions, many of which showed abundant fascin (Figure 3.27B).  To 
investigate the effect of fascin on invasion and migration of CHL-1 cells, fascin 
was depleted using either siRNA transient or shRNA stable knockdown 
(Figure 3.27E), and invasiveness of resulting cells was measured using 
inverse invasion assay and transwell migration assay. The invasion and 
migration of CHL-1 cells were significantly reduced when fascin was depleted 
(Figure 3.27G, D). I also examined whether fascin is required for cell invasion 
in 3D matrix using another melanoma cell line: MV3 and MDA-MB-231 human 
breast adenocarcinoma cell line in which both cell displayed mesenchymal 
type of migration (Friedl et al., 1997; Wolf et al., 2007). Fascin knockdown in 
both cell lines resulted in significant reduction in cell invasion through the 3D 
Collagen I/Matrigel matrix and migration through the filter (Figure 3.28 and 
3.29). Collectively, these findings suggest that cells, which use a 
mesenchymal type of migration for invasion into 3D matrix may selectively 
require fascin. 
 
To test if fascin is required for collagen degradation in 3D, the ability of NT or  
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Figure 3.27. Fascin is required for efficient mesenchymal-type invasion in 3D
(A) Western blot of CHL-1 cells expressing NT control siRNA, MT1-MMP siRNA probed with anti-
MT1-MMP, and anti-actin loading control. (B) Left: CHL-1 in collagen I-Matrigel matrix fixed and 
stained with anti-fascin (55K2). Serial Z stack images (0.5 µm) were combined and shown here. 
Scale bars represent 10 mm. Right: densitometric analysis of fascin signal with arrows at peak 
fascin intensities.
(C) CHL-1 cells in 3D collagen I-Matrigel matrix treated with siRNA or inhibitor (as indicated) were 
fixed and stained with rhodamine phalloidin and DAPI. Serial Z stack images (0.5 µm interval) were 
combined. Filopod-like protrusions were arrowed.
(D) Relative migration cross the filter (light grey), relative invasion >20 mM into collagen I-Matrigel 
(black), relative release of soluble fluorescein isothiocyanate (FITC) from collagenolysis caused by 
CHL-1 cells within 3D FITC-collagen lattices (white), and relative number of filopod-like protrusions 
per cell (dark gray). (E) Western blot of CHL-1 cells stably express LMP vector or fascin shRNA 
probed with anti-fascin, and anti-actin loading control. (F) CHL-1 cells in 3D collagen I-Matrigel 
matrix stably express LMP vector or fascin shRNA fixed and stained with rhodamine phalloidin. 
Filopod-like protrusions were arrowed. Scale bars represent 10 µm.  (G) Relative invasion >20 µM 
into collagen I-Matrigel. All error bars show mean ± SEM. **p < 0.01 and *p < 0.05 by t test. 
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Figure 3.28. Fascin is required by MV3 Melanoma cells for efficient migratin and invasion
(A) Western blot of MV3 melanoma cells expressing NT control siRNA or fascin  siRNA probed 
with anti-fascin, and anti-actin as loading control. (B) Representative images of transfilter 
migration assay. MV3 cells expressing NT or fascin siRNA crossed the filter were fixed and 
stained with DAPI.  (C) Quantification of relative migration of MV3 crossed filter. (D) 
Representative images of MV3 cells invading into 3D collagen I-Matrigel matrix.  (E) 
Quantification of relative invasion >20 µM into collagen I-Matrigel.  Error bars show mean ± SEM. 
** p < 0.01, * p < 0.05 by t test. 
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Figure 3.29. Fascin is required by MDA-MB-231 for efficient migratin and invasion
(A) Representative images of transfilter migration assay. MDA-MB-231 cells expressing NT 
or fascin siRNA crossed the filter were fixed and stained with DAPI. (B) Quantification of 
relative migration of MBA-MB-231 cell crossed filter. (C) Representative images of MDA-
MB-231 cells invading into 3D collagen I-Matrigel matrix.  (D) Quantification of relative 
invasion >20 µM into collagen I-Matrigel.  Error bars show mean ± SEM. ** p < 0.01 by t test. 
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Fascin siRNA expressing CHL-1 cells to degradate 3D collagen matrix was 
measured using FITC collagen release assay as previously described (Wolf et 
al., 2003a; Wolf et al., 2007). 3D collagen degradation was significantly 
deceased upon fascin knockdown (Figure 3.27D). In addition, the shape of 
CHL-1 cells were changed by either transient or stable fascin knockdown, with 
a decrease in filopod-like protrusions and some remaining small puncta and 
stubby protrusions (Figure 3.27C, D, F and Movie 4). I postulated that finger-
like protrusions in CHL-1 cells could be invasive filopodia and aid the 
movement of mesenchymal-type cells in 3D matrix. The requirements for 
other components of invadopodia, including N-WASP, which organizes Arp2/3 
complex mediated actin assembly, and the transmembrane matrix 
metalloprotease MT1-MMP, which controls matrix degradation at invadopodia 
were probed. Knockdown of N-WASP, which causes a reduction of 
invadopodia (Figure 3.12) but no change in the filopod-like protrusions in 3D 
(Figure 3.27C, D), reduced both invasion collagen I-Matrigel matrix and 3D 
collagen degradation (Figure 3.27D). Likewise, the MMP inhibitor GM6001 or 
siRNA reduction of MT1-MMP (Figure 3.27A) did not affect filopod-like 
protrusions in 3D matrix but significantly reduced invasion of mesenchymal-
type cells and 3D collagen degradation (Figure 3.27A, C, D; 3.28D, E and 
3.29C, D and Movie 4). These results show that filopod-like protrusions alone 
are not sufficient for 3D invasion and suggest that invadopodia or their 
equivalents in 3D are required for mesenchymal-type cells to degrade the 
matrix during 3D invasion.  
 
3.3.16 Fascin phosphorylation regulates mesenchymal-type 
cancer cell invasion, degradation in 3D environment 
In order to examine the effect of fascin bundling activity on cell invasion, 
Xtfascin S33A and Xtfascin S33D were used to rescue fascin knockdown in 
CHL-1 cells. Wild type Xtfascin or Xtfascin S33A restored the normal number 
of protrusions, relative invasion, migration and 3D collagen degradation, 
whereas Xtfascin S33D did not (Figure 3.30).  
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Figure 3.30. Fascin dephosphorylation at Serine 39 is required for efficient migration and 
mesenchymal-type invasion.
(A) CHL-1 cells in 3D collagen I-Matrigel matrix treated with siRNA were rescued with Xtfascin 
constructs (as indicated) were fixed and stained with rhodamine phalloidin and DAPI. Serial Z stack 
images (0.5 µm interval) were combined. Scale bars represent 10 µm. Filopod-like protrusions were 
arrowed. (B) Quantification of relative migration cross the filter (light grey), relative invasion >20 µm 
into collagen I-Matrigel (black), relative release of soluble fluorescein isothiocyanate (FITC) from 
collagenolysis caused by CHL-1 cells within 3D FITC-collagen lattices (white), and relative number 
of filopod-like protrusions per cell (dark gray) in cells expressing GFP/RFP and NT siRNA, GFP/
RFP and siFascin, or GFP/RFP-Xtfascin and mutants, as indicated in the figure. All error bars show 
mean ± SEM. **p < 0.01 by t test.  
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Taken together, these data suggest that actin bundling activity fascin is 
important for the formation of stable actin-based degradative structures 
(invadopodia on 2D matrix and their equivalent in 3D) and for filopod-like 
protrusions that contribute to invasion in 2D and in 3D. Formation of filopodia 
alone was not sufficient for optimal migration in 3D because knockdown of N-
WASP and MT1-MMP reduced invasion but didn’t reduce the formation of 
filopod-like protrusions.  
 
3.4 Discussion 
3.4.1 Fascin localize with actin at invaodpodia actin comet 
structures 
Invadopodia have been most closely compared with podosomes, which are 
dot-shaped F-actin containing structures found in cells such as osteoclasts, 
endothelial cells and macrophages (Buccione et al., 2004). Unlike 
podosomes, however, invadopodia appear as highly dynamic actin comet 
structures similar to those previously described on intracellular pathogens 
such as Listeria monocytogenes or other bacteria and viruses (Baldassarre et 
al., 2006; Lambrechts et al., 2008).  These comet-like structures also have 
been described on endocytic vesicles in various cells (Fehrenbacher et al., 
2003) and are thought to function in trafficking.  We provide new insight into 
the mechanism of actin dynamics at these comet-like structures.  We show 
that invadopodia comets appear to be tethered and the tail spins somewhat 
reminiscent of a corkscrew (Movie 1 part 1).  We found that Arp2/3 complex 
and cortactin localized largely throughout the actin comet structure, together 
with fascin, whilst N-WASP was localized primarily at the head.  This agrees 
with a model whereby N-WASP orchestrates the activation of Arp2/3 complex 
in association with a PIP2-rich membrane surface (Caldieri and Buccione, 
2010; Yamaguchi and Oikawa, 2010), forming an actin tail consisting of a 
branched network.  The role of fascin seems to be to stabilize some of the 
actin in the tail of the comet to provide a platform for force production and 
possibly also to aid in the secretion of metalloproteases. 
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3.4.2 Fascin and filopodia proteins are required for 
invadopodia formation 
Our studies suggest that invadopodia contain not only branched actin, but 
also longer straight networks found in fascin microspikes and in filopodia. 
Diaphanous related formins were shown to be important players in 
invadopodia assembly (Lizárraga et al., 2009) also supporting the role of 
unbranched actin at these structures.  Knockdown of DRFs1-3 greatly 
reduced matrix degradation and invadopodia formation in MDA-MB-231 
breast cancer cells and that this also affected invasion of these cells into 
Matrigel.  We find that DRF proteins, IRSp53 and the related IRTKS also 
localize to invadopodia, although knockdown of IRSp53 did not prevent 
invadopodia formation in our experiments (Data not shown). It is interesting to 
note that once a network is initiated by Arp2/3 complex, the actin bundling 
activity of fascin can drive Listeria monocytogenes propulsion in vitro, 
producing actin tails with long straight actin filaments (Brieher et al., 2004).  
This implies that actin bundling activity can contribute to protrusive force and 
motility in cells. In addition, recent study using EM revealed a dense array of 
thin filaments resembling actin bundles at the very tip of the protrusions or at 
the sides during elongation of invadopodia (Schoumacher et al., 2010). 
Moreover, fascin depleted cells form much shorter invadopodia 
(Schoumacher et al., 2010), which strongly support our idea that fascin may 
bind to parallel bundles of slowly exchanging actin filaments that can generate 
force and structural stability for invadopodia over long periods of time. 
Although invadopodia have properties of invasive filopodia, since several 
filopodia-inducing proteins are found to have an important role in their 
formation and stability, they are clearly different from filopodia, as they contain 
actin comet structures not seen in typical filopodia.  
 
3.4.3 Fascin stablizes actin at invadopodia 
In vitro, fascin forms parallel-polarized bundles of actin filaments and shows a 
very slow exchange rate compared with other bundling proteins such as 
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alpha-actinin (Tseng and Wirtz, 2004).  Fascin also formed side-branched 
networks in vitro, which is interesting in light of the localization of fascin to 
lamellipodia and the effects of fascin knockdown on mesenchymal type 
motility (Adams et al., 1999).  We found that fascin overexpression increased 
the amount of actin trapped at invadopodia in photobleaching experiments, 
while a decrease in fascin expression increased the mobile fraction of actin 
filaments.  This suggests that in invadopodia, at least some fraction of the 
fascin forms stable actin bundles that do not exhange on the time scale of 
minutes.  This observation is consistent with our observation that most single 
invadopodia persist for more than 10 hours in cultured cells (supplementary 
movies and our unpublished observations).  These structures are distinct from 
what have previously been termed short-lived precursor structures in MTLn3 
cells (Chan et al., 2009; Cortesio et al., 2008; Yamaguchi et al., 2005).  Many 
types of actin puncta have been reported in cultured cells including what 
appear to be small surface ruffles and also endocytic events, so we only 
counted invadopodia as degradative structures.  Myosin-II and myosin V can 
drive the sliding of actin-fascin bundles (Ishikawa et al., 2003) suggesting that 
in filopodia, myosins may drive retrograde flow of filopodial actin bundles 
(Kovar, 2007). Myosin-X is an actin-based motor, which uses its motor activity 
to move forward along actin filaments to the tips of filopodia. Intersetly, 
myosin-X has been shown to be required for invadopodia formation 
(Schoumacher et al., 2010). This suggests that myosin-X could work as a 
molecular motor transporting molecule such as VASP (Tokuo and Ikebe, 
2004) and possibly MMPs to the tip of invadopodia. Since we found that 
fascin is required for the degradative function of invadopodia, we speculate 
that fascin bundles may also serve as a platform for cargo transport and the 
secretion of metalloproteases at invadopodia.  
  
3.4.4 Fascin is selectively required for invasion of 
mesenchymal-type cancer cells 
We found that not only was fascin required for invadopodia assembly and 
matrix degradation, but it also impacted significantly on the ability of some 
cancer cells to migrate into collagen/matrigel 3D plugs.  Our studies have 
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raised the question of whether mesenchymal cells need invadopodia more 
than amoeboid cells for invasion into 3D matrix.  This is interesting in light of 
other studies showing that cells use a combination of rounded acto-myosin 
based motility termed “amoeboid” and elongated protrusive motility termed 
“mesenchymal” (Sahai, 2005; Sahai and Marshall, 2003; Wolf et al., 2003a).  
Mesenchymal motility is defined in some studies as requiring protease activity 
and involving Rac1 induced lamellipodial protrusions.  We find that, in 
general, loss of fascin impairs invasion of cells that use primarily 
mesenchymal motility.  Thus, our data suggest that amoeboid cells might not 
need invadopodia for their invasion and agree with a role for fascin in 
protrusions as well as matrix invasion and degradation.  Interestingly, 
Huttenlocher and colleagues also published that they observed a separation 
between enhanced invadopodia formation and the invasive capacity of cancer 
cells (Chan et al., 2009).  They showed that FAK deficient MTLn3 cells 
showed impaired invasion across Matrigel coated filters, yet had enhanced 
capacity to form invadopodia.  This likely reflects the complex nature of 
invasion, which requires a fine balance of adhesion, migration and matrix 
remodeling, as well as perhaps that MTLn3 cells use a primarily amoeboid 
mode of motility in 3D gels (Wyckoff et al., 2006). 
Previous studies suggest that cell leading edges are not necessarily major 
places of matrix degradation but rather that degradation happens at lateral 
points where the matrix restricts the cell movement and at structures that 
have been called ‘‘lytic protrusions’’ (Wolf and Friedl, 2009). Some of the 
filopod-like protrusions in CHL-1 cells may be involved in matrix remodeling 
because they all contained GFP-MT1-MMP (data not shown). However, our 
data strongly suggest that matrix remodeling promoted by ‘‘invadopodia 
equivalents’’ is more important for efficient cell invasion than filopod-like 
protrusions. Attempt to identify "invadopodia equivalents" in 3D was 
unsuccessful as most of antibodies that we use to label invadopodia (anti-
cortactin, anti-p34) in 2D do not work in 3D collagen I-matigel matrix. 
‘‘Invadopodia equivalents’’ may be smaller and more transient in 3D than in 
2D on very stiff matrix, analogous to focal adhesions (Cukierman et al., 2001). 
Moreover, invadopodia formation in cells grown on a 3D dense matrix based 
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on cell-free dermis suggest a different morphology of invadopodia in 2D and 
3D and matrix-degrading activity of invadopoida is localized to the base of 
invadopodia rather than at matrix-penetrating protrusions (Tolde et al., 2010). 
Historically, invadopodia were first described as invasive finger-like 
protrusions into gelatin beads (Chen, 1989; Mueller and Chen, 1991), but 
invadopodia with obvious actin comet tails have not yet been visualized in 3D 
gels. We find that fascin promotes long protrusions in 3D and stabilizes actin 
in invadopodia and that this enhanced stability allows for more efficient 
invasion by mesenchymal cells, both in 2D and in 3D. 
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Chapter IV 
Rac1 drives melanoblast organization 
during mouse development by 
orchestrating pseudopod-driven motility 
and cell cycle progression. 
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4.1 Summary 
During embryogenesis, melanoblasts proliferate and migrate ventrally through 
the developing dermis and epidermis as single cells. I demonstrate here that 
targeted deletion of Rac1 in the melanoblasts of developing mice causes 
defects in migration, cell cycle progression and cytokinesis.  Rac1 null cells 
migrate markedly less efficiently, but global steering, crossing the 
dermal/epidermal junction and homing to hair follicles are normal.  
Melanoblasts navigate in the epidermis using two classes of protrusion: short 
stubs and long pseudopods.  Short stubs are driven by actin assembly, but 
unexpectedly are independent of Rac1, Arp2/3 complex, myosin or 
microtubules.  Rac1 positively regulates the frequency of initiation of long 
pseudopods, which promote migration speed and directional flexibility. 
Scar/WAVE and Arp2/3 complex drive actin assembly for long pseudopod 
extension, which is also microtubule dependent.  Myosin contractility balances 
the extension of long pseudopods by effecting retraction and allowing force 
generation for movement through the complex 3D epidermal environment. 
 
4.2 Introduction 
Mammalian melanoblasts are the precursor cells of melanocytes; they 
emerge from the neural tube during embryogenesis, with other neural crest 
cells and migrate and proliferate to populate the skin and hair follicles. 
Genetic studies in the mouse have made a considerable contribution to our 
understanding of melanoblast development, identifying over 127 genes 
essential to normal pigmentation (Bennett and Lamoreux, 2003). Of the loci 
that have been cloned, over one third comprise genes that regulate 
melanocyte development. Mutations in these genes often manifest 
themselves as ‘white-spotting’ phenotypes, as a consequence of defects in 
melanocyte precursor proliferation, survival, migration and/or tissue invasion 
(Baxter et al., 2004). From these studies, several molecules involved in 
melanoblast pathfinding have been identified, including both receptor tyrosine 
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kinases (e.g. Kit) and G- protein-coupled receptors (e.g. Ednrb) and their 
ligands (KitL and Endothelin3, respectively). However, how melanoblasts 
migrate in during development and how these molecules affect melanoblast 
behaviour are still unknown. Recently, a high power ex-vivo microscopic 
method (Mort et al., 2010) became available so that we are now in a position 
to understand the mechanisms of migration of these fascinating cells. 
 
Rac1 is the major ubiquitous isoform of Rac expressed in mammalian tissues, 
with Rac2 being primarily hematopoietic and Rac3 being expressed in some 
regions of the brain (Didsbury et al., 1989; Haataja et al., 1997).  Rac1 
controls assembly of the actin cytoskeleton via a number of signaling 
pathways, the major ones being activation of the Scar/WAVE complex leading 
to Arp2/3 complex mediated actin nucleation (Insall and Machesky, 2009) and 
activation of p21-activated kinase (PAK) and LIM kinase leading to changes in 
cofilin phosphorylation and actin turnover (Delorme et al., 2007).  Both of 
these pathways are thought to be important in normal and cancer cell 
migration.  Loss of Rac1 in tissue culture and primary cells leads to a loss of 
lamellipodia and a general reduction of migration speed (Guo et al., 2006; 
McCarty et al., 2005a; Vidali et al., 2006).  Rac1 depletion also reduces focal 
adhesions and stress fibers in mouse embryonic fibroblasts (Delorme et al., 
2007; Guo et al., 2006; Vidali et al., 2006). 
In vivo, we have limited knowledge of the role of Rac1 in migration.  
Drosophila oocyte border cells, which migrate through the egg chamber 
collectively as a small cluster, are unable to migrate when they express 
dominant negative Rac (Bianco et al., 2007; Duchek et al., 2001; Geisbrecht 
and Montell, 2004; Murphy and Montell, 1996; Wang et al., 2010) and their 
motility can be induced by photoactivation of a Rac analog (Wang et al., 
2010).  Border cells use cadherin-based adhesion to navigate among nurse 
cells and Rac triggers the generation of long protrusions made by leader cells 
during this migration (Bianco et al., 2007; Duchek et al., 2001; Geisbrecht and 
Montell, 2004; Murphy and Montell, 1996).  Likewise, sequestration of Rac1 
activity in zebrafish germ cells inhibits actin brush formation, cell polarity and 
migration (Kardash et al., 2010).  In zebrafish embryos, neural crest cell 
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migration toward SDF-1 is regulated by Rac1 (Theveneau et al., 2010). 
Mouse anterior visceral endoderm (AVE) cells also require Rac1 for 
protrusion formation and collective migration to the developing anterior side of 
the embryo between days E5.5-6.0 during body axis specification (Migeotte et 
al., 2010).  Surprisingly, mouse neural crest cells do not require Rac1 for 
homing to initial target structures, but Rac1 loss impairs proliferation (Fuchs et 
al., 2009). Thus Rac1 emerges as an important controller of in vivo migration, 
but our mechanistic insight is limited. 
Rac is activated downstream of Ras and can activate JNK1, possibly via Pak 
kinases to stimulate cell cycle progression (Olson et al., 1995).  Both cell-cell 
and cell-matrix adhesion transmit signals to increase cyclin D1 levels for 
progression through the cell cycle and Rac1, together with ERK regulates this 
signaling (Fournier et al., 2008; Klein et al., 2008).  The mechanism by which 
Rac1 controls cyclin D1 mRNA levels is not known. Rac1 is tightly regulated 
in cytokinesis, both temporally and spatially and is inhibited at the cleavage 
furrow by centralspindlin, a GTPase activator (GAP) (Canman et al., 2008). 
No positive role for Rac1 in cytokinesis has been demonstrated to our 
knowledge. 
In the present Chapter, I have described here an important role for Rac1 in 
migration, proliferation and cytokinesis in mouse embryonic melanoblasts in 
skin ex vivo and revealing an important role for Rac1 as a coordinator of the 
rate of protrusion generation during migration. In addition, Rac1 deletion in 
melanoblasts results inability of cells to mount a Rac – Scar/WAVE – Arp2/3 
mediated protrusion response for migration. Surprisingly, though, Rac1 null 
melanoblasts can still use short stubby protrusions to migrate independently 
of this pathway by a novel actin-driven mechanism.  
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4.3 Results 
4.3.1 Rac1 loss in melanoblasts causes coat color defects, 
indicating impaired migration and proliferation 
To assess the functions of Rac1 in the melanocyte lineage in vivo, we crossed 
mice carrying a floxed allele of Rac1 (Corbetta et al., 2009; Walmsley et al., 
2003) with mice expressing Cre recombinase under control of the tyrosinase 
promoter (Tyr::Cre) (Delmas et al., 2003) (Figure 4.1A) in a C57BL6/J 
background.  Rac1 f/f Tyr::Cre+/o mice were born healthy at the expected 
Mendelian ratio, however, they were smaller than littermates and they 
exhibited tremor (Figure 4.2 and Methods). Recombination was confirmed by 
genomic PCR, amplifying distinct fragments for wild-type, floxed, or null 
alleles of Rac1, respectively (Corbetta et al., 2009).  The Rac1 null allele was 
only observed together with Tyr::Cre (Figure 4.1B) indicating efficient 
recombination in the melanocytes. 
Rac1 f/f Tyr::Cre+/o mice (n=15) exhibited a distinctive white patch of hair 
along their ventral region, ranging in size from half to whole the width of the 
mouse underside (Figure 4.3). In addition, more than 80% of the mice had at 
least one white patch along the dorsal midline (Figure 4.3, white arrows) as 
well as white hairs among the black dorsal fur. The limbs and tail in all Rac1 
f/f Tyr::Cre+/o mice were also hypopigmented (Figures 4.3B and C). 
Dopachrome tautomerase (Dct), is involved in the biosynthesis of melanin 
(Tsukamoto et al., 1992). Dct is first expressed in embryonic melanoblasts 
(E10) and is still expressed later in melanocytes and stem cellsin adults 
(Nishimura et al., 2002) thus can be used as melanocyte specific marker. 
Histological analysis of P14 control skin or black areas of the Rac1 f/f 
Tyr::Cre+/o mice with DCT antibody showed melanocytes in hair follicles 
(Figures 4.4A and C), indicating that some melanocytes lacking Rac1 can still 
home correctly. Whereas, no melanocytes were present in dorsal white 
patches or ventral skin of Rac1 f/f Tyr::Cre+/o mice (Figure 4.4B). Thus, Rac1 
deficiency in melanocytes causes a pigmentation defect resulting from a lack 
of melanocytes in areas distal to their migration origin near the neural tube. 
	   147	  
 
!"#$%&'(%)*+,,-./
!"#$%01%)*+23-./
!"#$%4566%)*+$3-./
01701 878 878
9:;<;=%)*+>3-./
?:'@%)*+2>-./
A;:%)*+>>-./
<1; !"#$%BC <1;
D
E
Figure 4.1 Rac1 conditional knockout in melanocytes 
(A) Gene targeting strategy for generating Rac1 f/f Tyr::Cre+/o mice. Cre 
recombinase, under control of the tyrosinase promoter, mediates the excision of 
Rac1 in the melanocyte lineage. (B) A representative genotyping assay using 
DNA extracted from melanocyte-rich ear skin for: wild-type (left lane), Rac1 f/f 
Tyr::Cre+/o (middle lane) and Rac1 f/f Tyr::Creo/o (right lane). Sex of mice is 
determined using male-specific maker Sry and universal maker Myog. 
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Figure 4.2 Rac1 f/f Tyr::Cre+/o mice show decreased body size compared to 
control litter mates.
Box plot of quantification of body weight of mice at day 7 (A) and day 14(B). 
Lower quartile, median, and upper quartile are shown. At least 6 mice from 3 
different litters were quantified. **, P< 0.01 compared to control by t-test. 
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Figure 4.3 Rac1 specific deletion in melanocytic cells results in 
hypopigmentation in C57BL6 mice. 
(A) Coat-color of P14 Rac1 f/f Tyr::Cre+/o  (Rac1 f/f) mouse with control 
littermate (Ctr). Left: dorsal side. Right: Ventral side. White arrows point to typical 
dorsal white patches.  (B) Forelimb of P14 Rac1 f/f Tyr::Cre+/o mouse with 
control littermate. (C) Tails of control and Rac1 f/f Tyr::Cre+/o . 
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Figure 4.4 Rac1 f/f Tyr::Cre+/o show absence of melanoblasts in dorsal and 
ventral patches. (A) Dorsal and ventral skin of P14 control and (B) Rac1 f/f 
Tyr::Cre+/o; dorsal skin from white patch and ventral skin with anti-DCT 
(melanocyte). Insets show hair follicles. (C) Dorsal skin (pigmented region) of 
P14 of Rac1 f/f Tyr::Cre+/o were subjected to immunohistochemical analysis with 
antibody against DCT to detect melanocytes. Scale bars 100µm.
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4.3.2 Rac1 null melanoblasts progress towards the normal 
target areas of the embryo, but fail to complete population of 
the embryo skin 
Mouse melanoblasts migrate out of the neural tube around E10 and continue 
to proliferate and migrate to fill the skin by the time of birth. The melanoblast 
distribution was examined to determine whether loss of Rac1 affected number 
and position of melanoblasts between E11.5 and E15.5 using a DCT::LacZ 
transgene (Mackenzie et al., 1997). On E11.5, when the Tyr::Cre is expressed 
(Delmas et al., 2007; Delmas et al., 2003), the number and distribution of 
melanoblasts were similar in control and Rac1 f/f Tyr::Cre+/o embryos (Figures 
4.5A, E). In E13.5 control embryos, the melanoblast population started to 
expand ventrally (Figures 4.5B, E). By E15.5, melanoblasts colonized almost 
the entire embryo (Figures 4.5C, E). However, by E13.5, there were fewer 
melanoblasts in Rac1 f/f Tyr::Cre+/o embryos than controls and this difference 
increased by E15.5 (Figures 4.5B, C, E). The E15.5 Rac1 f/f Tyr::Cre+/o 
embryos also displayed a notable absence of melanoblasts on both the 
ventral region and limbs corresponding to the future unpigmented region 
(Figures 4.5C, D). Additionally, Rac1 depleted melanoblasts appeared less 
elongated than controls (Figure 4.6).  Melanoblasts in Rac1 f/f Tyr::Cre+/o 
failed to cover the entire dorsal midline region on E15.5 accounting for the 
future dorsal white patches (Figure 4.7). Furthermore, Rac1 f/f Tyr::Cre+/o 
showed half the normal number of melanoblasts at P0.5 after birth (Figure 
4.8). Thus, Rac1 is important for melanoblast position and number during 
embryogenesis. However, it is also clear that melanoblasts lacking Rac1 can 
still proliferate, migrate, home to hair follicles and produce and secrete 
melanin to pigment the hair, albeit less efficiently than those expressing Rac1. 
 
4.3.3 Melanoblasts migrate in embryo epidermis with Rac1 
driven long pseudopods and Rac1 independent short stubs 
To investigate the functions of Rac1 in melanoblast migration in vivo, mice  
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Figure 4.5 Loss of Rac1 alters melanoblast number and position from 
E13.5. (A-C) !-galactosidase stained whole mount DCT::LacZ control and Rac1 f/
f Tyr::Cre+/o embryos at E11.5, E13.5 and E15.5. White dot lines in A, B and C 
indicate the trunk regions in which melanoblasts were quantified in box plot as 
shown in (E).  Each image is representative of at least 5 embryos from four 
different litters. (D) Enlarged images of forelimb from E15.5 DCT::LacZ control 
and Rac1 f/f Tyr::Cre+/o embryos. (E) Quantification of melanoblasts in 
DCT::LacZ control and Rac1 f/f Tyr::Cre+/o littermate embryos at E11.5, 13.5 and 
15.5 from (>=5 embryos, 4 litters). Lower quartile, median, and upper quartile are 
shown. **, P< 0.01 by t-test  Scale bars are 1mm.
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Ctr Rac1 f/fE15.5
 Figure 4.6 Loss of Rac1 alters melanoblast morphology in vivo. Enlarged 
images of  !-galactosidase stained whole mount E15.5 DCT::LacZ control (left) 
and Rac1 f/f Tyr::Cre+/o (right) embryos trunk regions showing individual 
melanoblasts. Scale bar is 50µm.
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Figure 4.7 Rac1 f/f Tyr::Cre+/o mice show paucity of melanoblasts at the dorsal midline. (A) 
Diagram showing where melanoblasts emerge from the neural tube into the neural crest area (also 
called migration staging area) leaving the dorsal midline devoid of melanoblasts until they commence 
both dorsal (red arrows) and ventral migration (black arrows). (B-F) Images of dorsal side of 
DCT::LacZ control and Rac1 f/f Tyr::Cre+/o embryos at (B) 11.5 (C) E12.5, (D) E13.5, (E) E14.5 and 
(F) E15.5. Note that at E11.5-13.5, melanoblasts were absent from the dorsal midline in both control 
and Rac1 f/f Tyr::Cre+/o embryos. From E14.5 to E15.5, melanoblasts start to migrate into the dorsal 
midline and eventually cover the whole area. However, fewer melanoblasts migrate into dorsal midline 
in Rac1 f/f Tyr::Cre+/o embryos at E14.5, which results in unpopulated patches by E15.5 (white 
arrowed). Scale bars are (B-F) 1mm. 
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Figure 4.8. Loss of Rac1 alters melanocytes number in new born 
pups. (A) Representative images of !-galactosidase stained dorsal 
skin samples DCT::LacZ control (left) and Rac1 f/f Tyr::Cre+/o (right) 
pups at P0.5. Each image is from (>= 3 pups, 3 litters). Insets show 
representative thresholded images used in quantification. (B) Relative 
area covered by melanocytes per image for control and Rac1 f/f 
Tyr::Cre+/o. Data derived from (5 images each from >=3 pups, 3 
litters). Lower quartile, median, and upper quartile are shown. **, P< 
0.01 by t-test. Scale bar is 100µm.
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carrying a Z/EG double reporter transgene (Novak et al., 2000) were crossed 
onto the Rac1 f/f Tyr::Cre+/o background to allow specific GFP-expression in 
the melanoblast lineage.  E15.5 embryonic trunk skin was then imaged as 
previously described (Mort et al., 2010). Skin explants consisted of epidermis, 
developing hair follicles and part of the dermis with most melanoblasts in the 
epidermis above the basement membrane among the keratinocytes (Movie 
5). GFP-labelled melanoblasts in whole mounted skin explants exhibited an 
elongated morphology. They showed long cellular protrusions (>cell body 
width) traversing the regions in between adjacent keratinocytes that had 
microtubule cores with several actin rich tips (Figure 4.9 and Movie 5). 3D 
reconstructions revealed a rounded cell body with frequently one or two long 
protrusions, one of which was in the direction of migration (Figure 4.10, Movie 
5). Melanoblasts and keratinocytes express E-cadherin and use E-cadherin to 
contact each other in the developing mouse embryo epidermis  (Figures 4.9 
and 4.11). Loss of Rac1 did not detectably alter E-cadherin localization in 
Rac1 f/f Tyr::Cre+/o melanoblasts or melanoblast position relative to 
keratinocyte neighbors (Figure 4.11). Keratinocytes also do not require Rac1 
for adherence junctions in vivo (Benitah et al., 2005; Chrostek et al., 2006). It 
is likely that loss of Rac1 in melanoblasts didn’t completely disrupt their cell-
cell contacts. In summary, melanoblasts exhibit elongated shape and long 
protrusions between neighboring keratinocytes, which are rich in tubulin and 
actin and may use E-cadherin to contact the neighboring keratinocytes. Loss 
of melanoblast Rac1 gives cells a more rounded shape, but does not cause 
any detectable defects in melanoblast positioning in contact with 
keratinocytes.	  
Live time-lapse imaging of embryo skin explants revealed severe motility 
defects in Rac1 null melanoblasts.  At any one time, nearly every normal 
melanoblast had at least one long protrusion (average 0.9 per cell) compared 
with average 0.2 per cell for Rac1 nulls (Figure 4.12A white arrows long 
protrusions, yellow arrows short stub protrusions and Figure 5.12B, Movie 5).  
Around 35% of the Rac1 depleted melanoblasts and only 4% of normal 
melanoblasts showed no protrusions (Figure 4.12C).  Long protrusions were 
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GFP Phalloidin
Anti-Tubulin Merge
Figure 4.9. Epidermal melanoblasts display an elongated shape with 
long protrusions. Combined Z-stack image (1µm depth) of E13.5 Z/EG 
Tyr::Cre+/o control embryo stained with phalloidin, anti-tubulin and DAPI. 
Insets show distal tips (yellow arrowed). All scale bars are 10µm
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Figure 4.10. Epidermal melanoblasts forms long protrusions in skin 
explants. 3D reconstruction of E15.5 GFP-melanoblasts.  Scale bars are 
10µm
	   159	  
Figure 4.11. Rac1 depleted melanoblast showed normal E-cadherin 
localization. Representative combined Z-stack images (1µm depth) of 
sections from E15.5 control and Rac1 f/f Tyr::Cre+/o embryos stained for 
Collagen IV, E- cadherin, DCT and DAPI. “E” denotes epidermis and “D” 
denotes dermis above and below the red line of collagen IV staining that 
delineates the basement membrane. The insets are shown as X-Y and X-Z 
projections to view the melanoblasts relative to surrounding keratinocytes. 
Scale bar is 10µm.
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Figure 4.12. Loss of Rac1 in melanoblasts reduces the number of long 
protrusions. (A) Combined Z-stack images (1µm depth) of melanoblasts in 
skin explants from Z/EG+/o Tyr::Cre+/o and Z/EG+/o Rac1 f/f Tyr::Cre+/o 
embryos. Long protrusions and short protrusions are white and yellow 
arrowed respectively. (B) Number of long/short protrusions per melanoblast 
n>60 cells per explant >= 3 explants per genotype. (C) Proportion of 
melanoblasts with long/short protrusions. Error bars indicate Mean ± SEM. **, 
P< 0.01, by t-test. Scale bar is 10µm.
	   161	  
 long-lived, with an average lifetime of 1h (Figure 4.13A and B).  The 
protrusions in Rac1 depleted cells were much shorter-lived (Figure 4.13A and 
B) and the rate at which Rac1 depleted cells initiated long protrusions was 
nearly 3-fold decreased (Figure 4.13C, Movie 6). In contrast to Drosophila 
embryos or mouse AVE cells where Rac1 was required for movement 
(Migeotte et al., 2010; Murphy and Montell, 1996) around 90% of Rac1 
depleted melanoblasts migrated despite having only short stubs (Figure 
4.14B), although the average speed was around 50% slower than controls 
(Figures 4.14A, C and Movie 6). The formation of short stubs was always 
followed directly by the translocation of the cell body in Rac1 null 
melanoblasts, unlike in controls where short stubs elongated into long 
pseudopods and cells frequently changed direction, making them less 
persistent than Rac1 null cells (Figures 4.14D and Movies 6).  Thus Rac1 null 
cells were impaired in long pseudopod generation leading to a reduction in 
speed and protrusion lifetime. Rac1 loss also decreased the frequency of 
protrusion initiation, indicating a role for Rac1 as an initiator and potentiator of 
protrusion.  
 
4.3.4 The actin dynamics of Rac1 knockout melanoblasts 
migrate in embryo epidermis 
Short stub protrusion formation occurred completely independently of Rac1 
(Figure 4.13 B, C). To distinguish short protrusions from blebs, we created a 
conditional Lifeact expressing mouse where we could monitor F-actin 
dynamics specifically in melanoblasts ex-vivo. Blebs arise by a dissociation 
between the cell cortex and plasma membrane, followed by a gradual 
recruitment of actin and myosin and bleb retraction (Charras and Paluch, 
2008). Live time-lapse video of melanoblasts expressing lifeact driven by 
Tyr::Cre expression revealed bright flashes of F-actin near the 
tips and in the bodies of both long and short protrusions (Figure 4.15A yellow 
arrows and Movies 7). In contrast, when we added 50µM LY294002, a PI-3- 
kinase inhibitor, to skin explants, we induced blebbing, which could be 
followed with the lifeact probe (Figure 4.15A and Movie 7). Blebs were clearly  
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Figure 4.13. Loss of Rac1 in melanoblasts reduces lifetime and 
frequency of  long protrusions. (A) Live cell imaging of protrusion dynamics 
in explants. Images captured every 5 min, yellow arrows - protrusions. (B) 
Lifetime of actively growing short/long protrusions formed in 20 cells per 
explant from >= 3 explants. (C) Frequency of short and long protrusion 
formation. Error bars indicate Mean ± SEM. **, P< 0.01, by t-test. Scale bar is 
10µm.
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Figure 4.15. The actin dynamics of control and Rac1 depleted melanoblasts in E15.5 
skin explants. (A) !Live cell imaging of F-actin dynamics in GFP- Lifeact f/f Tyr::Cre+/o 
control or GFP-Lifeact f/f Rac1 f/f Tyr::Cre+/o explants or control explant treated with 
50µM Ly294002. Yellow arrows - protrusions/blebs. (B) Frequency of blebs and short 
protrusions (C) Lifetime of blebs and protrusions. Error bars indicate Mean ± SEM. **, P< 
0.01, by t-test. Scale bars are 10µm.
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distinct in shape, as short stubs in Rac1 null melanoblasts often included 
spiky protrusions (Figure 4.15A, yellow arrows, Movie 7). They also had 
distinct actin distribution; Actin accumulated at the neck region (Figure 4.15A, 
15”) and then later as they began to retract actin accumulated near the 
periphery of blebs (Figure 4.15A, 30”), while it was distributed throughout 
short protrusions (Figure 4.15A and Movie 7). Furthermore blebs occurred 
with high frequency (Figure 4.15B) and were much shorter-lived than short 
protrusions (Figure 4.15C). Thus Rac1 null cells were impaired in long but not 
short pseudopod generation leading to a reduction in speed and protrusion 
lifetime. Rac1 loss also decreased the frequency of long but not short 
protrusion initiation, indicating a role for Rac1 as an initiator and potentiator of 
long protrusions that drive migration. Short stub protrusions are distinct from 
classical blebs and thus emerge as a novel Rac1-independent form of actin-
based pseudopod. In addition, protusions formed by Rac1 depleted 
melanoblasts also contain tubulin rich core (Figure 4.16), indicated that tubulin 
orientation is not affected by Rac1 deletion. 
 
4.3.5 Rac1 contributes to focal adhesion formation in vitro, 
but is not required for melanoblast contact with the basement 
membrane in vivo. 
It was unclear whether melanoblasts in skin required Rac1 for long 
protrusions because of the environment of the skin or because melanoblasts 
are somehow different from fibroblasts, which require Rac1 for wide fan-
shaped lamellipodia in culture (Delorme et al., 2007; Guo et al., 2006; Vidali et 
al., 2006). Cultured immortalized primary melanocytes from 1-day pups were 
examined using conditional inducible Rac1 deletion.  Rac1 deletion was 
induced with tamoxifen analog 4-hydroxytamoxifen (OHT), using 
Tyr::CreERT2+/o Ink4a-Arf-/- Rac1 f/f melanocytes plated on fibronectin 
(Ackermann et al., 2005; Serrano et al., 1996).  Anti-DCT staining confirmed 
that our cultures were nearly purely melanocytes (Figure 4.17A) and Rac1 
was lost during 4 days of OHT treatment (Figure 4.17B and 4.18A) without  
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Rac1 f/f
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Ctr Phalloidin Anti-Tubulin Merge E15.5
Figure 4.16. The actin and tubulin localization is not affected by Rac1 depletion in 
melanoblasts. Combined Z-stack image (1µm depth) of E15.5 GFP-Lifeact f/f Tyr::Cre
+/o control embryo stained with phalloidin, anti-tubulin and DAPI. Insets show distal tips 
(yellow arrowed) and tubulin riched core (white arrowed). (B) Sections from E15.5 
control and Rac1 f/f Tyr::Cre+/o embryo stained with anti-Rac1-GTP, anti-DCT and 
DAPI. All scale bars are 10µm.
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Figure 4.17. Induced Rac1 deletion affects melanocytes morphology. (A) Rac1 f/f 
Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cells (clone#4) on fibronectin coated 
glass coverslips were fixed and stained with rhodamine phalloidin and anti-DCT to 
confirm the purity of melanocytes.  Hela human cervical cancer cells were used as 
negative control for DCT antibody. (B) Immunoblots of cell lysates extracted from OHT 
treated Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cells (#4) as indicated 
were probed with antibody against Rac1 and GAPDH (loading control), which showed 
deletion of Rac1 after 4 days. (C) DMSO or OHT treated Rac1 f/f Tyr::CreERT2+/o 
Ink4a-Arf-/- primary melanocyte cells (#3 and #4) on dished were trypsined and 
subjected to cell size analysis using CASY Cell Counter according to manufacture's 
instruction. (D) DMSO or OHT treated Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- primary 
melanocyte cells (#4) on fibronectin coated glass coverslips were fixed and stained with 
rhodamine phalloidin. (E) Qantification of cell body width/length ratio. Error bars indicate 
Mean ± SEM from 50 cells **, P< 0.01. by t-test. All scale bars are 10µm.
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Figure 4.18. Rac1 controls lamellipodia and stress fiber formation, focal adhesion 
density  in primary mouse melanocytes. (A) DMSO or OHT treated Rac1 f/f 
Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cells (#4) on fibronectin coated glass 
coverslips were fixed and stained with rhodamine phalloidin and anti-Rac1 as indicated. (B) 
DMSO or OHT treated Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cells (#4) 
on fibronectin coated glass coverslips were fixed and stained with rhodamine phalloidin, anti-
p34 and anti-paxillin as indicated. (C) DMSO or OHT treated Rac1 f/f Tyr::CreERT2+/o Ink4a-
Arf-/- primary melanocyte cells (#4) on fibronectin coated glass coverslips were fixed and 
stained with rhodamine phalloidin and anti-Abi1 as indicated.  (D) Enlarged picture of focal 
adhesion (anti-paxillin) from inserts of figure B. (E) Number of focal adhesions in two 
independent primary melanocyte cell lines. More than 50 cells were scored per experiment 
and experiments repeated three times. All error bars indicate Mean ± SEM. **, P< 0.01 by t-
test. All scale bars are 10µm.
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affecting the size of melanocytes (Figure 4.17C).  DMSO treated control 
melanocytes continuously formed lamellipodia during migration (Figure 4.17D 
and Movie 8) and Arp2/3 complex and Scar/WAVE complex strongly localized 
to lamellipodia protrusions (Figures 4.18B and C). In contrast, Rac1-deleted 
melanocytes displayed elongated cell morphology that lacked lamellipodia 
(Figures 4.17D, E and 4.18). Expression levels of WAVE complex (WAVE1, 
WAVE2 and Nap1) and Arp2/3 complex (p34) remained unchanged in OHT 
treated melanocytes (Figure 4.19). No upregulation of other Rac family 
members (Rac2 and Rac3) (Figure 4.19A) and no alteration of activity of 
Cdc42 and RhoA were observed (Figure 4.20).  Rac1 depleted cells failed to 
form any lamellipodia during migration with absence Arp2/3 or WAVE 
complex localization at the periphery (Figure 4.18B, C and Movie 8), they also 
had fewer focal complex/adhesions (Figure 4.18B, D and E), but expression 
of paxillin, vinculin and β1-integrin was unchanged (Figure 4.19A). Migration 
was severely impaired following Rac1 loss (Figure 4.21). However, in vivo the 
same number of control and Rac1 deleted melanoblasts contacted the 
basement membrane (BM) at E15.5 (Figures 4.22) indicating that the ability to 
recognize and contact this structure is intact (Figure 4.22). Furthermore, 
expression levels of E-cadherin and ZO-1 (Figure 4.19A) and surface 
expression of E-cadherin were normal in cultured Rac1 depleted melanocytes 
(Figure 4.19B).  Thus, loss of Rac1 in cultured melanocytes parallels 
observations in fibroblasts that lamellipodia and focal adhesions are affected 
(Guo et al., 2006), but Rac1 depleted melanoblasts can still position 
themselves relative to the basement membrane in vivo. The specific nature of 
Rac1 involvement in adhesion in vivo requires further study, as these 
interactions are complex. 
 
4.3.6 Melanoblasts migrate individually in developing skin 
using a novel form of long protrusion based on microtubules 
and Arp2/3 complex 
We further analysed the motility of melanoblasts in live skin explants to  
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Figure 4.19. Levels of various cytoskeletal proteins in melanocytes or skin explants 
following loss of Rac1 or treatment with inhibitors. (A) Cell lysates from two independent 
Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cell lines (#3 and #4) treated with 
DMSO or OHT were separated by SDS-PAGE, transferred to PVDF membranes and probed 
with antibodies as indicated. (B) Cell surface protein from Rac1 f/f Tyr::CreERT2+/o Ink4a-
Arf-/- primary melanocyte cell lines (#4) treated with DMSO or OHT were biotinylated for 15 
mins on ice. Surface E-cadherin and total E-cadherin were probed with E-cadherin antibody.
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Figure 4.20. Rac1 depletion in mouse primary melanocyte had not effect on level of 
active RhoA and Cdc42. Relative levels of active GTP-bound RhoA, Cdc42 and Rac from 
primary melanocyte cell line (#4) treated with DMSO or OHT were measured by use of 
Rhotekin (for RhoA) or Pak1-PBD (for Cdc42 and Rac) domain. Relative levels were 
quantified and the relative intensity of active Rho GTPase (GTP bound) signal was 
normalised to total Rho GTPase. The results shown are the means of three independent 
experiments.  
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Figure 4.21. Rac1 controls  migration speed in primary mouse melanocytes. (A) 
10 hr tracks of individual melanocytes (#4) treated with DMSO or OHT migrate on 
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Figure 4.22. Rac1 knockout does not affect the proportion of melanoblasts 
contacting the basement membrane Representative combined Z-stack images (1µm 
depth) of sections from E15.5 control and Rac1 f/f Tyr::Cre+/o embryos stained for 
Collagen IV to visualize basement membrane, DCT (melanoblasts) and DAPI (DNA). 
Melanoblasts contacting the basement membrane were yellow arrowed, which those 
contacting the basement membrane were white arrowed. Percentage of melanoblasts 
attached to the basement membrane in control and Rac1 f/f Tyr::Cre+/o embryos. More 
than 200 cells were examined per embryo from at least three embryos for each genotype. 
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understand more about the molecular mechanism of movement within the 
keratinocyte layer. Inhibition of actin polymerization (latrunculin A) or tubulin 
polymerization (nocodazole) nearly completely stopped migration (Figure 4.23 
and 4.24 and Movie 9). Microtubule stabilization with taxol slowed migration 
(Figure 4.24 and Movie 9). In addition, latrunculin A severely inhibited 
formation in both long and short stub protrusions, whereas nocodazole or 
taxol only inhibited formation of long protrusions (Figures 4.23 and 4.24 and 
Movie 9). Long protrusions formed by melanoblasts in skin are thus 
fundamentally different from lamellipodia, in that microtubule dynamics are 
required for normal protrusion extension and subsequent cell translocation 
(Ballestrem et al., 2000; Verkhovsky et al., 1999). However, the mechanism 
by which microtubules act is likely to be complex, as previous studies showed 
that microtubules sequester RhoGEFs, such as GEFH1 and their 
depolymerization can alter Rho activity and contractility in cells (Redd et al., 
2006; Takesono et al., 2010; Zhou et al., 2010). We therefore tested whether 
inhibiting myosin-II mediated contractility in nocodazole treated melanoblasts 
could compensate for a possible increase in Rho activity caused by 
microtubule depolymerization. Indeed, the Rho-kinase inhibitor Y27632 
restored the formation of protrusions in melanoblasts in nocodazole treated 
explants and cells cultured in vitro back to the levels seen in wild-type cells 
but did not restore the migration speed (Figures 4.24 and Movie 9). 
Furthermore, long protrusions formed in the presence of Y27632 and 
nocodazole were devoid of visible microtubules (Figure 4.24G) indicating that 
microtubules do not perform an essential structural role in long protrusions. 
Together, these data indicate that actin and tubulin dynamics are very 
important for melanoblast migration in epidermis, and that microtubule 
depolymerization may trigger RhoA activation in melanoblasts in vivo. 
 
Myosin-II mediated contraction is important for cell body translocation, but not 
for Rac1 mediated lamellipodia assembly in cultured cells (Ponti et al., 2004; 
Vidali et al., 2006). We investigated the role of myosin-II in melanoblast 
migration and long protrusion formation using ROCK (Y27632) or myosin II 
inhibitor (Blebbistatin). At the concentrations we used, Y27632 treated skin  
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DMSO Latrunculin A
Figure 4.23. Melanoblast migration and protrusions are regulated by actin.
(A) Combined Z-stack images (1µm depth) of Z/EG+/o Tyr::Cre+/o melanoblasts in skin 
explants treated with inhibitor as indicated. (B) Migration speed. (C) Number of long 
and short protrusions per melanoblast for > 60 cells per explant from >= 3 explants per 
genotype. (D) Proportion of melanoblasts with short or long protrusions. (E) Lifetime of 
actively growing protrusions. (F) Frequency of protrusions formed in 20 cells per 
explant from >= three explants per condition. Error bars indicate Mean ± SEM. **, P< 
0.01. *, P<0.05 by t-test. Scale bar 10µm.
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Figure 4.24. Melanoblast migration and protrusions are regulated by microtubules
(A) Combined Z-stack images (1µm depth) of Z/EG+/o Tyr::Cre+/o melanoblasts in skin explants 
treated with inhibitor as indicated. (B) Migration speed. (C) Number of long and short protrusions per 
melanoblast for > 60 cells per explant from >= 3 explants per genotype. (D) Proportion of 
melanoblasts with short or long protrusions. (E) Lifetime of actively growing protrusions. (F) 
Frequency of protrusions formed in 20 cells per explant from >= three explants per condition. (G)
Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- (#4) primary melanocytes treated with DMSO or Y27632 or 
nocodazole or both Y27632 and nocodazole were plated on 3D collagen I matrix. Cells were stained 
with rhodamine phalloidin, anti-tubulin and DAPI. Yellow arrows indicate accumulation of tubulin in 
protruions (for DMSO and Y27632) or in cell body (Y27632+nocodazole). (H) % cells with elongated 
morphology and (I) Number of protrusions per cell for >300 cells x 3 repeats. Error bars indicate 
Mean ± SEM. **, P< 0.01, *, P< 0.05 by t-test. Scale bar 10µm. 
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explants exhibited a reduction in myosin light chain phosphorylation (Figure 
4.25A) without any obvious change in keratinocyte actin structure or tissue 
integrity (Figure 4.25B). Both Y27632 and Blebbistatin caused a near halt in 
melanoblast migration (Figures 4.25D), but a significant increase in the 
number of both short stubs and long apparently thinner protrusions (Figures 
4.25C, E, F and Movie 9). Protrusion formation occurred with the same 
frequency as in controls (Figure 4.25G) but protrusions were about 2-fold 
longer lived (Figure 4.25H). Thus, myosin II activity is not required for the 
initiation of protrusions but is important for the retraction dynamics of 
protrusions and for melanoblast translocation among keratinocytes in 
epidermis. 
To test whether high contractility in Rac1 depleted melanoblasts might be 
inhibiting protrusion formation, we inhibited Rho-kinase with Y27632.  These 
cells showed even slower migration than untreated Rac1 depleted or Y27632 
treated control explants (Figure 4.25D, Movie 9), but they displayed a similar 
number of long protrusions to control cells with Rac1 (Figure 4.25C, D and E).  
These protrusions were around 2-fold longer-lived than controls (Figure 5E).  
Cell migration was mostly halted (Figure 4.25H, Movie 9).  Importantly, long 
protrusions in Rac1 depleted cells formed with a 3-fold lower frequency than 
controls, regardless of myosin inhibition (Figure 4.25G, Movie 9) and inhibiting 
myosin didn’t increase the frequency of protrusion formation in normal 
melanoblasts (Figure 4.25G).  We also did not see any obvious difference in 
myosin light chain phosphorylation between normal and Rac1 null 
melanocytes in vitro (Figure 4.19A).  Thus, Rac and myosin are not 
apparently opposing each other, but rather when Rac is active, myosin-based 
contractility mediates protrusion retraction and enables long protrusions to 
generate force for movement.  When Rac is not present, long protrusions 
rarely form and if they do form, they are weaker and less resistant to 
contractile forces.  Thus Rac controls the rate of protrusion formation and 
myosin controls contractility that mediates retraction as well as generating 
pulling and squeezing forces for motility. 
Pak kinases have been implicated in motility downstream of Rac1 (Edwards 
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Figure 4.25. Melanoblast migration and protrusions are regulated myosin (A) Western 
blots of lysates extracted from skin explants treated with either DMSO or drug as indicated. 
Blots were then probed with antibody as indicated. (B) Confocal images of E15.5 epidermis 
from Z/EG+/o Tyr::Cre+/o explants treated with drugs as indicated for 5 hr. the explants were 
fixed and stained with rhodamine phalloidin and DAPI. (C) Combined Z-stack images (1µm 
depth) of Z/EG+/o Tyr::Cre+/o control or Z/EG+/o Rac1 f/f Tyr::Cre+/o (Rac1 f/f) 
melanoblasts in skin explants treated with inhibitor as indicated. (D) Migration speed. (E) 
Number of long and short protrusions per melanoblast for > 60 cells per explant from >= 3 
explants per genotype. (F) Proportion of melanoblasts with short or long protrusions. (G) 
Frequency of protrusions formed in 20 cells per explant from >= three explants per 
condition. (H) Lifetime of actively growing protrusions.  Error bars indicate Mean ± SEM. **, 
P< 0.01. *, P<0.05 by t-test. Scale bar 10µm.
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 et al., 1999; Smith et al., 2008; Yang et al., 1998), so we explored the role of 
the conventional PAKs 1-3 (group I Paks) and their downstream targets in 
migration. Treatment of skin explants with Pak inhibitor (IPA-3) (Deacon et al., 
2008) and its downstream targets LIM kinase (LIMKi) (Scott et al., 2010) and 
ERK (U0126, a MEK1/2 inhibitor that inhibits ERK1/2 activation) showed no 
effect on melanobast motility despite reducing phosphorylation of their targets 
in skin explants (Figure 4.26, Movie 9 and data not shown). In addition, siRNA 
knockdown of Pak2, the only group I Pak isoform expressed in melanocytes 
(Figures 4.27A and B), did not change melanocyte morphology on 3D 
collagen I matrix (Figure 4.27C and Movie 10). Furthermore, despite the 
decrease in Pak2 and ERK phosphorlyation in our melanocyte cell lines (#3 
and #4) in vitro (Figure 4.27D), we found no detectable changes in 
phosphorlylation of LIMK effector cofilin between DMSO and OHT treated 
melanocytes (Figure 4.27F). Thus, Rac1 regulates melanoblast migration in 
epidermis and formation of long protrusions through pathways other than Pak 
or its downstream targets. 
The main effector of actin nucleation downstream of Rac is the Scar/WAVE 
complex; it activates Arp2/3 complex to induce branched actin assembly. 
Since we could not use a pharmacological inhibitor of Scar/WAVE, RNA 
interference was used to knock down Arp2/3 complex (p34 siRNA), WAVE 
complex (Nap1 siRNA) in primary melanocytes in vitro.  Knockdown of p34 or 
Nap1, which, for Nap1, also caused significant reduction of expression of 
other WAVE complex constituents (Figures 4.28A and B), however, caused a 
dramatic morphological change similar to loss of Rac1 or Arp2/3 complex 
(Figures 4.28C Movie 10) in 3D. We also investigated the function of Arp2/3 
complex in melanoblast migration by treating skin explants with inhibitor 
against Arp2/3 complex (CK-869) (Nolen et al., 2009).  CK-869 reduced 
melanoblast migration in explants without affect keratinocyte actin 
organization (Figure 4.29A and C). The control compound CK-312 had no 
effect (Figure 4.29B-G and Movie 9). In addition, melanoblasts in CK-869 
treated explants resembled Rac1 deleted cells with significant reduction in the 
formation of long but not short stub protrusions (Figures 4.29B, D and E). The 
frequency of protrusion initiation and lifetime of each protrusion was also  
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Figure 4.26. PAK signaling is not required for melanoblast migration and formation of  
protrusions (A) Western blots of lysates extracted from skin explants treated with either 
DMSO or drug as indicated. Blots were then probed with antibody as indicated. (B) 
Combined Z-stack images (1µm depth) of Z/EG+/o Tyr::Cre+/o control or Z/EG+/o Rac1 f/f 
Tyr::Cre+/o (Rac1 f/f) melanoblasts in skin explants treated with inhibitor and/or of genotype 
as indicated. (C) Migration speed. (D) Number of long and short protrusions per melanoblast 
for > 60 cells per explant from >= 3 explants per genotype. (E) Proportion of melanoblasts 
with short or long protrusions. (F) Lifetime of actively growing protrusions. (G) Frequency of 
protrusions formed in 20 cells per explant from >= three explants per condition. Error bars 
indicate Mean ± SEM.  Scale bar 10µm.
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Figure 4.29. Arp2/3 complex is required for melanoblast migration and formation of  
protrusions (A) Confocal images of E15.5 epidermis from Z/EG+/o Tyr::Cre+/o explants 
treated with drugs as indicated for 5 hr. the explants were fixed and stained with rhodamine 
phalloidin and DAPI. (B) Combined Z-stack images (1µm depth) of Z/EG+/o Tyr::Cre+/o 
melanoblasts in skin explants treated with inhibitor as indicated. (C) Migration speed. (D) 
Number of long and short protrusions per melanoblast for > 60 cells per explant from >= 3 
explants per genotype. (E) Proportion of melanoblasts with short or long protrusions. (F) 
Lifetime of actively growing protrusions. (G) Frequency of protrusions formed in 20 cells per 
explant from >= three explants per condition. Error bars indicate Mean ± SEM. **, P< 0.01. 
Scale bar 10µm.
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decreased (Figures 4.29F and G).  Surprisingly, this indicates that short stub 
protrusions form independently of Arp2/3 complex, but that Scar/WAVE and 
Arp2/3 are the major effectors driving actin dynamics in long protrusions. 
In addition to Scar/WAVE, Arp2/3 complex can also be activated by N-WASP 
to drive efficient invasive cell migration (Insall and Machesky, 2009; 
Machesky, 2008) and N-WASP is robustly expressed in primary melanocytes 
(Figure 4.19A). Surprisingly, melanoblasts lacking N-WASP in Z/EG+/o N-
WASP f/f Tyr::Cre+/o explants (Snapper et al., 2001) showed no difference in 
migration and formation of long protrusions as compared with melanoblasts in 
Z/EG+/o Tyr::Cre+/o control explants (Figure 4.30 and Movie 9).  Additionally, 
the Tyr::Cre deletion of N-WASP revealed no coat color changes in a 
C57Bl6/J background (Figure 4.31A) and the number and position of 
melanoblasts in E15.5 DCT::LacZ N-WASP f/f Tyr::Cre+/o  embryos showed 
no differences to control (Figure 4.30B-E), indicating normal melanocyte 
lineage function in the absence of N-WASP.  Furthermore, depletion of N-
WASP in melanocytes in vitro did not alter melanocyte morphology in 3D 
(Figures 4.32 and Movie 10). In summary, Rac1 regulates melanoblast 
migration in epidermis and formation of long protrusions through Scar/WAVE 
and Arp2/3 mediated actin assembly and independently of N-WASP. 
 
4.3.7 Melanoblast motility across the basement membrane 
and in skin is not invasive 
We were surprised that loss of N-WASP did not produce any apparent defects 
in melanoblast migration in the skin and it raised the question of whether 
melanoblasts use invasive matrix degrading migration during embryogenesis. 
N-WASP and Rac are essential for the formation of invadopodia by melanoma 
cells and for invasion of cultured cells into collagen gels (Li et al., 2010; 
Nakahara et al., 2003; Yamaguchi et al., 2005).  To further explore the idea 
that melanoblast migration in skin is not invasive, we examined if 
metalloprotease (MMP) is required for the formation of long protrusions and 
migration of melanoblasts by treating the Z/EG+/o Tyr::Cre+/o control skin 
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Figure 4.30. N-WASP is not required for melanoblast migration and formation of  
protrusions (A) Combined Z-stack images (1µm depth) of Z/EG+/o N-WASP f/f Tyr::Cre+/o 
melanoblasts in skin explants (B) Migration speed. (C) Number of long and short protrusions 
per melanoblast for > 60 cells per explant from >= 3 explants per genotype. (D) Proportion of 
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Figure 4.31. N-WASP f/f Tyr::Cre+/o mice revealed normal coat colour and distribution of 
melanoblasts  (A) Ventral coat-color of P14 N-WASP f/f Tyr::Cre+/o mouse. Inset shows hind 
limb. (B) !-galactosidase stained whole mount DCT::LacZ control (left) and N-WASP f/f Tyr::Cre
+/o (right) embryos at E15.5. White dot lines in B indicate the trunk regions in which 
melanoblasts were quantified in box plot as shown in (E).  Each image is representative of 4 
embryos from two different litters. (C) Enlarged images of E15.5 trunk regions showing individual 
melanoblasts. (D) Enlarged images of forelimb from E15.5 DCT::LacZ control (left) and N-WASP 
f/f Tyr::Cre+/o (right) embryos. (E) Quantification of melanoblasts in DCT::LacZ control and N-
WASP f/f Tyr::Cre+/o littermate embryos at E15.5 from 4 embryos from 2 different litters. Lower 
quartile, median, and upper quartile are shown. Scale bars are (B, D) 1mm, (C) 50µm.
	   187	  
 
  
NT siN-WASP
N-WASP (65kDa)
GAPDH (37kDa)
siN-WASP
A
NT
siN
-W
AS
P
0.0
0.5
1.0
1.5
2.0
2.5
**
N
um
be
r o
f P
ro
tr
us
io
ns
 p
er
 C
el
l 
NT
siN
-W
AS
P
0
20
40
60
80
100
**
Pe
rc
en
ta
ge
 o
f E
la
ng
at
ed
 C
el
ls
B
C D
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 explants with MMP inhibitor (GM6001). However, long protrusions and cell 
migration speed were not affected (Figures 4.33 and Movie 9), indicating that 
MMPs are not required for melanoblast migration in the epidermis. 
During mouse embryogenesis, melanoblasts migrate from dermis to 
epidermis between E11.5 and E13.5 and this involves crossing the embryonic 
epidermal BM (Figure 4.34A).  This is potentially a step in migration where 
melanoblasts would need to use invasive migration.  However, the lack of a 
pigmentation defect (Figure 4.30) in the Tyr::Cre+/o N-WASP f/f mouse 
suggests that melanoblasts do not need invadopod-like structures mediated 
by N-WASP either for migration or for crossing the embryonic BM. To confirm 
this, the trunk region of X-gal stained Dct::LacZ control, Rac1 f/f Tyr::Cre+/o 
and N-WASP f/f Tyr::Cre+/o embryos were sectioned and the proportion of 
melanoblasts in the three distinct skin layers: dermis, epidermis and 
epidermal/dermal junction of the skin tissue sections was determined. On 
E13.5 and E15.5, the relative distribution of melanoblasts within each of the 
skin layers did not differ significantly between Rac1 depleted or N-WASP 
depleted or control embryos (Figures 4.34B, C). Thus, melanoblast migration 
from dermis to epidermis is unaffected by loss of Rac1 or N-WASP. 
 
4.3.8 Rac1 is required for normal cell cycle progression of 
melanoblasts during embryogenesis 
It was clear that melanoblast position in developing embryos was affected by 
the loss of Rac1 due to defects in migration, but we also observed a decrease 
in the number of melanoblasts that required further investigation. The number 
of melanoblasts undergoing the cell-cycle or apoptosis were determined by 
co-expression of DCT (melanoblast) and Ki67 (proliferation) or cleaved 
caspase3 (CC3, apoptosis) in E15.5 control or Rac1 f/f Tyr::Cre+/o embryos. 
The average percentage of melanoblasts expressing either Ki67 or CC3 
between control and Rac1 depleted sections was not significantly changed 
(Figure 4.35A and data not shown), indicating that melanoblast reduction in  
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Figure 4.33. Metalloproteases is not required for melanoblast migration and formation 
of  protrusions (A) Combined Z-stack images (1µm depth) of Z/EG+/o Tyr::Cre+/o 
melanoblasts in skin explants treated with 10µM GM6001. (B) Migration speed. (C) Number 
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per genotype. (D) Proportion of melanoblasts with short or long protrusions. (E) Lifetime of 
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Rac1 f/f Tyr::Cre+/o embryos is not a consequence of reduced numbers of 
cells undergoing the cell cycle or apoptosis. Next, we examined whether loss 
of Rac1 induced a cell cycle progression defect in melanoblasts. We observed 
a significant decrease in BrdU incorporation into Rac1 depleted melanoblasts 
when animals were given either a 2hr or 24hr pulse before sacrifice (Figures 
4.35B and C). Furthermore, there was a significant reduction in the 
percentage of phospho-histone 3 (PH3, mitosis) positive melanoblasts in 
Rac1 f/f Tyr::Cre+/o embryos (Figure 4.35D). Consistent with in vivo 
observations, the growth rate of OHT treated melanocyte cell lines #3 and #4 
(Tyr::CreERT2+/o Ink4a-Arf-/- Rac1 f/f) was significant decreased compared to 
their DMSO treated control. Whereas, growth rate and cell morphology of 
OHT treated control melanocyte cell line #2 (Tyr::CreERT2o/o Ink4a-Arf-/- Rac1 
f/f) was unaffected (Figures 4.36A, B  and data not shown). Flow cytometry 
analysis of Rac1 knockout melanocytes showed shifting to the G1 phase with 
a significant reduction of cells in S phase as compared to control (Figures 
4.36C, D). Thus, Rac1 is required for normal G1-S phase cell cycle 
progression but not cell cycle entry or prevention of apoptosis in melanoblasts 
in vivo. 
 
4.3.9 Rac1 is required for efficient cytokinesis of melanoblasts 
during embryogenesis 
Time-lapse videos revealed alterations in cytokinesis of Rac1 deficient 
melanoblasts that likely also contribute to growth rate slowing.	   	   Normal 
melanoblasts in Z/EG+/o Tyr::Cre+/o control explants undergo very efficient 
cytokinesis in skin explants , taking about 10 minutes to first show a cleavage 
furrow and about 30min from the initiation of furrowing to the separation of two 
daughter cells (Figures 4.37A, B). Interestingly, Rac1 depleted melanoblasts 
formed a furrow with normal timing, but exhibited a 3- fold delay in time to 
separation (Figures 4.37A, B and Movie 11) and the two daughter cells 
migrated apart more slowly (Figure 4.37C). Despite the strong delay in 
cytokinesis, Rac1 f/f Tyr::Cre+/o melanoblasts did not become multinucleate 
(data not shown) indicating that Rac1 is not essential for cytokinesis but  
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Figure 4.36. Rac1 is required for melanocyte cell cycle progression in vitro. (A) 
Western blots of lysates from Rac1 f/f Tyr::CreERT2o/o Ink4a-Arf-/- (#2) and two 
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control). (B) Growth curve of melanocyte cell lines (#2, #3 and #4) treated with DMSO 
or OHT. Each point (Mean ± SEM) is derived from 3 replicate dishes from 3 
independent experiments. (C) Representative experiment from Rac1 f/f 
Tyr::CreERT2+/o Ink4a-Arf-/- (#4) melanocytes treated with DMSO or OHT were 
pulse-labeled for 2 h with BrdU, and analyzed by flow cytometry for BrdU 
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f  Tyr::Cre+/o skin explants undergo cytokinesis. Images were captured every 5 min. Time-point 
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required for efficient daughter cell separation in vivo. To see if the cytokinesis 
defect also exists in vitro, control and Rac1 depleted melanocytes were 
subjected for live time imaging. Interestingly, no obvious delay of cytokinesis 
was found in Rac1 depleted melanocytes on 2D cell culture dish (Figure 
4.38). Together, these data suggest a more significant requirement for Rac to 
control cytokinesis in the tissue environment than in culture dishes. 
 
4.4 Discussion 
4.4.1 Melanoblasts move using a mixture of short Rac1-
independent and long Rac1-dependent protrusions. 
Melanoblasts extend a mixture of long and short protrusions in skin and short 
protrusions mature into long ones.  Short stubby protrusions require actin 
assembly but not microtubules, myosin or components of the Rac-
Scar/WAVE-Arp2/3 pathway.  They might initiate by stochastic actin assembly 
reactions that are normally cycling in the melanoblasts (Betz et al., 2009; 
Michelot et al., 2007) or by some form of signaling.  A candidate to signal 
short protrusion initiation might be Rho, which was found to precede Rac in 
motile cultured cells (Pertz et al., 2006) and downstream might lie diaphanous 
related formins (DRFs), to initiate formation of unbranched actin networks that 
could later serve as a platform for Arp2/3 mediated actin assembly.  DRFs are 
attractive candidates, since they also coordinate actin and microtubule 
assembly and dynamics (Palazzo et al., 2001). Indeed, expression of GFP-
mDia1 or GFP- mDia2 in normal and Rac1 null melanocytes on 3D collagen I 
matrix showed localization at tips of long and short protrusions (Figure 4.39). 
However, further studies are required to elucidate the role of formins in 
melanoblast motility. Treatment of skin explants with broad formin inhibitor 
(SMIFH2) (Rizvi et al., 2009) resulted in massive cell death within half hour 
incubation even at 100nM inhibitor (Data not shown), indicating that formin 
function may be crucial for melanoblast survival or that this inhibitor is toxic to 
our skin explants. In the future, we hope to understand the role of individual  
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Figure 4.38. Rac1 deletion in mouse primary melanoblasts does not affect cytokinesis in 
vitro. (A) Representative stills from live-cell imaging of DMSO or OHT treated Rac1 f/f 
Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cells (#4) in culture on fibronectin coated 
coverslips undergoing cytokinesis. Images were captured every 10 min. Initiation of furrowing is 
yellow squared; Daughter cell separation point is red squared. (B) Quantification of the duration 
of cytokinesis from initiation of furrowing to separation of two daughter cells. Error bars indicate 
Mean ± SEM of 20 cells from 10 divisions. Scale bars 10µm.
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Figure 4.39 Localization of mDia2 to short protrusions. Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- 
(#4) primary melanocytes expressing GFP- mDia1, GFP-mDia2, GFP-p21-Arc or GFP-N-WASP 
treated with DMSO or OHT as indicated were plated on 3D collagen I matrix. Cells were stained with 
rhodamine phalloidin and DAPI. Yellow arrows indicate co-localization of GFP- tagged protein and 
actin at tips of protrusions. Scale bar is 10µm.
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formins in melanoblast motility using mouse genetic experiments. Additionally, 
Small and colleagues propose that lamellipodial protrusions can be driven by 
proteins such as Mena/VASP, which can support extension of actin-based 
unbranched networks (Urban et al., 2010). It remains to be determined the 
relative roles of other actin network inducing proteins in stub protrusions. Our 
data suggest that short stubs are distinct from blebs (Fackler and Grosse, 
2008), as they generally are thin and spiky or jagged in shape (rather than 
lobule-shaped like blebs) and they are rich in dynamic filamentous actin, 
similar to longer protrusions. Short stubs are thus novel Rac1 independent 
actin structures that can act as precursors to long pseudopods and might not 
occur on rigid flat substrates, where lamellipodia dominate. 
 
Melanoblast long protrusions required on actin, microtubules and the Rac-
Scar/WAVE-Arp2/3 pathway, but not myosin.  Long protrusions traversed 
between keratinocytes, often spanning the length of 2 or 3 keratinocytes and 
existing in multiple planes, appearing to contact keratinocytes all over their 
surfaces. Melanoblast long protrusions have in common with neurite 
processes that they are microtubule-rich and have actin-rich tips.  However, 
while Rac1 and the Scar/WAVE complex are important for lamellipodia of 
neuronal growth cones, the growth of long microtubule-rich processes from 
neuronal cells in culture wasn’t ablated by loss of Rac1 or inhibition of Arp2/3 
complex (Strasser et al., 2004; Tahirovic et al., 2010).  A cell type that might 
be comparable to melanoblasts for migration in vivo is chick embryo muscle 
precursor, which migrates from somites into the limb bud.  Horwitz and 
colleagues showed that these cells extend long stable protrusions similar in 
lifetime to melanoblasts (50 min vs 60 min in our study) and migrate with 
similar average speed (37µm/hr vs 30µm/hr in our study).  They also found 
that dominant negative Rac stopped migration and limited protrusion (Knight 
et al., 2000). 
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4.4.2 Rac1 controls the frequency of long pseudopod 
extension 
We were surprised that overall migration and directional steering of 
melanoblasts occurred normally in the majority of dorsal areas of the mouse 
skin.  It was also unexpected that when myosin was inhibited, Rac1 was no 
longer required for long pseudopod generation; but it still strongly controlled 
the frequency of generation of long pseudopods.  This only became apparent 
when we inhibited myosin activity in skin explants by adding Y27632 or 
blebbistatin, so it might be interesting to apply these compounds to Drosophila 
border cells or Rac1 deficient AVE cells. Scar/WAVE and Arp2/3 complex 
might be able to generate long pseudopodia in a Rac-independent manner in 
the case where cortical tension and contractility is low enough to be 
permissive for this.  This may depend on other signaling, such as via 
phosphorylation (Lebensohn and Kirschner, 2009) or phospholipid or adapter 
protein interactions (Chen et al., 2010). While Rac1 is a major controller, it is 
likely that multiple signal inputs modulate the Scar/WAVE complex. 
 
4.4.3 Loss of Rac1 affects focal adhesion formation but not 
contact with BM or cell-cell adhesion structures 
Adhesion to extracellular matrix was likely affected by loss of Rac1, since in 
culture, melanocytes depleted for Rac1 showed reduced focal adhesions.  
This could alter the lifetime of long protrusions and their ability to adhere for 
force generation towards translocation.  However, we could not find any 
change in the percentage of melanoblasts contacting the basement 
membrane in embryo skin, indicating that cells didn’t likely completely lose 
contact between integrins and extracellular matrix. E-cadherin and actin 
surrounding the melanoblasts and neighboring keratinocytes in skin explant 
whole mounts appeared normal, as did levels of E-cadherin or ZO-1 
expressed by cultured melanocytes following Rac1 depletion.  We can’t be 
sure that melanoblasts are making E-cadherin junctions with keratinocytes, 
but the extension of long protrusions into the spaces between keratinocytes, 
coupled with the precedent in other systems (Geisbrecht and Montell, 2002; 
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Kardash et al., 2010) suggests that E-cadherin is a good candidate to mediate 
interactions between these cells.  This requires further study, such as with E-
cadherin depleted melanoblasts or cadherin-blocking reagents. 
 
4.4.4 Melanoblast motility across the basement membrane 
and in skin is not invasive 
Melanoblasts traverse at least three very different tissue environments on 
their journey from the neural tube to the epidermis and hair follicles.  They first 
emerge in the dermis, a complex matrix of collagen and proteoglycans and 
they migrate in the dermis until around E13.5, when they cross what appears 
as a collagen-rich BM into the epidermis.  At E13.5, the epidermis is only ~1 
cell-layer thick (Figure 4.34B) but by E15.5, multiple keratinocyte layers are 
present and around half of melanoblasts are touching the BM, but ~70% have 
crossed over and are above the BM (Figure 4.34C).  We can find no evidence 
that this motility depends on either N-WASP or Rac, which are important for 
the assembly of invadopodia (Li et al., 2010; Nakahara et al., 2003; 
Yamaguchi et al., 2005) and for the invasion of cancer cells into 3D matrix 
(Kurisu et al., 2004; Li et al., 2010).  Furthermore, migration of melanoblasts 
within the skin was not affected by inhibition of MMPs.  Thus early dermal 
ECM and epidermal BM are likely permissive to cell transmigration 
independent of pericellular proteolysis, whch is similar to lymphatic endothelial 
BM and dendritic cells (Pflicke and Sixt, 2009).   During melanoma formation, 
the acquisition of a BM degrading ability is thus unlikely to be a simple 
reversion to the normal melanoblast genetic programme. Melanoma cells 
require N-WASP for efficient invasion in vitro and use MT1-MMP to make 
invadopodia (Li et al., 2010), but melanoblasts do not appear to depend on 
similar invasive behavior during embryogenesis.	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4.4.5 Rac1 is required for normal cell cycle progression and 
cytokinesis of melanoblasts during embryogenesis 
Rac1 is important for G1 progression of melanoblasts during normal 
development.  A major controller of melanoblast proliferation is c-kit, a 
tyrosine kinase receptor, which signals to Ras and activates entry into the cell 
cycle via PI3-kinase, Akt and MEK pathways (Smalley, 2009).  Rac1 is well 
documented to act downstream of Ras in concert with PI3-kinase and to 
regulate G1 progression in vitro (Olson et al., 1995). However, unlike 
melanoblasts, anterior visceral endoderm cells can dispense with Rac1 for 
proliferation (Migeotte et al., 2010).  Murine neural crest cells have increased 
apoptosis with loss of Rac1 induced by wnt-1 cre, unlike melanoblasts with 
Tyr::Cre (Thomas et al., 2010).  We wonder if Rac1 loss affects stem cell 
survival of melanocytes in hair follicles, as was the case for keratinocytes 
(Benitah et al., 2005; Chrostek et al., 2006), but some expression of Tyr::Cre 
in the nervous system (Tonks et al., 2003) caused a shakiness of Rac1 
deleted mice that required culling before they could be aged over several hair 
cycles. 
There is little precedent for the positive involvement of Rac in control of 
cytokinesis, so it was surprising to find a 3-fold increase in time to divide in 
Rac1 null cells.  However, Rac drives the assembly of the cortexillin-actin 
networks in dividing Dictyostelium cells (Faix, 2002) and recently Insall and 
colleagues found that Scar/WAVE proteins enabled cells to repolarize and 
crawl apart following cleavage, suggesting a late requirement for Rac at 
opposite poles of the dividing cells (King et al., 2010).  In C. elegans early 
cleavage furrow formation, Rac1 inhibited by a complex containing the 
RacGEF CYK4 and centralspindlin, so that Rho can effect contractility 
(Canman et al., 2008).  Rac1 depleted melanoblasts dividing in skin could still 
round up with the normal timing, but took far longer to divide, indicating a 
likely requirement for Rac1 in adhesion of the dividing cell to the surrounding 
milleu and repolarization of the dividing cells to then crawl apart. This defect 
wasn’t seen in cultured cells, indicating that it was specific to the epidermal 
environment.  So while in early cytokinesis, Rac1 may be inhibited at the 
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furrow, later cytokinesis may in some tissue environments utilize activation of 
Rac for adhesion, polarization and migration of the two daughter cells. 
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Chapter V 
The role of Rac1 downstream of activated 
N-RasQ61K in melanocyte survival  
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5.1 Summary 
Rac1 is important for Ras-mediated transformation in vitro, but its role 
downstream of Ras, especially N-Ras, is not fully understood. The aim of this 
chapter was to characterise the role of Rac1 in mice with melanocyte specific 
expression activated N-Ras transgene. This work led to the identification that 
Rac1 is required for activated N-Ras induced dermal melanocytes survival in 
vivo. In addition, melanoblast migration and proliferation in conditional Rac1 
knockout mouse embryos cannot be compensated by expression of activated 
N-Ras.  
 
5.2 Introduction 
By switches between inactive GDP- and active GTP-bound states, small 
GTPases function as critical relays in communicating signals from outside of 
the cell to the nucleus. Ras subfamily small GTPases is activated upon ligand 
engagement of membrane receptors and mediates cell growth, differentiation 
and survival (Downward, 2003). Such pleiotropic effects depend on the ability 
of Ras-GTP to activate multiple signaling pathways through direct binding to 
effector proteins. Mutations in the Ras proto-oncogene family (H-Ras, N-Ras 
and K-Ras) are amongst the most frequently mutated genes in human 
cancers, being found in 20% to 30% of all human tumours (Downward, 2003). 
The most common mutations are found at residue G12 in the phosphate-
binding loop and the catalytic residue Q61 (Malumbres and Barbacid, 2003). 
Constitutively Active N-RasQ61K are frequently found in nevi and early-stage 
melanomas (Platz et al., 2008). Expression of dominant-active human N-
RasQ61K to the melanocyte lineage by tyrosinase regulatory sequences in 
mice results hyperpigmented skin (Ackermann et al., 2005), which can 
develop cutaneous metastasizing melanoma on an INK4a-Deficient 
background at 6 months . 
Growing evidence have identified that the MAPK pathway as a key effector in 
Ras signaling (Cook and McCormick, 1994; Marshall, 1995). However, the 
recruitment of many other Ras targets is indispensable to elicit a full Ras 
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biological response. Among these Ras-dependent, Raf-independent pathways 
are those connecting Ras to the Rho family of small GTPases. In contrast to 
the relatively frequent incidence of activating mutations in Ras genes, there 
are no published reports of activating Rho mutations in human tumors. 
However, numerous lines of research indicate that Rho proteins do indeed 
contribute to cancer (Sahai and Marshall, 2002). 
 
Rac1 small Rho GTPase has been known for over 15 years to be essential for 
Ras-induced transformation, at least in vitro (Qiu et al., 1995b), but relatively 
little is known about its role in cancer in vivo.  Rac is essential for 
transformation in a K-RasG12D activated lung cancer model (Kissil et al., 
2007a). In addition, Samuel at al, showed that Rac1 is required for K-Ras G12D 
driven epithelial cell hyperproliferation and that Rac1 activity is elevated in 
tissues expressing mutant oncogenic K-Ras (Samuel et al., 2011). Rac is 
activated downstream of Ras and can activate 70 kDa ribosomal S6 kinase 
(Chou and Blenis, 1996) and JNK1, which for JNK1, possibly via Pak kinases 
to stimulate cell cycle progression (Olson et al., 1995).  
 
The aim of this Chapter was to identify of role of Rac1 downstream of active 
N-RasQ61K in melanocytes in vivo. I demonstrate here that Rac1 is required for 
activated N-Ras induced dermal melanocytes survival in vivo. Activated N-
Ras does not play a role within melanoblast migration and proliferation during 
embryogenesis.  
 
5.3 Results 
5.3.1 Activated N-Ras doesn’t compensate for loss of Rac1 in 
either melanoblast migration or proliferation 
I have demonstrated in the last Chapter that Rac1 loss in melanoblasts 
causes coat colour defects in mice, which is due to impaired migration and 
proliferation. It has been shown that expression of dominant-active human N-
RasQ61K under control of tyrosinase promoter in mice results in 
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hyperpigmented skin (Ackermann et al., 2005), which is due to 
hyperproliferation of melanocytes. To investigate whether hypopigmentation 
resulting from Rac1 knockout can be overcome by activated N-Ras 
expression, mice carrying a Tyr::N-RasQ61K transgene were crossed onto 
Rac1 f/f or Dct::LacZ background. Tyr::N-RasQ61K+/o control and Tyr::N-
RasQ61K+/o Rac1 f/f  Tyr::Cre+/o mice were born healthy at the expected 
Mendelian ratio. Consistent with the previous report (Ackermann et al., 2005), 
Tyr::N-RasQ61K+/o control mice have much darkened skin compared to wild-
type mice (Figure 5.1A, D). Histological analysis of P14 Tyr::N-RasQ61K+/o 
control ventral skin revealed presence of increased number of melanocytes 
not just in hair follicles but also the dermis below the epidermis and 
throughout the fatty tissue (Figure 5.2). Interestingly, Tyr::N-RasQ61K+/o Rac1 
f/f Tyr::Cre+/o mice revealed no effect on the pattern or colour of the areas of 
unpigmented skin (Figure 5.1A, B). This was further confirmed by the fact that 
the number of white patches on the dorsal skin between Dct::LacZ Tyr::N-
RasQ61K+/o Rac1 f/f Tyr::Cre+/o and Dct::LacZ Rac1 f/f Tyr::Cre+/o mice was 
similar (Figure 5.1C). Strikingly, despite the large increase in the numbers of 
melanocytes in skin in adult mice, quantification of number of melanoblasts in 
E15.5 embryos or P0.5 skin only showed a slight increase in the presence of 
activated N-Ras in a normal background (Figure 5.3 and 5.4), and a 
significant reduction in melanoblast number in Rac1 f/f Tyr::Cre+/o embryos 
regardless of the presence of activated N-Ras, indicating that activated N-Ras 
doesn’t likely confer a hyperproliferation of melanoblasts during 
embryogensis. Indeed, we found that the coat colour was indistinguishable 
between control and Tyr::N-RasQ61K+/o control mice just after birth (Figure 
5.5A), and coat colour in Tyr::N-RasQ61K+/o control mice become darker after 
day 3 (Figure 5.5B and C), suggesting that the melanocyte hyperproliferation 
phenotype in Tyr::N-RasQ61K+/o mice was developed after birth. 
In addition, we also noted that expression of activated N-Ras didn’t affect the 
morphology, motility, protrusion dynamics, epidermal/dermal localization and 
cytokinesis of either normal or Rac1 depleted melanoblasts detectably (Figure 
5.6, 5.7, 5.8, 5.9 and data not shown).  In summary, the cell cycle or motility  
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Figure 5.1 Expression of N-RasQ61K in the melanocyte lineage doesn’t 
rescue the loss of Rac1. (A) Coat-color of dorsal side (left) and ventral side 
(right) of P14 Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o (Rac1 f/f N-Ras) mouse 
with its Tyr::N-RasQ61K+/o (N-Ras) control littermate. Three typical white 
patches on the dorsal side of the Rac1 f/f N-Ras mouse were white arrows. (B) 
Coat-color of forelimb and tail of P14 Rac1 f/f N-Ras mouse with its Ctr N-Ras 
control littermate. (C) Quantification of number of white patches on dorsal surface 
for genotypes of number of mice as indicated. (D)Coat-color of dorsal side (left) 
and ventral side (right) of P14 Rac1 f/f Tyr::Cre+/o (Rac1 f/f) mouse with its 
control littermate. Typical white patches on the dorsal side of the Rac1 f/f mouse 
were white arrowed. 
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Ventral skin
Ctr N-Ras
Rac1 f/f N-Ras
Ventral skin
P14
Figure 5.2 Melanocytes were absent in ventral white patches of Tyr::N-
RasQ61K+/o Rac1 f/f Tyr::Cre+/o.  Immunohistochemical analysis of ventral 
skin from P14 Ctr N-Ras and Rac1 f/f N-Ras mice with anti-DCT to detect 
melanocytes. Example of typical pocket of excess dermal melanocytes in Ctr N-
Ras mouse is black arrowed. Scale bars 100µm.
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Figure 5.3 Expression of N-RasQ61K in the melanocyte lineage doesn’t rescue the 
effect of loss of Rac1 on melanoblast number and distribution. (A) Images of !-
galactosidase stained whole mount DCT::LacZ embryos: control,  Tyr::N-RasQ61K+/o control, 
Rac1 f/f Tyr::Cre+/o  and Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o  embryos at E15.5. Each 
image is representative of at least 5 embryos from four different litters. Insets show higher 
magnification of belly area and cell shpae. White dot lines in A indicate the trunk regions in 
which melanoblasts were quantified in box plot as shown in (B). (B) Number of melanoblasts 
in DCT::LacZ embryos including control, Tyr::N-RasQ61K+/o control, Rac1 f/f Tyr::Cre+/o and 
Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o at E15.5. At least 5 embryos from four different litters 
were examined. Lower quartile, median, and upper quartile are shown. **, P< 0.01 compared 
to control by t-test.  The scale bar is 1mm. 
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Figure 5.4 Expression of N-RasQ61K in the melanocyte lineage doesn’t rescue the 
effect of loss of Rac1 on melanocytes number in new born pups. (A)  Representative 
images of !-galactosidase stained skin samples taken from dorsal side of DCT::LacZ Tyr::N-
RasQ61K+/o control (left) and DCT::LacZ Tyr::N-RasQ61K+/o Rac1 f/f  Tyr::Cre+/o (right) 
newborn pups at P0.5. Representative images of threshold area covered by melanocytes 
(white squared). (H) Relative area covered by melanocytes per image for DCT::LacZ control, 
DCT::LacZ Tyr::N-RasQ61K+/o control, DCT::LacZ Rac1 f/f Tyr::Cre+/o and DCT::LacZ Tyr::N-
RasQ61K+/o Rac1 f/f Tyr::Cre+/o. Data derived from five images per skin sample from at least 
3 pups from three different litters. Lower quartile, median, and upper quartile are shown. **, P< 
0.01 by t-test. The scale bar is 100µm. 
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Figure 5.5 Expression of Tyr::N-RasQ61K in mice induce skin hyperproliferation after 
birth.   Representative images of dorsal skin colour of control and Tyr::N-RasQ61K+/o control 
mice on P0.5 (A) and P3 (B). (C) Representative images of dorsal skin of control and Tyr::N-
RasQ61K+/o control, Rac1 f/f Tyr::Cre+/o and  Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o mice 
on P7. 
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defects caused by loss of Rac1 are not compensated for by activated N-Ras 
and N-Ras hyperactivation in a normal or Rac-depleted background has no 
detectable effect on melanoblast motility during embryogenesis. 
 
5.3.2 Rac1 is required for activated N-Ras induced 
hyperproliferation of epidermal/dermal melanocytes in vivo 
I have demonstrated within this chapter that expression of activated N-Ras 
does not play a role within melanoblast migration and proliferation during 
embryogenesis and Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o mice revealed no 
rescue on hypopigmentation. However, careful inspection of pigmented area 
of P14 Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o mice revealed that the coat colour 
were lighter than Tyr::N-RasQ61K+/o control mice (Figure 5.1), indicating a 
possible growth defect of melanocytes. Histological analysis of distribution of 
melanocytes using pigmented dorsal skin from Tyr::N-RasQ61K+/o Rac1 f/f 
Tyr::Cre+/o showed excess melanocytes in hair follicle (Figure 5.10B), which 
also found in Tyr::N-RasQ61K+/o control mice (Figure 5.10A). However, In 
Tyr::N-RasQ61K+/o control mice, melanocytes accumulated in epidermis/dermis 
and throughout the fatty tissue (Figure 5.10A). Interestingly, We did not see 
any melanocytes in the dermis in skin taken from Tyr::N-RasQ61K+/o Rac1 f/f 
Tyr::Cre+/o mice (Figure 5.10B). Together, these data indicate that Rac1 is 
required for Tyr::N-RasQ61K+/o induced epidermal/dermal localization of 
melanocytes. 
 
5.3.3 Expression of N-RasQ61K promotes survival of 
epidermal/dermal melanocytes via Rac1  
I have demonstrated that the melanocyte distribution in dermis/epidermis was 
not affected by expression active N-RasQ61K during embryogenesis, therefore 
the appearance of epidermal/dermal melanocytes in active N-RasQ61K control 
mice could either be due to better survival of residual epidermal melanocytes 
after birth, or migration of melanocytes from hair follicle to dermis during hair  
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Figure 5.6. Expression of N-RasQ61K did not rescue protrusion defects 
caused by deletion of Rac1. (A) Combined Z-stack images (1µm depth) of 
melanoblasts in skin explants from Z/EG+/o Tyr::N-RasQ61K+/o Tyr::Cre+/o 
control and Z/EG+/o Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o embryos. Long 
protrusions and short protrusions are white and yellow arrowed respectively. 
(B) Number of long/short protrusions per melanoblast n>60 cells per explant 
>= 3 explants per genotype. (C) Proportion of melanoblasts with long/short 
protrusions. Error bars indicate Mean ± SEM. **, P< 0.01, by t-test. Scale bar 
is 10µm.
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Figure 5.7. Expression of N-RasQ61K did not rescue migration defects 
caused by deletion of Rac1. (A) 3 hr tracks of individual melanoblast migration in 
skin explants, black tracks indicated migrated faster than average control, red 
indicates slower. (B) Migration speed. >300 melanoblasts from three explants were 
randomly selected. Error bars indicate Mean ± SEM. **, P< 0.01, by t-test. 
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Figure 5.8. Expression of N-RasQ61K did not rescue lifetime and frequency of 
protrusion defects caused by deletion of Rac1.(A) Live cell imaging of protrusion 
dynamics in explants. Images captured every 5 min, yellow arrows - protrusions. (B) 
Frequency of protrusion formation. (C) Lifetime of actively growing protrusions formed 
in 20 cells per explant from >= 3 explants. Error bars indicate Mean ± SEM. **, P< 
0.01, by t-test. Scale bar is 10µm.
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Figure 5.9 Expression of N-RasQ61K in the melanocyte does not affect 
melanoblast migration from dermis to epidermis. (A) Images show the 
localization of melanoblasts in E15.5 DCT::LacZ  Tyr::N-RasQ61K control and Tyr::N-
RasQ61KRac1 f/f Tyr::Cre+/o embryos. (B) Quantification of localization of 
melanoblast in E15.5 DCT::LacZ  control, Tyr::N-RasQ61K control, Rac1 f/f Tyr::Cre
+/o and Tyr::N-RasQ61KRac1 f/f Tyr::Cre+/o embryos. More then 200 cells were 
examined per embryo from at least three embryos for each genotype. Melanoblasts 
are black arrowed. Black dot lines in each picture represent the epi/dermal junction. 
Scale bar is 20µm. 
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Figure 5.10 Rac1 is required for  N-RasQ61K induced survival of dermal 
melanocytes in mice. Immunohistochemical analysis of dorsal skin from P14 
Tyr::N-RasQ61K control (A) and Tyr::N-RasQ61KRac1 f/f Tyr::Cre+/o (B) mice 
with anti-DCT to detect melanocytes. High magnification images of hair follicle 
and  dermis were shown Example of typical pocket of excess dermal 
melanocytes in Ctr N-Ras mouse is black arrowed. Scale bars 100µm.
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follicle morphogensis. In order to study how active N-RasQ61K induces 
melanocyte localization in dermis and how Rac1 deletion affects this, the first 
hair follicle cycle was tracked by taking dorsal skin from control, Tyr::N-
RasQ61K+/o control and Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o mice at day 0.5, 3, 
5, 14, and 21. The skin were then sectioned and stained with DCT antibody to 
analyse the distribution of melanocytes (Figure 5.11 and 5.12). In both control 
and Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o mice, melanocytes in the epidermis 
gradually disappeared from day 0.5 to day 3 (Figure 5.11A and 5.12). 
However, in Tyr::N-RasQ61K+/o control mice, melanocytes in epidermis survived 
from day 0.5 and number of melanocytes in epidermis increased as the 
mouse getting older (5.11B), indicating that expression of N-RasQ61K promotes 
melanocyte survival in epidermis/dermis and Rac1 is required for this. 
Although Rac1 is required for N-RasQ61K promoted melanocyte survival in the 
epidermis/dermis, melanocytes hyperproliferation during anagen phase was 
found in the hair follicle of both Tyr::N-RasQ61K+/o control mice and Tyr::N-
RasQ61K+/o Rac1 f/f Tyr::Cre+/o mice. This suggest that expression of Tyr::N-
RasQ61K+/o promotes melanocyte proliferation in hair follicles and Rac1 has a 
very little role during this process.  
It has been shown that the transition from anagen to telogen is an apoptosis- 
driven process that leads to shortening of the hair follicle length by about 70% 
due to the well-coordinated apoptotic death of the vast majority of follicular 
keratinocytes, and during this process, most of the follicular melancytes 
undergo apoptosis (Sharov et al., 2005). Consistent with this, we found that in 
the telogen phase of the first hair follicle cycle (day 21), only the permanent 
part of the hair follicles remained in dorsal skin taken from control mice 
(Figure 5.11A). Although, the lower part of hair follicles in Tyr::N-RasQ61K+/o 
control mouse have already degenerated, most of follicular melanocytes can 
still be found in the place corresponding to earlier hair bulbs, together with 
continuous accumulation of melanocytes in epidermis/dermis (Figure 5.11B). 
Interestingly, these follicular melanocytes can no longer be maintained if Rac1 
is deleted (Figure 5.12). Together, these data suggest that active N-Ras  
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Figure 5.11. Expression of N-RasQ61K promote survival of dermal melanocytes 
in mice. Immunohistochemical analysis of dorsal skin from Ctr (A) and Ctr N-Ras (B)  
mice at P0.5, P3, P5, P14 and p21 with anti-DCT to detect melanocytes. Example of 
dermal melanocytes are black arrowed. Scale bars 100µm.
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Figure 5.12. Deletion of Rac in meanocytes results gradually loss of 
dermal melanocytes in  N-RasQ61K background. Immunohistochemical 
analysis of dorsal skin from Ctr and Ctr N-Ras  mice at P0.5, P3, P5, P14 and 
p21 with anti-DCT to detect melanocytes. Example of dermal melanocytes are 
black arrowed. Scale bars 100µm.
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protects follicular melanocytes from undergoing apoptosis during hair follicle 
degeneration, which is dependent on Rac1. 
 
5.4 Discussion 
5.4.1 Activated N-Ras doesn’t compensate for loss of Rac1 in 
either migration or proliferation during embryogenesis 
Since around 20% of human melanomas acquire N-RasQ61K, we wondered 
whether expression of activated N-Ras would compensate for loss of Rac1 for 
growth, motility defects.  Knockdown of Rac1 in melanoma cells caused a 
block in NFkB activity that resulted in defective proliferation in vitro and in 
tumour xenografts (Bauer et al., 2007), suggesting that Rac1 might be 
important downstream of Ras in tumorigenesis.  Additionally, in a K-Ras 
induced lung cancer model, loss of Rac1 prevented tumor formation (Kissil et 
al., 2007), indicating also the importance of Rac in mediating the downstream 
effects of Ras on proliferation.  We were surprised that expression of 
activated N-Ras in melanoblasts didn’t increase the number of melanoblasts 
and motility parameters during embryogenesis, indicating that these pathways 
are already running at a high level during embryogensis and Ras is likely 
already active during embryogenesis, so adding more active Ras doesn’t 
greatly change proliferation rates.  
 
5.4.2 Rac1 is required for activated N-Ras induced survival of 
dermal melanocytes 
Animals expressing activated N-Ras under control of tyrosinase promoter 
accumulate more melanocytes in their dermis and in the hair follicles than 
normal mice. Interestingly, Rac1 deletion in melanocytes results in loss of 
dermal melanocytes in a similar fashion as normal mice, suggesting that Rac1 
plays a very important role downstream of N-Ras in regulating melanocyte 
survival. However, it is still unclear how the epidermal/dermal melanocytes 
disappeared from skin during the first a few days after the mouse was born, 
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as we failed to detect any apoptotic melanocyte in dermis with cleaved 
caspase-3 antibody in both P0.5 and P3 skin sections (data not shown). It 
could be possible that the removal of epidermal/dermal melanocytes is due to 
infiltration of macrophages.  
Kit signaling via KitL is known to trigger proliferation and survival via activation 
of Ras via MAPK/ERK signaling (Mackenzie et al., 1997) and PI3 kinase 
signaling. It has also been shown that KitL accumulated in the hair bulbs of 
anagen hair follicles with very little or no expression in the epidermis (Peters 
et al., 2003). This may explain why in normal mice, melanocytes cannot 
survive in the epidermis, which is probably due to the low concentration of 
KitL in epidermis. However, expression of activated N-RasQ61K in the 
melanocyte may overcome the requirement of KitL, thus promote melanocyte 
survival and proliferation by activating the downstream targets in a Kit 
independent manner, which is dependent on Rac1 (Figure 5.13 and 5.14). It 
will be of interest to see if the Rac1 function can be compensated by ectopic 
expression of KitL in epidermis (Kunisada et al., 1998).  
Similar to Tyr::N-RasQ61K control mice, we observed more melanocyte 
accumulation in hair bulbs during anagen in Tyr::N-RasQ61K+/o Rac1 f/f 
Tyr::Cre+/o mice. We think this is probably due to the fact that the transgenic 
mouse line we used has both ectopic expression of N-RasQ61K and 
endogenous expression of wildtype N-Ras. Therefore, in the presence of KitL 
in hair bulbs, the endogenous N-Ras and activated N-RasQ61K may work 
synergistically to promote the proliferation and survival of melanocytes (Figure 
5.13 and 5.14). Rac1 deletion does seem to affect melanocytes in the hair 
bulbs, although it is unclear whether Rac1 is required for melanocyte 
proliferation in hair bulbs as it is impossible to determine the number of 
melanocytes in each hair bulb by skin sections. However, during the telogen 
of hair cycle, KitL concentration dropped and hair bulb degenerated (Peters et 
al., 2002; Sharov et al., 2005), which leads to turning off endogenous N-Ras 
pathway in melanocytes. Therefore, hair follicle melanocyte in Tyr::N-RasQ61K 
control mice would survived as they do in dermis and deletion of Rac1 in 
these hair follicle melanocyte may disrupt activated N-RasQ61K induced  
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Figure 5.13. A predicted model for how Tyr::N-RasQ61K induces melanocyte survival in the 
Kit independent pathway. Left: Expression of KitL is concentrated in hair bulbs during anagen of 
hair cycle, which activate endogenous N-Ras signling pathway via Kit receptor.  expression of 
activated N-RasQ61K work synergistically with endogenous N-Ras to promoter melanocyte 
hyperporliferation. Right: In epidermis/dermis or telogen of hair cycle,  expression of KitL is very low 
or absent. The endogenous Kit pathway is off. The melanocytes are protected by expression of 
atcive N-RasQ61K.
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Figure 5.14. A predicted model for how Rac1 affects Tyr::N-RasQ61K induced melanocyte 
survival. Left: Expression of KitL is concentrated in hair bulbs during anagen of hair cycle, which 
activate endogenous N-Ras signling pathway via Kit receptor.  Expression of activated N-RasQ61K 
work synergistically with endogenous N-Ras to promoter melanocyte hyperporliferation. Rac1 is 
dispensable for this process probably because another survival pathway can be activated by Kit 
signaling thus bypass the requirement for Rac1.  Right: In epidermis/dermis or telogen of hair 
cycle,  expression of KitL is very low or absent. The endogenous Kit pathway is off. The 
melanocytes are protected only by atcive N-RasQ61K induced survival pathway, which is probably 
through Rac1. Thus, deletion of Rac1 cause loss of melanocyte in dermis. 
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survival pathway, thus result loss of melanocytes in a similar fashion as 
wildtype mice (Figure 5.13 and 5.14).  
In conclusion, Rac1 is important downstream target of activated N-RasQ61K for 
melanocyte survival in skin, but that N-Ras doesn’t contribute detectably to 
migration or cytokinesis independently of Rac1 during embrogensis. 
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Chapter VI 
Summary and future directions 
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6.1 Summary 
One of the key aims of this thesis was to investigate the potential molecular 
mechanism for how fascin increases the invasiveness of cancer cells, which is 
mainly described in Chapter 3.  
In order to address this question, I used immunofluorescence or expression of 
GFP-tagged fasicn to show for the first time that fascin is an integral 
component of invadopodia in multiple cancer cell types.  
In addition, I have used siRNA or shRNA to successfully knockdown fascin in 
several different cancer cell lines. Consistent with previous studies, I showed 
that fascin is required for filopodia formation. Remarkably, I demonstrated that 
fascin is also required for the assembly of the actin cytoskeleton in 
invadopodia as well as for the degradation of matrix on different types of 
matrix.    
I also confirmed the effect of phosphorylation of fascin S39 on filopodia 
formation and further demonstrated that phosphorylation of fascin at S39 also 
contributes to regulation at invadopodia.  
Furthermore, I observed invadopodia similar to a comet-like organization 
resembling bacteria-propelling actin tails. I used immunofluorescence and 3D 
reconstruction to show that Arp2/3 complex, cortactin, and fascin localized 
throughout comet heads and tails, whereas N-WASP concentrated mostly in 
the head. In addition to these, I also found several other filopodia proteins 
(IRSP53, IRTKS and mDia2) at invadopodia. This implies the first time that 
invadopodia might be a hybrid structure containing both actin branches and 
bundles. 
Next, I demonstrated that fascin is a very stable component of invadopodia 
and its presence enhance the stability of actin structures at invadopodia both 
in molecular level using FRAP or in cell level using live time imaging.  
Finally, I implicate the important role of fascin in invasive migration into 
collagen I-Matrigel gels and 3D collagen degradation particularly in cell types 
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that use a degradation dependent, elongated mesenchymal type of motility 
(Figure 6.1). I demonstrated that fascin but not N-WASP or MT1-MMP is 
required for formation filopod-like protrusions in 3D. However, knockdown N-
WASP or MT1-MMP which is required for invaopodia formation significantly 
reduce cell invasion and collagen degradation in 3D but not filopod-like 
protrusions, which implicate existence of two types of protrusion in 3D: the 
stable actin-based proteolytic structures similar to invadopodia in 2D and 
filopod-like protrusions. Therefore I have elucidated for the first time that 
fascin promotes long protrusions in 3D and stabilizes actin in invadopodia and 
that this enhanced stability allows for more efficient invasion by mesenchymal 
cells, both in 2D and in 3D.  
Secondly, another aim of this thesis was to examine the role of Rac1 in 
melanoblast migration during mouse embryogenesis, which is mainly 
described in Chapter 4.  
To assess the functions of Rac1 in the melanocyte lineage in vivo, I generated 
conditional Rac1 knockout mice by crossed mice carrying a floxed allele of 
Rac1 with mice expressing Cre recombinase under control of the tyrosinase 
promoter. I showed in the first time that Rac1 is required for normal 
pigmentation and melanocyte distribution in mice. Which is due to both 
migration and proliferation defect during embryogensis.  In order to study the 
function of Rac1 in melanoblast migration in real time. I crossed mice carrying 
a Z/EG or GFP-Lifeact flox transgene onto the Tyr::Cre Rac1 f/f background. I 
showed that melanoblasts extend long dynamic pseudopodia containing both 
actin and microtubules and they squeeze between epidermal keratinocytes. In 
addition, I demonstrated that Rac1 is required for the formation of long 
pseudopodia in melanoblast, which also dependent on microtubules and 
Arp2/3 complex driven actin assembly.  
In addition, I demonstrated here that Rac1 is not essential for melanoblast 
migration, which is different to previously published model with cells undergo 
collective migration (Murphy and Montell, 1996; Migeotte et al., 2010).	  
I also implicated that melanoblasts can initiate short  
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a common pathway. Further characteriza-
tion of cytoskeletal changes accompanying 
upregulation of fascin at tumor invasion 
fronts will be informative. It is tempting 
to speculate that fascin may have other 
key cellular roles besides organising actin 
bundles. While fascin is becoming estab-
lished as a marker for tumor progression, 
its role in promoting cancer aggressiveness 
is much less well established or understood. 
Further testing of fascin’s role in invasion 
and metastasis in vivo in physiologically 
relevant models for cancer metastasis are 
needed to determine how active a role fascin 
plays in cancer aggressiveness and whether 
it is a potential clinical target.
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It is becoming clear that upregulation of 
fascin expression confers both normal 
and cancerous cells with increased motile 
properties and the ability to assemble spiky 
actin-based protrusions that aid in invasion 
and cell motility. Many questions remain as 
to why fascin appears to be relatively unique 
among the actin bundling proteins as hav-
ing an important role in cancer invasive-
ness. It is likely that other actin modulating 
proteins work together with fascin to allow 
cells to increase their motility and change 
their morphology when they undergo epi-
thelial to mesenchymal transition (for can-
cer) or when dendritic cells mature. Some 
studies have suggested that cortactin may 
cooperate with fascin to promote cancer 
aggressiveness,1,22,30-33 but this may just be 
a coincident increase in expression and co-
localization in similar cytoskeletal struc-
tures, rather than a direct cooperation in 
low expression of Ki-67, a marker for pro-
liferation.25,26 Hashimoto et al. pointed 
out that this may indicate fascin expres-
sion selectively in highly metastatic but 
non-proliferative cells, an idea that war-
rants further investigation.
In some cases, high fascin expression 
has been correlated with low E-cadherin 
(epithelial cadherin) expression, indi-
cating that as cells progress through the 
epithelial to mesenchymal transition 
(EMT), they gain fascin whilst losing 
E-cadherin.27,28 There is evidence that fas-
cin expression is regulated by the wnt acti-
vated LEF-TCF transcriptional signalling 
pathway that promotes EMT.11 However, 
fascin expression is also regulated by 
cyclic-AMP response element binding 
protein (CREB) and the aryl hydrocarbon 
receptor (AhR).29 How these two systems 
work together to regulate fascin expres-
sion in tissues and in cancer remains to be 
studied further.
Figure 2. A model showing fascin stabilizing actin bundles in an invasive cell migrating in the 3D 
environment of the tumor stroma. Sites of matrix remodeling can occur at protrusions or at other 
sites along the periphery of the cell, wherever the extracellular matrix (ECM) impedes cell migra-
tion and thus needs to be degraded for the cell to pass through. CHL-1 melanoma cells made both 
actin-rich spots and long thin !lopod-like protrusions in matrigel-collagen gels. We have drawn 
fascin-actin bundles here close to the plasma membrane, but it is possible that they could form 
a core inside of the branched actin networks rather than or additional to a shell around them. 
Arp2/3 complex and cortactin contribute to formation of branched actin networks and may also 
assist in membrane tra"cking to and from sites of ECM remodeling. Integrins allow the cell to 
grab and pull against the ECM to aid migration.
Figure 6.1. Model of fascin stabilizing actin bundles in an invasive cell migrating in the 3D 
environment f the tumor stroma. Sites of matrix remodeli g can occur at protrusions or at other 
sites along the periphery of the cell, wherever the extracellular matrix (ECM) impedes cell migra- 
tion and thus needs to be degraded for the cell to pass through. CHL-1 melanoma cells made both 
actin-rich spots and long thin filopod-like protrusions in matrigel-collagen gels. We have drawn 
fascin-actin bundles here close to the plasma membrane, but it is possible that they could form
a core inside of the branched actin networks rather than or additional to a shell around them. arp2/3 
complex and cortactin contribute to formation of branched actin networks and may also assist in 
membrane trafficking to and from sites of ECM remodeling. Integrins allow the cell to grab and pull 
against the ECM to aid migration.
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actin-based protrusions independently of Rac1, Arp2/3 complex or myosin, 
suggest a novel form of actin dynamics, which drive melanoblast migration in 
a Rac1 independent manner in vivo.  
Furthermore, I demonstrated that Rac1 is not absolutely required for long 
protrusion formation or polarized motility when myosin activity is suppressed. 
However, Rac1 controls the rate of protrusion initiation and the balance 
between myosin-based retraction and Rac-based pseudopod initiation 
governs translocation (Figure 6.2).  
I further suggest that melanoblast migration across basement membrane from 
dermis to epidermis is not an invasive process. I demonstrated here that 
deletion of either Rac1 or N-WASP had no effect on melanoblast 
dermis/epidermis distribution, although both Rac1 and N-WASP play an 
important role formation of invadopodia and cell invasion.  
Moreover, I investigated melanoblast growth defect both in vivo. I have shown 
that growth defect in Rac1 depleted melanoblast mainly due to defect in Brdu 
incorporation and proliferation, but not cell cycle exit or apoptosis. I also 
confirm this in vitro, and further suggested that the growth defect is mainly 
due defect in G1 to S phase transition.  
Unexpectedly, I found that Rac1 depleted melanoblast undergo cytokinesis 
almost 3 fold slower then control melanoblast. However, in vitro, I did not 
notice any defects on Rac1 depleted melanocyte undergo cytokinesis, 
implicated a special requirements for Rac in cytokinesis in vivo than in culture 
dishes.  
Overall my results here revealed a novel mode of in vivo migration controlled 
by Rac1 that is important for normal development and likely in melanoma. 
Lastly, in Chapter 5 I investigated the role of Rac1 downstream of active N-
RasQ61K in melanoblast during embryogenesis and melanocytes proliferation 
in adult mice. I have shown that active N-RasQ61K did not contribute 
significantly to melanoblast migration and proliferation during embryogenesis.  
	   231	  
  
Rac
Myosin
Wildtype
Rac
Myosin
Rac1 f/f
Rac
Myosin
Rac1 f/f +
Myosin Inhibitor
Long Protrusions
Actin 
Microtubule
Arp2/3 
Rac
Not Myosin 
Pak
ERK
LIM Kinase
N-WASP 
MMPs
Short Protrusions
Actin
Not Microtubule
Arp2/3 
Myosin 
Pak
ERK
LIM Kinase
N-WASP 
MMPs
Rac indepednet 
Long Protrusions
Actin
Myosin Myosin
D
ire
ct
io
n 
of
 m
ig
ra
tio
n
?
Figure 6.2. Model of melanoblast motility in epidermis. 
In wild type melanoblasts, Rac1 positively regulates the frequency of initiation of long pseudopods, 
which promote migration speed and allow cells to change their direction of migration. Scar/WAVE 
and Arp2/3 complex drive actin assembly for long pseudopod extension, which also depends on 
microtubule dynamics. Myosin contractility balances the extension of long pseudopods by effecting 
retraction and allowing force generation for movement through the complex 3D epidermal 
environment. In absence of Rac1, melanoblasts mainly use short stubs for migration. the short 
stubs are distinct from blebs and are driven by actin assembly, but are independent of Rac1, Arp2/3 
complex, myosin or microtubules. when myosin was inhibited in absence of Rac1, Rac1 was no 
longer required for long pseudopod generation; but it still strongly controlled the frequency of 
generation of long pseudopods.
?
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I also demonstrate here that Rac1 is required for activated N-Ras Q61K induced 
dermal melanocytes survival in vivo, which implicated Rac1 as an important 
target downstream of activated N-RasQ61K. 
 
6.2 Future directions 
6.2.1 Function of fascin in pancreatic cancer formation and 
metastasis 
Although the work present here clearly demonstrates that fascin is important 
for cancer cell invasion in vitro, it is still unclear whether fascin is required for 
tumour invasion and metastasis in vivo, and if it is, which stage of the 
metastasis is specially fascin dependent.  
Pancreatic cancer is malignant neoplasm of the pancreas. The prognosis is 
relatively poor; the three-year survival rate is now about thirty percent, but 
less than 5 percent of those diagnosed are still alive five years after diagnosis 
and complete remission is still rather rare (Ghaneh et al., 2007). Pancreatic 
cancer is sometimes called a "silent killer" because early pancreatic cancer 
often does not cause symptoms and because of late diagnosis and frequent 
invading local structures or metastasizing makes the pancreatic cancer very 
difficult to be cured by surgery. Therefore, preventing pancreatic cancer 
metastasis is very important to improve the treatment and survival rate. 
Fascin is upregulated in different types of invasive cancer, and its expression 
level often correlates with patient survival rate (Machesky and Li, 2010). My 
preliminary data using human pancreatic PDAC TMA revealed a strong 
correlation of high expression of fascin with poor survival (Figure 6.3), high 
tumour grade and high vascular invasion (Data not shown).  
It has been shown that LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre 
transgenic mice model frequently develop metastatic pancreatic tumors (jen 
PNAS). I noticed that in this model, fascin is not expressed in normal  
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Figure 6.3. Fascin expression in human PDAC.
 IHC analysis of tumour assay in human PDAC. representative images 
are shown for normal duct, PDAC with no, low, moderate and high 
staining (B) Kaplan&endashMeier analyses showing cases with high 
Fascin expression (n = 63) have poorer outcomes compared to those 
with low expression (n = 59; P < 0.003) Histoscore Median=74
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pancreas (Figure. 6.4A) and PanINs (Figure 6.4B), but upregulated in both 
primary PDAC invasive front and metastatic PDAC to the liver (Figure 6.4C-
H). Recently, fascin knockout mice have been generated, which develop 
normally with minor defect in neural development (Yamakita et al., 2009). 
It would be interesting to see whether fascin is important for pancreatic cancer 
formation and metastasis in vivo by crossing the LSL-KrasG12D/+;LSL-
Trp53R172H/+;Pdx-1-Cre transgenic mice into fascin null background. A 
recent paper showed that macroketone, the synthetic homologue of 
migrastatin can stop cancer cell becoming localized to lung in tail vein 
injection xenografts (Chen et al., 2010). Thus it will be interesting to see if 
macroketone can stop metastasis in this transgenic mice model. 
In addition, fascin null PDAC cell lines derived from such genetically 
engineered mouse model could be used to significantly strengthen the role of 
fascin in tumour invasion. For example, typical invasion assay (without 
helping by fibroblast for invasion) (Li et al., 2010), organotypic assay (with 
help by fibroblast for invasion) (Gaggioli et al., 2007) with fascin null PDAC 
cell lines can be compared with wildtype, phospho-mimic and dephospho-
mimic fascin rescued cell line to see if putting fascin back can promote 
invasion and if actin bundling activity of fascin is critical for this.  
 
Furthermore, in vivo metastasis experiment by tail vein or intraspleen injection 
of cells into nude mice can be used to compare the metastatic ability of those 
cell line to localize to the lung or liver. Subcutaneous injection can be used to 
determine whether fascin also promote cancer cell growth and if this is 
dependent on actin bundling activity of fascin. 
 
6.2.2 Function of Rac1 in melanoma progression and 
metastasis 
 
Previous study showed that Tyr::N- RasQ61K+/o INK4a-/- transgenic mice 
develop metastatic melanoma at about 6 months (Figure 6.5) (Ackermann et  
	   235	  
 
  
Normal duct Anti-Fascin
Anti-Fascin
PDAC H&E Anti-Fascin
A
C D
E F
G H
Figure 6.4. Fascin is upregulated in invasive front and metastasis in mouse PDAC 
All sections from LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre pancreatic cancer 
mouse model. Fascin is not expressed in (A) normal duct and (B) PanIN 1a.  In PDAC, 
fascin expression is strongly upregulated at invasive front (D and F) compared to centre 
of the tumour (D and E). The centre (E) and invasive front (F) of the tumour are 
enlarged. fascin upregulation also found in liver metastasis (G and H). Sections stained 
with H&E  and fascin antibody as indicated.  
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Figure 6.5.Tyr::N- RasQ61K+/o INK4a-/- transgenic mice frequently develop 
metastatic melanoma. 
Primary melanoma formed near mouth (A) and on the back (B) of the mouse. Lung 
metastasis (C) and brain metastasis (D) were detected frequently in these mice. 
melanoma cells are black arrowed.   
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Lung Meta Brain Meta
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al., 2005). In addition, Rac1 is required for initiation of lung cancer formation 
in a K-RasG12D activated lung cancer model (Kissil et al., 2007). However, 
whether Rac1 is required for cancer metastasis is still unknown.  We would 
like to first confirm whether Rac1 would affect melanoma formation in our 
melanoma model, Two cohorts can be compared on melanoma formation:  
Tyr::N- RasQ61K+/o INK4a-/- Tyr::CreER+/o Rac1 f/f and Tyr::N- RasQ61K+/o 
INK4a-/- Tyr::CreERo/o Rac1 f/f treated with tamoxifen. In addition, we would 
like to further address whether Rac1 is required for melanoma progression 
and metastasis in vivo. In this case, tomoxifen or vehicle will be applied to 
Tyr::N- RasQ61K+/o INK4a-/- Tyr::CreER+/o Rac1 f/f mice when melanoma is 
formed. Furthermore, in vitro or in vivo invasion and metastasis experiments 
(as discuss above) using melanoma cells derived from these tumours will be 
used to further confirm the role of Rac1 in tumour progression and metastasis.   
 
6.3 Conclusion 
The work presented here has further characterized the regulation of actin 
bundling protein fascin and has identified novel functional roles for this protein 
in regulation of invadopodia stability and matrix degradation during cancer cell 
invasion. Furthermore, this study has revealed a novel mode of in vivo 
migration by mouse melanoblast during embryogenesis, and identified a novel 
role of Rac1 as regulator of dynamics of protrusions that is important for 
normal melanoblast migration. Moreover, this study also shed some light on a 
novel mode of actin dynamics that drive melanoblast migration independent of 
Rac1 and implicated that melanoblast migration through basement membrane 
is not invasive. Finally, I provided evidence to show that Rac1 is important for 
melanoblast proliferation and cytokinesis, and Rac1 play a role in 
constitutively active N-RasQ61K induced melanocyte hyperproliferation in mice, 
which together suggested a important role of Rac1 in normal development 
and likely in melanoma. Together, these results add to the convincing body of 
evidence implying a significant role for Fascin and Rac1 in the regulation of 
cell morphology, motility and tumour cell invasion, embryogensis and 
tumourigenesis.  
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Appendix 
 
Movie 1. Part 1 (Frame 1 to 45): Time-lapse confocal images of A375MM 
cells expressing GFP-actin show actin comets in invadopodia. Images were 
acquired every 4 sec. Elapsed time is indicated. Part 2 (Frame 46 to 95): 
Time-lapse confocal images of A375MM cells expressing GFP-fascin show 
localization throughout the entire actin comets at sites of gelatin degradation. 
Images were acquired every 0.428 sec. Elapsed time is indicated. Part 3 
(Frame 96 to 199): 3D reconstruction of immunofluorescence of actin comets 
stained with anti-actin (red) and anti-fascin (green) antibody, which shows 
fascin localized throughout the actin comets. Part 4 (Frame 200 to 249): Time-
lapse confocal images of A375MM cells expressing GFP-N-WASP and RFP-
actin show N-WASP concentrated only at the head of the actin comet. Images 
were acquired every 10 sec. Elapsed time is indicated. Part 5 (Frame 250 to 
354): 3D reconstruction of actin comets of invadopodia in A375MM cells 
expressing GFP-N-WASP (green) and stained with rhodamine phalloidin 
(red), which showed GFP-N-WASP localized only at the head of the comets.  
 
Movie 2. Left: Photo-bleaching of GFP-fascin at invadopodia. Images were 
acquired every 0.428 seconds. Elapsed time is indicated. Right: Photo-
bleaching of GFP-actin at invadopodia. Images were acquired every 4.28 sec. 
Elapsed time is indicated. 
 
Movie 3. Control (Top) or Fascin (Bottom) siRNA-treated A375MM cells 
stably expressing RFP-Lifeact cultured on gelatin matrix onvernight in 
presence of 5µM GM6001. The timelapse was started within 1 hour after 
medium was replaced to remve GM6001. Formation of invadopodia, in which 
most of invadopodia had a lifetime exceeding 10 h. Images were acquired 
every 5 min. Elapsed time is indicated. Gelatin is shown to indicate 
degradation. 
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Movie 4. Time-lapse confocal images of NT, Fascin siRNA or 5µM GM6001-
treated CHL-1 cells stably expressing GFP-Lifeact invading into collagen I-
matrigel matrix displayed numerous filopodia-like protrusions. Images were 
acquired every 10 min. At each time point, a Z-stack images were taken with 
0.5 µm Z-spacing and showed as a combined Z-stack. Elapsed time is also 
indicated. 
Movie 5. Melanoblasts show long protrusions in E15.5 epidermis explants 
and 3D reconstruction of melanoblasts in control and Rac1 knockout explants. 
This movie shows the motility of melanoblasts in epidermal explants as well 
as a confocal z-stack through the epidermis showing melanoblast shape and 
position. 
 
Movie 6. Melanoblasts in Rac1 depleted explants migrate slower and are 
more rounded than controls. This Movie shows a 3D reconstruction of the 
melanoblasts in the skin to demonstrate the shape differences between wt 
and Rac1 KO.  
 
Movie 7. Melanoblasts migrating in epidermis show bright flashes of F-actin 
near the tips of protrusions, which are distinct from blebs. This movieshows 
Lifeact expressing melanoblasts migrating in skin explants.  
 
Movie 8. Inhibtion of actin, tubulin or Arp2/3 complex, ablates long cellular 
protrusion formation of melanoblast in skin explants. This movie shows the 
cell motility data for Chapter 4, where we have shown quantification and still 
photos. 
 
Movie 9. Deletion of Rac1, Arp2/3 or WAVE complex in primary mouse 
melanocytes reduces the formation of long protrusions. This movie shows the 
motility data for cells depleted of Rac1 or components of the WAVE complex 
in vitro. 
 
Movie 10. Rac1 is required for lamellipodia formation and cell migration of 
melanocytes on fibronectin coated 2D surfaces. This movie shows the 
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dynamics of melanocytes depleted of Rac1.  
 
Movie 11. Deletion of Rac1 in melanoblasts delays cytokinesis in skin 
explants but not in culture dishes. This movie shows that Rac1 deleted cells 
have delayed cytoskinesis in skin explants but not in a culture dish. 
 
